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COMMISSION  OF  THE  EUROPEAN  COMMUNITIES 
COM(93)  351  final  - SYN  465 
Brussels,  27  July  1993 
Proposal  for  a 
COUNCIL  DIRECTIVE 
09ncernlng  the placing of  biocidal  products 
on  the market 
{presented  by  the  Commission) - _  _,Ao--
EXPLANATORY  MEMORANDUM 
:'· 
I NIBODUCT I  ON  . 
Biocidal  products  comprise  a  wide  range  of  products  necessary  for  the 
control  of  organisms  that  are  harmful  to human  or  animal  health or  that 
cause  damage  to  natural  or .manufactured  products.  They·  Include ·such 
diverse  groups  of  products  as  wood  preservatives,  Insecticides,  water 
blocldes and  disinfectants. 
During  the  discussions  of  Directive  91/414/EEcCl)  concerning  ·the 
placing  of  plant  protection products  on  the  market,  the  councl I  of  the 
European  Communities  requested  that  It  be  Informed  of  the  Commission's 
Intention  In  the·  area  ·'of  non-agricultural  pesticides.  (bloclda.l 
products). 
Also,  at  the  time  of ·adoption  of  the  Eighth  Amendment  to  Directive 
76/769/EEcC2)  on  21  December  ·1989,  the  .. Council  requested  that  the 
Commission  develop  a  Community  strategy  on  the  marketing  and  use  of 
biocidal  products particularly wood  preservatives. 
Accordingly,  Commission·  services  reviewed  the  possibilities  for 
Introducing  regulatory  measures  at  the  Community  level  for  biocidal 
products. 
The  review  found  that  biocidal  products  are  an  extremely  varied  group 
of  preparations  with  very  varied  exposure  scenarios  and  widely 
(1)  O.J.  N"  L230,  19.08.1991,  p.  1 
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differing  regulatory  controls  In  Member  States.  The  Commission 
therefore  made  a  statement  towards  the  Council  concerning  non-
agr lcultural  pesticides  (biocidal  products)  (doc.  SEC(90)  1895)  and 
proposing  the development  of  a  directive  In  this area .. 
What  are  the obJectives of  the action envisaged  In  connection with  the 
obligations which  the CCIIWnlty  has? 
The  review  found  that biocidal  products currently have  a  highly diverse 
regulatory status  In  the Community  that could  lead  to barriers to trade 
between  Member  States  creating  unequal  conditions  of  competition  and 
thereby  directly  affecting  the  establishment  and  functioning  of  the 
Internal  market.  Also  their  production  and  use  may  entail  dangers  for 
man  and  the environment.  Details of  the different  regulatory approaches 
adopted  by  Member  States are set out  In  annex  I 
In  order  that  the establishment  and  functioning  of  the  Internal  market 
Is  not  affected  and  to ensure  that  there  Is  a  high  level  of  protection 
for  man  and  the  environment  with  regard  to  these  products.  the 
Commission  therefore  conslderes  that  there  Is  an  urgent  need  for 
Community  action  In  this area. 
Does  the  action envisaged  fall  within  the  exclusive  competence  of  the 
Oomunlty  or  Is  It a  competence shared with Member  States? 
The  Commission  proposes  action  In  the  form  of  a  directive  based  on 
Article 100a  of  the Treaty which  Is concerned with  the  approximation of 
the  laws.  regulations  and  administrative  provisions  relating  to  the 
placing on  the market  of biocidal  products. 
The  proposed  Directive will  ensure  that  a  harmonlsed  approach  Is  taken 
within  the  Communities  to  placing  biocidal  products  and  their  active 
substances  onto  the  market.  Th 1  s  wIll  stop  fragmentation  of  the  EEC 
market  In  chemicals.  Therefore  competence  In  this  area  Is  exclusively 
for  the COmmunity. - 3  a.-
Is  a  uniform  regulation  necessary  or  would  a,  dlrect!ve  glvln~  ger~eral 
obJectives  be  sufficient  In  the  case  that  the  execution  would  be  done 
by  Member  States  and  what  modalities  for  action are at  the.dlsposal  of 
the Community? 
A Directive has  been  chosen  as  the  most  appropr"late method  of  achle~lng 
the  necessary  harmonisation.  It  will  enable  a  broa_d  legislative· 
framework  to  be  established  a  community  _level  with  Individual  _Member 
States  left to  Implement ·detailed requirements  necessary  top~~ It .Into 
effect. 
The  proposal  follows similar principles to  those  laid down·ln Directive 
91/414/EEC  and  Is  closely  harmonized  with  It,  to  avoid  double  testing 
of  act lve  substances  COIII!IK)n_  to  both  plant  .protect len  products  and 
blpcldal  products  •  A  positive  list  approach  Is  also  proposed  with 
requirements  for  Inclusion onto  It  varying  as  a  function of. the  natur~ 
of  the  substance  and  Its envisaged  use,  taking  as  a  ~ase,  a  high  l.evel 
of  protection  for  man  and  the  environment.  A  r_eglm~·  of  mu~ual 
author I sat I on  of  b Icc  Ida I  products  between . Member  Stat~~- 1-s  · a I so 
provided  for. 
The  Directive  Is  concerned  with  preparations  and  substances  which  by 
their  nature  are  designed  to  have  d.etrlmenta!  effects on  the  organisms 
they  are  lnten~ed,  to  control,  and-a  .large  proportion  of1whlch_are 
classified  ~s dangerous.  The  Commission  has  theret.ore  chosen-to  .. develoP.; 
a  dIrect I ve  ¥th I ch  estab I I shes  a  framework ·.  based  ~n  .a  . system  · of 
authorisation  of  biocidal  product~  In  Member  States  with  listing  at,. 
Community  level  of active substances  ~o be  used  In  such  products.  It  Is 
appropr late that  a  clear  system of  refusal  or  acceptance  Is  e_stabllshec;t. 
for  biocidal  products  to  enable  a  high  level  of  protection  for  man  and 
the  environment  to  be  realised._ Furthermore,  It  Is appropriate  for  the. 
purpo_ses  of  harmonisation  of  thl~  directive  with  Directive  91/414/EEC 
which  establishes  an  authorisation  scheme  for  plant  Pr:c;>tectiQn. 
products.  ., .. - 4 a.-
THE  LEGISLATIVE  FRANEWQRK  AHD  SHARING  OF  RESPQNSIBILITIES 
The  authorization  scheme  for  biocidal  products  Is  to  operate  at·the 
level  of  the  Member  States,  unless  differences  arise  which  require 
referral  to  the  Community  level.  In  a  so-called  "decentrallsed 
procedure"  the  applicant  submits  his  application  In  the  form  of  a 
technical  dossier  to  the Competent  Authority  In  the  Member  State where 
the  prepflratlon  Is  to  be  marketed.  The  Competent  AuthorIty  wi II  then 
evaluate  the  dossier  and  decide  whether  It  fulfills  the  authorization 
conditions  laid  down  In  this Directive and  propose  any  restrictions on 
the use of  the preparation that  appear  necessary  to protect  man  and  the 
envIronment. 
In  general  terms  It  Is  necessary  that  this  proposal  for  a  Directive 
Includes  authorization  conditions.  The  conditions  are  designed  to 
ensure  that  authorisation  Is  given only  those  biocidal  products  which 
present  an  acceptable risk  through  their development,  use,  and  disposal 
for  man  or  the  envIronment ,  whIch  are  suffIcIent I  y  effIcacIous  and 
which  Include  active  substances  which  are  permitted  to  be  used  In 
biocidal  products  within  the  European  Community  following  agreement  at 
Community  level. 
If  an  application  Is  accepted,·the  biocidal  product  Is  then  authorized 
for  use  In  that  Member  State  subject  to  any  specified  use  conditions. 
Equally  Important  however  Is  the  provision  for  mutual  recognition  of 
thIs  author lsatlon.  According  to  thIs  prov Is !on  a  bloc Ida I  product 
authorised  In  accordance with  the directive must,  upon  application and 
In  line with  a  Member  State's obligations under  the  directive~  also be 
.  . 
authorized  as  a  matter  of  routine  In  any  other  Member  State  of  the 
Community.  In  order  to maintain  the  Integrity of  the  Internal  Community 
Market  for  biocidal  products,  this  principle  of  mutual  recognition  of 
authorisations  Is expected  to be  upheld  In  the  vast  maJority  of  cases, 
however  the  possibility  of  exceptions  to  this  general  rule  are 
recognized  In  the  Directive,  I.e.  where  one  of  the  conditions  for 
authorization cannot  be  met. 
currently,  there are approximately several  hundred  active substances on 
the market  within Member  States which  serve  as  the  biologically active 
components  for  several  thousand  biocidal  products.  For  the  active - 5  Q...-
substances,_ the  COmmission  proposes-that  Authorization  should  be  at  the 
level  of  the Community  In  a  "centralised procedure". 
Essentially,  the  same  authorization  conditions  and  possible  -use 
restrictions  will  be  applicable  to  active  substances  as  to  biocidal 
products  •. Under  the  terms  of  the_  Directi-ve,  following  authorlzat.l~n. 
active  substances  are  Included  on  a  positive  list of  actlv~ substances 
that  may  be  used  In biocidal  products Community-wide. 
'  . 
The  establishment  of  this  positive  list,  which  will  be_  Annex  I  to  the 
Directive,  will  mean  that  a  clear  unambiguous  list of_.actlve  substances 
for  use  In  biocidal  products  Is  available.  The  list  will  not  only 
facilitate  the  detection  of  those  actl_ve  substances  placed  on  the 
market  Illegally,  but  In  addition will  also  provide  a  useful  checklist 
for  formu-lators  In  the  chemicals  Industry as  to whlc~ active  s~bstances 
may  be  used. 
REQUIREMENTS  FOB  DATA  AND  REVIEW  OF  EXISTING  PRODUCTS 
Authorization  of  biocidal  product.s  and  acceptance  of  their  active 
substances  depends . upon  an . eva I ua  t I on  of  theIr  respect I ve  techn I ca I 
dossiers  containing  lnformat ion  supplied  according  .to  the  data 
requirements  In  Annexes  II-IV to .this Directive.  The  data  required  for 
a.  particular  product  wl.ll  be  closely  related  to  and  depend  upot:t.  the 
product's.uses  and  the  risks  that  are  likely  to arise  for:  man  and  the 
environment  from  such  .uses.  Or:lce.  such  data  has  been  submltte_d,  an 
evaluation  Is made  In the  l!ght of  the current  scientific and  technical 
knowledge.  Taking. thl.s  Into  account,  the  Commission  proposes  th~t  both 
active  substances  and  biocidal  products  should  be  reviewed 
perlodlca·lly,  a  fixed  authori-zation  period  of  ten  years  has~thus.  been 
specified  for  both.  Pr:-ovlslons  are  al~o made  In  the  Dlrectl_ve  for  the 
possibility of  review  at  any  t-Ime  In  circumstances  where  the  orlg!nal 
authorization criteria are  no  longer.  sat~sfled. 
R_eallstlcally  the  Commls,slon  appreciates  that  the  fUI·I  -lmplemen.tatlon 
of  the  authorlz.atlon  scheme  established  In  this  Directive  will  take 
several  years.  In  a  ten. year  transitional  period  therefore,  Member 
States  will  be  entitled  to  permit  the  placing  on  the  market  In  their 
territory of  biocidal  products  which  were  on  the  market  prior  to· the -sa-
lmplementaflon  date  'of  the  Directive.  After  the  adoption  of  the 
Directive.  It  Is  envisaged  that  the  Commission  will  commence  a 
programme  of  work  to  review  the  active  substances  of  these  existing 
···products. 
In  order  to  promote  and  sustain  Investment  In  the  continuing 
development  of  active  substances  and  products.  and  to  ensure  an 
efficient  programme  of  review.  It  Is  necessary  to  provide  protection 
for  the  Intellectual  property  (data)  an  applicant  submits  to  Member 
States  In  support  of  applications.  such  protection  must  apply  to  new 
data  submitted.  data  submitted  during  the  review  period  and 
subseQuently,  and  to  any· data  submitted  under  existing  national 
controls on  biocidal  products. 
The  data  reQuirements  for  biocidal  products and  their active substances 
are  very  similar  to those  that are  reQuired  In  Directive 91/414/EEC  for 
plant  protection  products  and  their  active  substances.  Given  the 
diversity of  the  chemicals being considered here,  It  has  been  necessary 
for  the Commission  to  adopt  a  flexible  approach  as  to which  particular 
data  are  reQuIred  for  each  product  type.  Therefore  cer ta 1  n  p 1  eces  of 
Information  which  are not  necessary owing  to the nature of  the chemical 
or  Its proposed or  existing uses  need  not  be  supplied.  Such  flexibility 
Is  particularly  necessary  for  existing  substances  and  products  which 
have  a  long  history of  safe use  as blocldes.  Conversely,  the  ccimpetent 
authorIty  will  be  entItled  to  ask  the  applicant  to  subml t  further 
Information,  If  the  assessment  of  the  dossier  shows  that  additional 
lnformat I  on  Inc lud lng  further  test lng  Is  necessary  to  evaluate  the 
risks  that  pl~clng on  the market  of  the biocidal  product  entails. 
Moreover,  the  Council  In  Its  resolution  of  1  February  1993  on  a 
Community  programme  of policy and  action  In  relation to  the environment 
and·  sustainable  development3,  recognized  that  economic  growth  and 
environmental  Quality  must  be  viewed  as  mutually  dependant. 
ConseQuently~  the  strenghthenlng  of  environmental  protection  Is 
~dependant  upon  the  economic  competitiveness  of  Industry  being 
maintained.  The  directive  Is drafted with  this  In  mind.  ItS provisions, 
part lcular ly  those  concerned  wl th  research  and  development  and  the 
3  0  ~ J .  No  c  138.  17. 05. 1993.  p .  1 . ' 
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protectlon·of  Intellectual  property,.  are  aimed  at  encouraging  the 
sustained  development  of  biocidal  products  with  a  reduced  Impact  for 
man  and  the environment. 
This  proposal  concerns· the  placing  on  the"market  of  biocidal  products. 
The  Commission  recognises  that,  In  the  future,  It  may  be  necessary  to 
provide  minimum  reQuirements  for  .tr:alnlng  and  experience  of  persons 
using certaIn  types .of b loc.lda I  products  • 
• 3 
PART ICULAB  CQWENIS ON· CERIA  IN ARTICLES. OF  THE  PROpOSED  D  I BECT lYE. 
Article 1 
Article  1  describes  the  purpose  and  the  scope  of  this  Directive.  The 
aim of  this  Dlre~tlve  Is  to harmonise within  the  Community  the  placing 
on  the market,  of biocidal  products  and  the establishment  at  COmmunity 
level  of  a  posit-Ive  list. of  act lve  substances  that  may  be  used  In 
biocidal  products. 
The  Direct lve  will  be  applied  wl thout  prejudice  to  other  areas  of 
existing  Community  law  and  therefore  to  avoid  duplication  of  effort, 
harmon I sat I on  will  be  ach leved  between  the  current  proposal  and  the 
other  legislation. 
Article 2 
Article  2  gives  the  definitions of  terms  used  In  this  Directive.  The 
definitions of  •biocidal  products•,  "active  substances•  and  •residues• 
are  analogous  but·;eotnPieme.ntary  to  the  definitions  given  In  Directive 
91/414/EEC. 
Article 3 
The  general  conditions relating to  the authorization  for  placing on  the 
market of biocidal  products are  laid down  In article 3. - 8  B.-
As  a  prerequisite  to  being  placed  on  the  market,  a  biocidal  product 
must  be  authorized  by  the  COmpetent  Authority of  the Member  State  where 
It  Is  to  be  marketed. 
Importantly,  for  the  harmonisation  of  this  authorization  scheme,  this 
article provides  for mutual  recognition between  Member  States.  However, 
the  Commission  acknowledges  that  owing  to differing conditions  between 
Member  States,  In  certain  exceptional  cases,  a  derogation  from  mutual 
recognition  should  be  applicable.  As  a  result,  this  article  permits 
Member  States  to  modify  the  biocidal  product  depending  on  the 
circumstances  and  sets out  the  course of  action  to  be  foll.owed_where  a 
Member  State  believes  It  cannot  authorize  a  product.  It  Is  stressed 
though  that  for  the  vast  maJority  of  cases,  mutual  recognition  will 
apply. 
Article 4 
In  order  to  maintain  a  high  level  of  protection  for  man  and  the 
environment  It has  been  necessary  to ensure  that  certain conditions are 
fulfilled before-a biocidal  product  may  be  authorized.  These  conditions 
are  laid down  In article 4. 
Articles 5  and  6 
Biocidal  products  already  authorized  and  on  the  market  may  need  to  be 
revIewed  If  new  lnformat I on  comes  to  light,  ArtIcle  5  provIdes  for 
this.  Article  6  deals  with  cancellation  or  modification  of  an 
authorization  and  sets  out  the  circumstances  under  which  such  changes 
may  be  made.· In  the  case  of  modification  of  an  authorization  and  In 
order  to  avoid  unnecessary  duplication  of  effort  and  additional  time 
and  cost  for  the  applicant,  the entire authorization procedure  need not 
be  followed  In  full  every  time.  Instead,  once  any  extra  Information 
requirements  are  supplied  and  the  Commission,  or  Member  State.  as 
appropriate,  Is  satisfied  that  the  authorization  conditions  are  met 
then  the  authorization may  be  extended  to the  new  use. - 9  9-..-
Article 7 
Article  7  Is  concerned  with  the  requirements  that  have  to  be  met  when 
an  application  Is made  for  the authorization of  a  biocidal  product.  The 
detailed  Information which  must  be  supplied  In  the  technical_dossler  Is 
laid  down  In  Annexes  II,  Ill  and  IV. 
Article 8 
Article 8  deals with  the placing on  the market·.of:actlve substances  for 
use  exclusively  In  biocidal  products.  The  article  Is  required  as  such 
substances  are  excluded  from. the  ·requirements  of,  67/548/EEcC4)(7th 
Amendment). 
Article 9 
ArtIcle  9  lays  dOWn  the  condItIons  whIch  must  be  ful f I lied  before  an 
active substance may  be  Included on  the positive  list  In  Annex  I  to  the 
Directive;  Inclusion  ln.  this  list  being  a  prerequisite  to  use  In  a 
biocidal  product. 
Active  substances  may  only  be  Included  In  Annex  I  If,  In  the  light  of 
current  scientific  and  technical  knowiedge  and  from  the  evaluation  of 
the  Information  required  under  Annex  II,  Ill  and  the  relevant  parts 
of  Annex  IV,  the biocidal  product  Into which  the active substance  Is  to 
·,be  Incorporated,  during  use  and  disposal,  will  not  have  any  harmful 
effects  on  hliman  or·  animal·  health,  or  any  unacceptable  effects  on  the 
envIronment. 
Additionally,  to  further  protect  man  and  the  environment,  provisions 
are  made  here  to  a I low  refusa I  of  entry  of  an  actIve  substance  onto 
annex  1  If  alternative substances,  or  methods  exist  which  In  the  light 
of:current  knowledge  offer significantly  less danger  to human  health or 
to  the environment.  A proviso  Is made  however,  that  such  an  al.ternatlve 
method  should'  not  present  significant  economic  or  practical 
( 4 )  0 . J .  N  .  L  196 ,  16 . 08 . 1967 ,  p .  1 - 10 Q..-
disadvantages  to  the  user  and  that  an  evaluat lon  demonstrat lng  this 
must  be  made. 
Article 10 
Article 10  lays down  the procedure  for  Inclusion of  an  active substance 
In  Annex  1.  All  decisions  concerning  the  active  substances·  Inclusion 
on  the positive  list will  be  decided at COmmunity  level.  The  Commission 
proposes  that  such  decisions  are  most  appropriately  dealt  with  at 
Community  level  because  Inclusion  on  the  positive  list will, mean  that 
an  active  substance  may  subsequently  be  used  widely  In  biocidal 
products  In  any  of  the  Member  States.  Biocidal  products.  on  the  other 
hand  are best  dealt  with  at  the  Member  State  level  since  they  wl"ll  be 
used  locally.  The  article  sets  out  the  procedures  and  tlmescales 
whereby  dossiers on  active substances are evaluated. 
Article 11 
Article 11  Is an  Important article from  the point of  view of commercial 
· data  protect lon  as  It sets  out  rules  whereby  data  held  by  Competent 
Authorities may  be  used  for  the benefit of other  applicants. 
·Under  Art lc  le 11,  the Commission  foresees  that  lnformat I  on  supplied  for 
the  purposes  of  Inclusion  of  an  act lve  substance  In  Annex  1  and 
authorization will  be  Pt:"Otected  for certain periods.  Article 11  obliges 
Member  States ng1 to use  any  such  Information  for  the  advantage  of  any 
subsequent  possible  applicants  unless  prior  agreement  Is  given  by  the 
fIrst app II  cant. 
Art lela 12 
Article  12  lays  down  provisions  to  avoid  unnecessary  testing  on 
vertebrate  animals.  It  provides  for  subsequent  . applicants  for 
authorisation  to make  use of  the  first applicants data  In  those  Member 
States  where  the  data  protect lon  per lod  has  expired.  Importantly  for 
animal  welfare,  In  circumstances  where  an  application  Is  made  for  the - 11 a-
Authorization of  a  biocidal  product  which  Is  Identical  to  a  previously 
authorized  preparation,  and  where  data  Is  still  subject  to  protection 
the  Competent  AUthorIty  In  that  Member  State  can  take  steps  to  avoid 
unnecessary  duplication of  testing on  vertebrate animals.  One  such  step 
Is  to  supply  the  name  and  address  of  the  current  author I  zat ton  holder 
to  the  second  applicant  with  a  view  to sharing  the  Information.  In  the 
event  that  an  agreement  ·cannot  be  reached  between  applicants,  this 
art tc te  permIts  Member  States  to  force  an  agreement  between  concer.ned 
parties  located  In  their  territory  through  the  Introducing of  national 
legislation to this effect.· 
Article 13 
In  the  event  of  new  Information  becoming  available  concerning  the 
potential  harmful  effects  of  any  authorized  biocidal  product,  or  any 
part of  It,  this article obliges the  applicant  to ·Immediately  pass this 
on  to  the  Competent  Authority  of  the  Member  State  where  the 
Authorization  Is  granted.  It  also  obliges  the  Member  State  to  Inform 
the  COcrunlsslon  and  other  Member  States  qu'lckly  where  such  lnformat ton 
becomes  available. 
Article 14 
Article 14  Is concerned wlth.transltlonal  measures  and  derogations  from 
the  normal  requirements of this Directive. 
In  the  draft lng  of  thIs  proposa 1  for  a  Dl rectI ve.  the  Commlss I  on  has 
recognised  that  limited  derogations  from  the  full  requirements  of  this 
Directive may  be  necessary  for  restricted periods.  Such  derogations are 
confined  to  circumstances  where  such  a  measure  appears  necessary 
because  of  an  unforeseen  danger  wh lch  cannot  be  dealt  wl th  other  than 
by  a  limited and  controlled use of  an  unauthorized  biocidal 'product  and 
to  provisional  placing  on  the  market  where  a  Member  State  believes  a 
product  and  active substance meet  the  requirements of  the directive but 
entry  Is not  yet  made  on  Annex  1. - 12  0..  -
Though  such  derogations  are  provided  for  In  this  article,  It  Is 
emphasised  that  strict  conditions  will  be  applied  to  the  derogations 
and  that  they  will  be  subject  to  pr lor  sat I sf  act-Ion  of  the  Member 
States  concerned  that  the  proposed  marketIng  will  not  enta II  harmful 
effects  for·  human  or  animal  health.or  have  ..  an ;unacceptable  effect  on 
the envIronment. 
This  article makes  also  provisions  for  a  ten  year  transitional  period 
after  the  Implementation  date of  this Directive.  To  enable  the chemical 
Industry  to  adjust  to  the  requirements  of .. thls  Directive,  during  the 
transitional  period,  Member  States may  authorize within their  territory 
biocidal  products  that  contain  active  substances  not  Included  In  the 
positive  list.  The  proviso  to  this  Is  that  such  active  substances  were 
already  used  In  biocidal  products  on  the  market  prior  to  the 
Implementation of  the Directive  . 
. The  Commission  will  ·tnltlate  a  work  programme  to  gradually. examine 
these  active  substances  :that  are  not  Included  l.n  Annex  I.  This 
programme  will  be  harmonlsed  with  other  work·  programmes  wlth.tn  the 
framework  of  other  Community  legislation  concerned  with  the  review  or 
authorization  of  substances  and  products.  In  the  meantime  however, 
Directive 76/769/EEC  on  the  approximation of  the  laws;  regulations  and 
administrative provisions of  the  Member  States relating  to restrictions 
on  the  marketing  and  use  of  certain  dangerous  substances  and 
preparations will  serve to provide  a  framework  to complement,  on  an  ad-
hoc  basis,  as  well  as systematically,  where  necessary,  the  restriction 
or  banning of  the use of certain active substances or  groups of  these. 
Article 15 
To  allow  for  research  and  development  of  new  active  substances  and 
biocidal  . product"s,  It  ·Introduces  provisions  analogous  to  those  In 
67/548/EEC  (7th  Amendment)  for  scIentIfIc  and  process  or I  en ted 
research.  To  ma lnta In  a  h lgh  degree  of  protect I  on  for  man  and  the 
environment  If  tr lals  Involving  release  Into  the  env.lronment  are  to 
take place a  •trials" authorization must  be  obtained  from  the  competent 
authority of  the Member  State where  the trials are  to take place. - 13 ~-
Article 16 
Artlcle-16 deals wlth  the·obll~atlons on  Member  States  w~th  respect  of 
the  operation  of  the· authorization  scheme  for  biocidal  products- and 
the  flow·of  Information between  Member·states  following authorization. 
Of  part leu tar  Importance.  ts·· the  necessity· of  lnformat lon  exchange. 
periodically.  between  Member  states  and  the  Conimlsslon.·  and  betweeri 
t hemse I ves.  such  I nforma  t I on  exchange  w  I I I  he I p  to  ensure  that  the 
Internal  market  for  chemicals  operates  effectively  and  that  mutual 
recognition  between  Member  States  Is upheld. 
Art lc!e 17 
This  article  Is  an  Important  one  for  the  chemicals  Industry  since  It 
spec If  lea l!y  dea Is  wl th  conf !dent I a II  ty  for  commercIa I  reasons  of  the 
Information  submitted  according  to  this  Directive.  In  a  manner 
analogous  to  that  of  other  EEC  chemicals  legislation.  Information 
submitted  here  may  be  regarded  as  confidential  If  so  requested  by  the 
app II  cant .  However •  as  usua I •  certaIn  bas I c  I nforma  t I on  essent I a r  to' 
ensure  the  safety  to  the  user.  to  the  env·l ronment  and  I nformat !on  that 
may  be  Important  In  case  of  an  accident  may  not  be  regarded  as 
confidential. 
Art lcles 18. · 
This  article  Is  concerned  with  the  classification.  pacKaging  and 
label ling of biocidal  products. 
In  general  terms  the  Commission  believes  that  for  the  classification, 
packaging  and  labelling  of  biocidal  products.  the  well  established 
provisions of ·Directive 88/379/EEc<S>  should  apply. 
( 5 )  0 . J .  N"  L187 •  16  • 07 • 1988  •  p .  14 
,  I, - 14 EL-
The  Commission  has  particularly  noted  that  for  the  very  diverse  group 
of  preparations which  biocidal  products  represent,  Directive 88/379/EEC 
most  comprehensively  provides  for  their  labelling,  rather  than  the more 
restricted  scheme  under  Directive 78/631/EEcC6)  which  Is  applicable  to 
plant  protection products  and  some  types of  biocidal  products.  Despite 
the  applicability  of  Directive  88/379/EEC,  In  the  current  proposal  It 
has.  nevertheless  been  necessary  to  add  certain,  biocide-specific 
labelling  requirements  to  those of.  the existing  labelling  Dlre~tlve. 
Articles 19.  20  end  21 
These  three  articles  are  concerned  with  specific  safety  requirements 
for  placing  biocidal  products  and  their  active  substances  onto  the 
market. 
Article 22 
This  article obliges Uember  States  to make  provisions  for  surveillance 
of  the  authorization  scheme  In  their- Individual  territories  and  to 
provide reports to the Commission. 
Article 23 
This  article requires  Uember  States  to establish competent  authorities 
to  undertake  authorizations  and  related  work  required  by  this 
directive. 
Article 24 
This  article  establishes  the  procedure  whereby  the  Commission  will 
prepare  a  proposal  In  respect  of  recommendations  on  active  substances 
or proposals  to refuse authorization. 
(6)  O.J.  N.  L206,  29.07.1978,  p.  13 - 15  e..-
Article  25 
ThIs  artIcle _establl shes  a  stand I  ng  comml ttee on  bloc Ida I  products  and 
provides  for  decision  taking  on  the  basis  of  either  procedure  I  and 
procedure  Ilia, according to the  nature of  the matter  to be  decided. 
Article 26 
This  article provides  for  the  development  of  common  principles  for  the 
evaluation of dossiers  to be  applied by  Member  States,  when  considering 
products tor authorisation. 
Article 27 
This article provides  for  adaptation to technical  progress. 
Article 28 
This  article  Is  Included  .to  ensure  that  persons  placing  biocidal 
products  on  the  market  cannot  claim  authorization  as  protection  from 




Article  28  Is an  Important  article since  It  Is  a  safeguard clause which 
can  override  the  normal  provisions oCthls Directive.  The  terms  of  the 
article  permit  any  Member  State  which  has  any  valid  and·  Justifiable 
reason(s)  to  suppose  that  a  product  constitutes  a  risk  to  man  or  the 
environment  to  restrict  or  prohibit  the  use  or  sale  of  It  in ·Its 
territory. 
However,  In  order  to  avoid·  inlsuse  of  this .clause  -and  ensure  a 
harmonized  approach  Is  taken.  to  any  such  action,  the  Commission - 16  ~-
propases  that  such  a  decision  will  be  referred  to  the  Standing 
Committee  described  In  article 25. 
Article 30 
This  article  lays  down  the  obligation  for  Member  States  to  Implement 
this Directive and  the date by  which  this must  be  achieved. 
AHNEX 
Annex  I  Is  to contain  the  list of  Community-approved  active  substances 
whIch,  In  the  I I  ght  of  cur rent  scIentIfIc  and  techn I  ca I  know I  edge  when 
used  In  biocidal  products,  do  not  have  any  harmful  effect  on  human  or 
animal  health or  any  unacceptable effect on  the environment. 
AHNEXES  II.  Ill  AND  IV. 
Annexes  1_1  to  IV  set  out  the  data  requirements  for  the  appraisal  of 
biocidal  products  and  their  active  substances.  Owing  to  the  diverse 
nature  and  broad  range  of  uses  which  are  characteristic  of  biocidal 
products,  the Commission  proposes  that  the data  requirements  In  Annexes 
II  to  IV  should  be  flex lb le.  Annex  II  therefore  provIdes  the  data 
requirements  for  active  substances;  and  where  necessary,  additional, 
use-specific  requirements  are  set  out  In  Annex  IV.  Similarly·  for 
biocidal  products  ,  the  data  requirements  are  laid  down  In  Annex  II I 
and· the  relevant  parts  of  Annex  IV.  The  lnterpretat Jon  of·  the  data 
requirements  will  be  assisted  by  common  principles  for  the  evaluation 
of  technical  dossiers. 
Tests  required  under  Annexes  II  to  IV  should  be  carried  out  In 
accordance  with  the  provisions  laid  down  In  Directive  86/609/EEc<7>  on 
the  protection  of  animals  used  for  experimental  and  other  scientific 
purposes .and  with  Directives  87/18/EEcC8)  and  88/320/EEc<9>  on  the 
( 7 )  0 . J •  N  '  L  358 ,  18 . 1  2 . 1988 ,  p •  1 
(8) O.J.  N'  L  15,  17.01.1987,  p.  29. 
(9)  O.J.  N'  L145,  11.06.1988,  p.  35 -17Q..-
application  of  the  principles  of  Good  Laboratory  Practice  and  the 
verification of  their applications  for  tests on  chemical  substances. 
ANNEX  V 
Annex  v  establishes  an  lndlcat lve  list  of  product  types  which  are 
considered  as  being biocidal  prod\.!.Cts. - 18 Q...-
ANNEX  I 
LEGISLATION  IN  THE  MEMBER  STATES  OF  THE  EUROPEAN  COMMUNITIES 
BELGIUM 
The  Royal  decree  of  5  June  1975  concerning  conservation,  trade  and  the 
utilisation of  pesticides  and  phytopharmaceutlcal  products  Is  extended 
to cover  certain  groups  of  biocidal  products.  Namely,  those  pesticides 
whIch  are  used  to  e I ImIna te  or  combat  organIsms  or  mIcro-organIsms 
which  cause  a  nuisance  In  buildings,  transport  means,  waste  sites, 
swlmmlng·baths  and  other  materials or  objects.  prevent  decay  or  damage 
to  animal  or  plant  products.  to  combat  or  eliminate  ecotoparasltes  of 
small  domestic  animals  and  those  which  are  used  to  treat  plants.  water 
or soli  l"n  order  to combat  organisms which  cause  lllne~ses to man  or  to 
animals.  Notable  exemptions  Include  substances and  preparations used  as 
antiseptics or  disinfectants  for  surgical  material,  additives  for  food 
and  feedlngstuffs  and  biocidal  products  used  for  research  and 
scientific trials. 
Authorization  of  the  biocidal  products  and  active  substances  thereof 
follow  submission  of  technical  data  as  for  phytosanltary  products. 
Surface disinfectants have  separate requirements  which  are  laid  down  by 
Superior  Council  of  Public Hygiene  {CSHP). 
The  authorization  may  be  refused,  or  It  may  be  subsequently  ~ithdrawn 
or  suspended  If  this  can  be  Justified  or  It  Is  for  reasons  of  public 
health. 
DENMARK 
An  approval  system  for  pesticides was  set  up  In  Denmark  with  the  entry 
Into  force  of  the  Chemical  Act  In  1980.  The  approval  system  Is 
applicable  to  both  agricultural  and  biocidal  products  with  fields  of 
application  In  Industry,  private  households  and  gardens  as  wei I  as  In 
agr leu I ture. - 19 e-.-
Approval  by  the  Danish  National  Agency  of  Environmental  Protection· 
{EPA)  Is  subject -to  proof  by  the  aJ)pllcant, that  the  product  Is  not 
considered  dangerous  to  health  or  to  the- environment.  All· relevant 
lnformaHon . Is  supplied  concerning  the  formulated  product  and  each 
active  substance.  Further  tests may  be  required._ 
With  the  amendment  of ;the  Chemical  Act  ·In  1987,  pr:ov.lslons. were  made. 
for  hazard  assessment  of  pesticides.  Criteria  have  been  worked  out  to 
decide  when  pesticides should  be  considered  dangerous or .harmful  to  the 
environment  and  therefore  cannot  be  approved.  Additionally,  alternative 
assessment  operates  such  that  a  given pesticide may  not  be  approved  If 
a  significantly  less  hazardous  alternative  exists  which  fulfills  the 
above  role. 
AI I  approvals  are subject  to  time  limits.  Pesticides classified as  very 
toxic or. toxic are  limited to an  approval ·of  four  years,  the  remainder, 
eight  years.  Currently,  the  Danish  EPA  Is.  re-evaluating  the  old 
pesticides  which  were  on  the market  before  1980. 
GERMANY 
Comprehensive  legislation  for  alI  biocidal  products  does  not  exist  In 
Germany.  Instead,  a  number  of  specific  substances  are  regulated  In 
different  pieces  of  legislation  (e.g.  DDT,· PCP,  certain  fumigants). 
Also  there  are  some  general  requlr:ements  which  apply  -for  cer.taln  groups 
of  chemicals  (e.g.  Indoor  Insecticides  and  specific  public  hygiene· 
disinfectants)  ..  Additionally,  there  are  some  standards  and  .voluntar.y 
labelling  guidelines  for  wood  preservatives  used  .In  the. construct ion 
Industry. 
GREECE  .,  ' 
In  Greece,  pesticides  for  plant  protection  or  other  applications  are 
all  .cl-assified  as  "Agricultural"  pesticides  and  their  marketing  ·Is 
governed  by  the  National  Law  721/7.10.1977  (Offici-al  Journal 
298/A/1977). - 20  ~-
According  to  this  law,  a  notification  procedure  Is  required  and  the 
producer  or  Importer  has  to  be  authorized  before  the  circulation  of 
each  product  Is permitted.  All  legally marketed  products  are  listed  In 
a  national·  Inventory.  Certain  restrictions  or  limitations of  products 
from  specific uses may  be  Imposed  by ministerial  decisions. 
Quality  control  of  marketed  products  Is  provided  by  random  sampling. 
Checks  are  made  on  the  authorization.  the  packaging  and  labelling  and 
on  the  active substances  as  compared  to that  which  are  described on  the 
label. 
B toe 1  da 1  products  are  regu I a ted  by  Roy a I  Decree  3349  of  30  November 
1983  which  approved  the  health  and  hygiene  regulations  governing  the 
manuf,acture,  marketing and  use of pesticides. 
The  scope  of  this  Decree  Includes  pesticides  for  domestic  use  by  non-
professionals;  preparations  for  personal  hygiene;  those  used  In  the 
environment  Including  for  disinfection  purposes;  Insect  and  rodent 
control;  pesticides  ~o  be  applied  In  the·  foodstuffs  Industry  and  for 
use  In stock  rearing. 
Use-specific  registers  are  kept  of  the  biocidal  products  that  are 
placed  on  the  market.  Inclusion  on  one  of  the  registers  reQuires  that 
approval  must  be  given  by  the  Directorate-General  for  Public  Health 
following  a  review  of  data  provided  concerning  the  potent tal  r lsk  of 
the  preparation  to human  health. 
A  surveillance  system  ex lsts  to  control  the  market lng  of  biocidal 
products which  are classified as  very  toxic or  toxic.  Such  products may 
not  be  sold  or  stored  In  establishments  where  food  products  or  animal 
feedlngstuffs  are  on  sale.  In  addition  these  preparations  which  are 
classified  as  very  toxic  may  only  be  used  by  Individuals  or  firms 
spec If  I ca II  y  author I zed  to  do  so.  AuthorIzatIon  fo  I lows  successfu  I 
complet ton  of  training  courses  or  examlnat Ions  and  the  use  of  the 
biocidal  products  Itself must  be  accompanied  by  warning  signs displayed 
In  the  treated areas. ' 
- 21  &--
The  same  restrictions  apply  to  preparations  for  use  In  the  environment 
which  are classified at  least  as  toxic. 
FRANCE 
.At  present  there  Is  no  framework  legislation  that  requires 
authorization  of  biocidal  products.  Certain  products  however,  must  be 
authorized prior  to being  placed on  the market. 
Depending  on  their  use.  herbicides  must  be  author lzed  by  the  Ministry 
of  Agriculture  following  the  law  of  2  November  1943  concerning  the 
control  of  antlparaslte  products  for  agrlcultura,1  usage.  Similarly, 
specific  categories  of  disinfectants  require  Authorization  as  do 
pesticides that are  Incorporated  Into medicines. 
Additionally, ·It  Is also possible  to  prevent  or  regulate strictly on  a 
case-by-case-basis  the  placing 9n  the market  of  biocidal  products  that 
present  specific dangers. 
The  labelling of  biocidal  products  Is  subJect  to  rules  from  the  Decree 
of  28  March  1989  which  transposed  Directive  78/631/EEC  Into  national 
law. 
IRELAND 
The  Pesticide control  Unit  of  the Department  of Agriculture  and  Food  Is 
the  competent  authority  In  Ireland  dealing  with  all  aspects  of 
Regulations  pertaining  to  pesticides,  Including  biocidal  products. 
Biocidal  products  are  regulated  by  two  Regulations  the  Polson 
Regulations.  1983  as  amended;  and  the  European  Communities 
(classification,  packaging  and  Labelling  of  Pesticides)  Regulations 
1985  as  amended. 
The  Poisons  Regulations  regulate  the  availability  of  pesticides. 
Certain  preparations  are  only  sold  by  pharmacies.  whilst  less  toxic 
ones  may  be  purchased  through  licensed outlets.  Others  are  limited  to - 22  e- -
professional  use  only  and  in  extreme  cases  certification  of  the  user 
may  be  reQuired  by  the  local  pollee. 
Clearance,  classification,  packaging  and  labelling of  biocidal  products 
is  provided  for  by  the  European  Communities  Regulations  1985.  Clearance 
is  granted  following  evaluation  of  a  dossier  containing  data  which 
approximate  the  reQuirements  of  Annex  VII  and  Annex  VIII  of  Council 
Directive  79/831/EEC.  The  preparation  Is  then  cleared  for  the  uses 
specified on  the  label. 
Since  1954,  Italian  legislation  has  reQuired  that  disinfectants  for 
agricultural  use  and  pesticides  be  registered  as  "medical/surgical 
eQuipment".  Further  Government  Decrees  cover  the  registration,  as 
medical/surgical'  eQuipment,  of  rodentlcldes  (Decree  dated  26.01.76), 
snail-lei I ters  and  Insecticides  for  use  on  flowers  or  plants  (Decree  of 
6.03.78),  fungicides,  and  of  Insecticides  and  snail  lclllers  for  use  on 
flowers  or  plants domestically. 
Registration  as  med I  ca'l /surg I  ca I  eQuipment,  part leu tar I y  of 
preparations  containing  new  active  substances  reQuires  certain  data. 
Data  reQuirements  Include  a  detailed  description  of  the  nature  and 
dosing  regime  of  the  preparation;  efficacy  testing  and  the  necessary 
toxicity  testing  to  classify  the  preparation  and  to  Identify  the  rl~lcs 
Involved with  Its use. 
The  ·label I lng·of  the  biocidal  product  should  be  In  c6nformlty  with  the 
preparation's main  action. 
LUXEMBOURG 
The  Statute  of  20  February  1968  with  the  purpose  of  controlling 
pest lcldes  and  phytopharmaceut leal  products  author lzes  The  Grand-Dulce 
to  regulate  the  manufacture,· Import  and  use  of< these  products.  The 
Implementing  Regulation  of  this  law  concerning  pesticides  for  non-
agricultural  usage  has  not  yet  been  adopted. - _,  23 Q..-
_  Certa I o  .,b locJ da 1  product~. are.  cc;>Vered, at  least ·  ln~.part  ·bY  the  three 
. ~xI  stIng._ 0 I rectI  ves -.(Class l·f 1  ca~ I on  and  Labe-l II  ng., ·Dangenous:Sut-stances 
and  Llmlta.tJon,of·  Use,  of-;Ce.rtaln  Products).  Others-.are:-covered.  In 
·practice  by  the  Regul·atlon  concernlrl'g  pesticides· for.  agrlcl,!l~ural 
usage,  though  ,.the  boundary: be.tween  ..  the·:.two  categories··  Is.  not  .always 
clear:. 
NETHERLANDS  .. 
' 
The  regulatIons  for  biocidal .:products ..  encompass  a  yery  broad  range  of 
products.  They·  ·Jn·clude  .-dlsl(n.tect.ants, :·:pesticides .-.fQr· :-dorne.st)lc  ··.and 
lndustrlal.use,  wood  preservatives,  anti-fouling  paJnts,  fumigants  for 
stored  products,  ectoparasltlcldes  and  human  skin  Insect  repellants. 
All  herbicides  however  are  considered  as  agricultural  pes.U:clqes·. 
-~or  biocidal  Pt"Oducts ·,_the  sa111~  basJc·regulatory  prJnc.lples.  apply  as 
for  agrlcultural·..-p_estJ·cJdes.  Tr.ade  Jn  and  use  o.f, these  produc.ts,.ls.only 
permlt;ted.  after  reglstr,at ion -and·  a ..  f.u.ll  dossier_. .Is  pr.ov,_lded  by.,  the 
applicant  which  Includes  efficacy  data,  public  health,  worker 
_protection  ~nd  environmental  r:l.sk  .da.ta.·.Speclflca,t.lons:-are:,lald.-down 
for  each  product  category. 
;Th~  Regulations:  ln.clude  provlslor:~s  :for  .use  lim  I. tat  ion.· of  •use ..  to 
specified  app_l.lcat:IQI1S,  ,user  category;  professional  ...  tr.alnlog·  and 
licensing  and.en.vl.ronmenta·l  requlremen~s sucl:l  as  ·dl:st~nqe of  fumigated 
object. to  surround! ng  bu I I d lngs ..  AddItionally ,-··rules  are:  I a I~  down  for 
pub I lclty and  advertising,  waste  disposal  of pesticides  and  containers,  . 
for  survefl1ance  and  for  residues  ln.toodstuffs. 
J,<  r,  ,  ~·  •  ~  .'  !. ·  ..  ~~ ·- •  1· 
. ·  ...... , 
·PORTUGAL 
Prior  to  being  placed  onto  the  market  In  Portugal  all  pesticides  have 
. to  be  reglstered:·~.Y- ~he·  Na~lpnal.  ~estlcld~·,,roxlcologlcal  Commission 
(CTP)  as  one  of  the.followl·ng .:.  agr_lcu.ltural-,·household·,/ Industrial.,  a 
wood_  preservat.Jv.e or  a  pest.lcl~e .for,  q.se.on  hum"'n·.t;>elngs~: - 24 e..-
The  data  requIrements· ·for  each  group  are  dIfferent. , The  requIrements 
for  ·agricultural  pesticides. are  usually  the  most  stringent,  but 
'  . 
preparations  for  one of  the other  categories which  contain a  new  active 
substance,  will  require  a  toxicological  evaluation  similar  to  that  of 
agricultural  pesticides.  In  any  case,  sufficient  data  must  be  supplied 
by  the applicant  to enable  a  classification  Into one  of  the categories. 
on  approval  of  a  !Particular  product  by  the  CTP  the  risk  and  safety 
statements  for  the  labe,lllng of  It will  thEm  be  defined. 
Pesticides  for  use  on  cattle,  poultry  and  domestic  pets  are  considered 
separately  and  evaluated by  the  commission  for  New  Medeclnes • 
. UNITED  KINGDOM 
Pesticides  In  the. United  Kingdom  are  controlled  by  The  Food  and 
Environment  Protection  Act  1985  and  the  control.  of  Pesticides 
Regulations .1986.  Northern  Ireland has  Its own.  Identical  Regulations. 
Under  the  Regul at Jon  no  pest lc  Ide  product  may  be  sold,  advert I sed, 
supplied,  stored  .or  used  until .Government  Ministers  give  approval. 
Approvals  are  usually  specific  for  a  particular  use  and  application 
method.  There  are  three  levels of  approval  :  an  experimental  permit,  to 
enable  the  product  to  be  developed;  a  provisional  approval,  when  the 
product  Is  considered  safe,  but. further  data  Is  required;  and  a  full 
approval,  when  the product  has  been  shown  to be  safe .and  effective. 
To  obtain  an  approval  for  a  product,  the  applicant  must  submit  data  to 
the  relevant  registration department.  For  most  biocidal  products,  this 
Is  the  He.alth  and  Safety  Executive,  the  exception  being  for 
rodentlcldes,  for  which  the  data  must  be  supplied  to  the  Ministry  of 
Agriculture,  Fisheries  and  Food. 
In  the  UK,  biocidal  products  Include  wood  preservatives.  Insecticides 
. (public  hygiene  and  domest lc  use), ·surface  bloc  Ides  and  ant 1-foullng 
paints~  Disinfectants,  substances  used  to  treat  textiles  and  surface 
water  blocldes  are.not  currently  covered  by  the  Regulations  but  these 
could  be  In  the  future. - 25 G.-
The  data  reQuired  for  approval  consists of  a  base  set  for  all  biocidal 
products  and  then  additional  data  Is  required  according  to  the  type  of 
product  and  Its  area  of  use.  An  eva luat ton  of  the  data  Is  made  and 
assessed  by  a  scI  entl  f I c-sub  corrun I ttee  whIch  then,  once  sat Is  fled, 
refers  the  appllcat ton  to  an  advisory  Conunlttee  (ACP)  set  up  by  the 
Food  and  Environment  Protection  Act.  The  ACP  then  makes  Its 
recommendations  to  Ministers.  The  approval  can  at  any  time  be 
suspended,  amended  or  revoked  If  new  data  becomes  available  which 
causes  concern. 
A  rev lew  scheme  Is  currently  In  ope rat  I on  to  examine  ex 1st lng  act 1  ve 
substance.s  for  pest I c I des.  A II  approved  pestIcIdes  are  pub I I shed 
annually  In  a  list form. . ..A-
,. 
Proposal  for  a 
Council  Directive 
·concerning .the  plactng-of biocidal-products 
....  on  the market 
THE  COUNCIL.OF  THE  EUROPEAN  COMMUNITIES. 
Having  regard  to the Treaty establishing  the  European  Economic  Community, 
an.d  In particular Article  100a  thereof,·  . 
.  ' 
Having  regard  to the  proposal  from  the  COnunl.sslon1 
-· .  ~  '  : : 
.In  cooperation with  the  European  Pari tament2, ·. 
Having  regard  to the opinion of  the  Economic  and  Social  Commlttee3, 
Whereas  provisions  relating  ··to  certain  dangerous  substances,  and 
preparations have already been ,laid down  In  Community  Directives;  whereas 
It  Is  still  necessary  t9  establish  rules  In  respect  of  other  products 
..  wh lch  contaIn  danger.ous  -substances  and  wh lch  may ..  Involve  r lsks  for  man 
and  the environment • 
.  . Whereas.  In  1989..  at  the  tIme  of  the  adopt I on  of  the .8th· Amendment4  to 
Council  Directive  7.6/769/EECS  ·on  the  marketing  ar:td  use  of  certain 
· dangerous  substances  and  preparatIons.  the  Council  .Invited  the  commission 
to  develop  speclfl<:  measures  for  Community  action  In  the  field  of  non-
agricultural  pesticides; 
·'• 
1  O.J. 
2  O.J. 
3  O.J. 
4  O.J.  Nol 398,  30. 1  2 • 1989.  p.  19 
5  O.J.  Nol 262,  27.09.1976.  p.  201 - 2-
Whereas  dur 1  ng  the  d 1  scuss I  on  In  the  Counc II  on  DIrectIve  911 414/EEcS, 
the  council.  expressed  concern  at  the  lack  of  harmonlsed  Community 
provisions  for  non-agricultural  pesticides and  Invited  the Commission  to 
examine  the situation  In  Uember  States and  the  possibility  for  action at 
COmmunIty  I  eve I; 
Whereas  the  term  "non-agricultural  pesticides• was  formerly  used  to  make 
a  distinction  with  plant  protection  products  which  are  essentially 
agricultural  pesticides; whereas.  however,  biocidal  product  Is  now  a  more 
accurate  and  appropr late  term  to  descrIbe  the  products  covered  by  thIs 
Direct lve. 
Whereas  biocidal  products  comprise  a-highly  diverse  group  of  products, 
Including  wood  preservatives,  rodentlcldes,  Insecticides,  antl-foullngs, 
surface  and  water  blocldes,  disinfectants,  fumigants,  preservatives  for 
technical  and  household  materials,  preservatives  for  works  of  art,  and 
others;  whereas  they  can  give rise to exposure of  man  and  the environment 
In  a  great variety of ways; 
Whereas  biocidal  products are necessary for  control  of organisms  that are 
harmful  to  human  or  animal  health  and  for  the  control  of  organisms  that 
cause  damage  to natural  or manufactured products; 
·Whereas  the  COmmission  review  showed  a  diverse  regulatory  status  In  the 
Uember  States;  whereas  there  are  rules  In  a  few  of  the  Uember  States 
governing  the  placing  on  t_he  market  for  use  of  biocidal  products  and 
whereas  these  rules  differ  as  to  t<he  conditions  for  such  placing  on  the 
market  and  whereas  such  differences  may  constitute  not  only  barriers  to 
trade  In  biocidal  products  but  also  to  trade  In  products  treated  with 
them,  thereby affecting the functioning of  the  Internal  market; 
Whereas  In  consequence  the  Commission  concluded  there  was  a  need  for 
action at  COmmunity  level  to eliminate such  barriers by  harmonizing  the 
6  0. J.  No  L  230,  19.08  ..  1991 ,  p.  1 - 3  -
rules relating to  the  placing on  the market  for  use of biOcidal  products, 
tak 1  ng  as  a  condItIon  a  h lgh  I eve I  of  protect I on. for  man  and . the 
environment; 
Whereas. therefore,  the  commission. made  a  statement  towards  the ·council 
proposing  the development  of. a  framework.of·rules;  whereas,  having  regard 
to  the  principle  of  subsidiarity,:  decisions  taken  at  Community  level 
should  be  restricted to those necessary  for  the  proper  functioning of  the 
Common  Market  -and  to  avoid  duplication of  work  by  Member  States  taking 
Into  account  the  necessity  to ensure  a  high  degree of  protection  for .man 
and  the  environment  throughout  the  Convnunlty  and  whereas  a  directive  on 
biocidal  products  (non-agricultural  pesticides)  Is  the  most  appropriate 
way  of establlshlng.such  a  framework; 
Whereas  such. rules  should  provide· that  biocidal  products  should  not  be 
placed  on  the market  for  use  un-less  they  have  been officially authorised; 
Whereas  such  official  authorisation  Is  appropriate  as  biocidal  products 
cons 1st  most l.y  of  dangerous  substances  and  are  preparatIons  des lgned ·to 
have  detrimental  effects  on  the  organisms  they  are  Intended  to  control; 
whereas  b 1  oc  Ida I  products  may  have  consequences  other  than  the ·  1  ntended 
effects  on  the  target  species,  they  were  designed  for  and  whereas,. 
therefore,  . they  may  especially  Involve  risks  for  inan  ar,d  the 
environment; 
Whereas  It  Is  appropriate  that  an  applicant  should  submit'  doss:lers  and 
whereas  It  Is  further  approprlate~that  the  dossiers  shall  contain  only 
that  Information which  Is necessary  to evaluate  the  risks  that will  arise 
from  proposed  uses of  the product; 
Whereas  ·It  Is:  nece.ssary,  ·at  the ·time  w.hen  biocidal  products  are 
authorized,  to  make  sure  that,  when  properly  -used  for  the  purpose 
Intended,  they  are sufficiently effective and  have  no  unacceptable effect 
on  their  target  species  (I.e.  they  do  not  cause  undesirable  resistance 
and  In  the  case of vertebrate animals unnecessary  suffering),  and  have  In - 4  -
the  light  of  current  scientific  and  technical  knowledge  no  unacceptable 
adverse  Influence  on  the  environment  and,  In  particular,  no  harmful 
effect on  human  or  animal  health; 
Whereas  authorization  should  be  ll.mlted  to  biocidal  products  containing. 
certain  ac.tive  substances  evaluated  on  the  basis  of  their  physico-
chemica I.  tox leo log  I ca I  and  ecotox leo  log lea I  proper.t les; 
Whereas  It  Is  necessary  to  estab  I Ish  ~ ·  Convnun I ty  II  st  of  actIve 
substances  permitted  for  Inclusion  In  biocidal  products;  whereas  a 
Community  procedure  must  be  I a ld  down  for· assess lng  whether  or  not  an 
actIve  substance  can  be  entered  In  the  CommunIty  II  st;  whereas  the 
Information  that  Interested  parties must  submit  with  a  view  to  admission 
of  a  substance  to  the  list has  to be  specified;  whereas.  In  the  Interest 
of  safety.  substances  on  the  list·  should  be  reviewed  periodically,  to 
take account  of  developments  In  science  and  technology; 
Whereas  In  the  ll~ht of  the diversity of both  the  substances  and  products 
concerned •.  the  test  requirements  should  allow  for  some  flexibility  to 
suit  the  Individual  circumstances  and  should  result  In  an  overall  r lsk 
assessment; 
Whereas  It  Is  In  the  Interest of  free circulation of biocidal  products  as 
we II  as  of  goods  treated  wl th  them.  that  author lzat  I on  granted  by  one 
Member  State.  and  tests  carried out  with  a  view  to authorization.  should 
be  recognized  by other  Member  States; 
Whereas  It  Is  therefore  desirable  that  a  system  for- the  mutual  exchange 
of  Information  should  be  established  and  that  Member  States  and  the 
Commission  should make  available to each  other  on  request  the particulars 
and  scientific  documentation  subml.tted.  In  connection  with  applications 
for .authorization of. biocidal  products; 
Whereas.  Member  States  must  be  able  to  authorize  biocidal  products.  not 
complying  with  the  above-mentioned  conditions  for  a  limited  period  of 
tIme.  espec I a I I y  In  case  -of  an  unforseen  danger  threatenIng  man  or  the 
envIronment  whIch  cannot  be  contaIned  by  other  means;  whereas  such _.  5  -
authorization  should  be  reviewed  by  the  Commission~ In  close  co-operation 
with  the  Member  States;  whereas  the  Community  procedure  should  not 
prevent  Member  ·states-' from  authorizing  for  use  In  their ·territory  for  a· 
llmlt~d  period  of  time  blbclda1  products  containing  an  active ·substanCe' 
not  yet  entered 'In  the  Community  llst,·-provlded .that  a  dossier  ·meeting: 
Coinmun 1  ty  reQuIrements  has  been  suomI tted  and·  the  Member  State· be II  eves · 
that  the  active -substance  and  the  biocidal  products. satl·sfy  the  Community· 
conditions  set  In  regard  to  them;~~  .-. 
.  ;.·t  ··'.  ,_.  .  ~  l  '· 
Whereas  active  substances  used  In  biocidal  products  may  also  be  used  ·in 
other  preparations  which  have  under  other  Community  legislation,  been 
tested  on- animals;·· wher-~as  double  testing  on  animals  must  be  avoided;' 
whereas,  close·  coordination- should  be  ·ensured  wftfl:··other ·Community· 
legislation and  In partiCular. with ol·rectlve'91/414/EEC on. the placing on 
the  market  of  plant  protection products; 
Whereas·,:ln· order--to ensure·tha't::the  reQuirements- lald'down  In  respect  of 
author·lzed  bioclaat· pr:odutts  a·re.  satisfied ·wtien"·they ,are  -placed  on·  the 
market,  Member  States  must:make  provision  for- appropriate  ·control  ~and· 
inspection  arrangements; 
Whereas  the  Implementation  of  this  Directive,  the  adaptation  of  Its 
Annexes  to  the  development  of  technical  and  scientific knowledge,  and  the 
registration  of  Community-approved  active  substances  necessi-tate  close 
co-operation  between  the  Commission  and  the  Member  States  and  the 
applicant;. whereas  the  procedure  of  the  Standing  Committee  on  Biocidal 
Products  offers  a  suitable  basis  for  this  co-operation;  whereas  this 
ental Is  transparency  of  the  administrative  procedures; 
Whereas  the  fu I I 
Article  14  (4} 
76/769/EEC  on 
Implementation  of  this  Directive  and  especially  of 
wll I  not  be  achieved  for  several  years,  Directive 
the  approxImatIon  of  the  laws.  regulatIons  and 
administrative  provisions  of  the  Member  States  relating  to  restrictions 
on  the marketing  and  use  of  certain dangerous  substances  and  preparations 
can  provide  for  a  framework  to  complement  the  development  of  the  positive 
I 1st  by  1 imitations of  the  marketing  an~ use  of  certain active  substances and  products or  groups of  these; 
Whereas  the  Council  ln.  Its  resolution  of  1  February  19937  on  a 
COmmunity  programme  of  policy  and  action  In  relation  to  the  environment 
and  sustainable  development  has  approved  the  general  approach  and 
strat~gy of  the  programme  presented  by  the  Conlftlsslon  which  states  that 
economic  growth  and  environmental  quality  must  be  viewed  as  mutually 
dependant;  whereas  therefore  the  strengthenIng  of  env I ronmenta I 
protection  requl res  the  rna lntenance  of  the  economic  competl tlveness  of 
Industry; 
Whereas  the  review  of  act lve  substances  shall  need  to  take  account  of 
other  work  programmes  within  .the  framework  of  other  community 
legislations concerned with  the  review or  authorisation of  substances  and 
products; 
Whereas  minimum  rules concernlng.the use of.blocldal  products at  work  are 
already  lal.d  down  under  directives on  health and  safety at  work  :  whereas 
It  Is desirable  to develop  further  these  rules; 
7  O.J.  No  C  138,  17.05.1993,  p.  1 - 7  -
HAS  ADOPTED  THIS  DIRECTIVE: 
Article 1 
Scope of applicability 
1.  This Directive concerns 
(a)  the  authorization  and  the  placing  on  the  market  for  use  of 
biocidal products within  the  Member  States; 
(b)  the mutual  acceptance of  authorizations within  the Community; 
(c)  the  establishment  at  Community  level  of  a  positive  list  of 
active substances which  may  be  used  In  biocidal  products. 
2.  This  directive  shall  apply  to  biocidal  products  as  defined  In 
Article  2,  1  (a)  but  shall  exclude  products where  they  are  covered 
by  the  following directives  for  the purposes of  these directives: 
(a)  Directive  65/65/EEC  on  the  approximation  of  provisions  laid 
down  by  law,  regulatIon  or  admlnlstrat lve  act I  on  relat lng  to 
proprietary medicinal  products8  • 
(b)  Directives  70/524/EEc9  and  82/471/EEc10  or  additives  and 
substances  for  exclusive use  In  animal  feedlngstuffs, 
(c)  Directive 76/768/EEc11  on  cosmetic products, 
8  O.J.  No  22,  09.12.1965,  p.  369 
9  0. J .  No  L  270,  14. 12 . 1970,  p.  1 
10  O.J.  No  L  213,  21.07.1982,  p.  8 
11  O.J.  No  L  262,  27.09.1976,  p.  169 - 8  -
(d)  Directive  89/107/EEc12  on  substances  used  exclusively  as 
a.dd It lves  to  foodstuffs  and  Directive  88/388/EEc13  on 
substances used exclusively as  flavourings  In  foodstuffs. 
(e)  Direct lve  91/414tEEc14  concerning  the  placing  of  plant 
protection products on  the market. 
(f)  Directive  ..  / ...  /EEc15  concerning medical  devices. 









(a)  Directive  76/769/EEC  on. the  approximation  of  the  laws. 
regulations  and  administrative  pro~lslons of  the  Member  States 
relating  to  restrictions  on  the  marketing  and  use"of  certain 
dangerous  substances and  preparations. 
(b)  ntrectlve  79/117/EEC  prohibiting  the  placing  on  the  market  and 
use  of  plant  protection  products  containing  certain  active 
substances16. 
(c)  Regulation  (EEC)  No  1734/88 on  the  export  from  and  Import  Into 
the Community  of certain dangerous  chemlcats17. 
(d)  DIrectIve  80/1107  /EEC  ·on  the  protection  of  workers  aga 1  nst 
dangers  from  exposure  to  chemical.  physical  and  biological 
agents  at  work18,  and  Directive  89/391/EEC  on  the  Introduction 
of  measures  to encourage- Improvements  In  the  safety  and  health 
of  workers  at  work19  and  Individual  Directives  based  on  these 
DIrectIves. 
O.J.  No  L  040.  1  2 . 02 . 1989 •  p.  27 
O.J.  No  l  184.  15.07.1988.  p.  61 
O~J.  No  L  230.  19.08.1991,  p.  1 
O.J.  No  ......... 
O.J.  No  L  33.  08.02.1979.  p.  36 
O.J.  No  L  155.  22.6.1988.  p.  2 
O.J.  No  L  327.  03.12.1980.  p.  8 
O.J.  No  L  183.  29 . 06 . 1989 •  p.  1 - 9  -
(e)  Directive  90/679/EEc20  on  the  protection  of  workers  from 
risks  related  to  exposure  to  biological  agents  at  work  (7th 
Individual  directive  within  the  meaning  of  Article  16  (1)  of 
Directive 89/391/EEC). 
4.  Article  18  does  not  apply  to  the  carriage  of  biocidal  products  by 
rail,  road,  Inland  waterway,  sea or  air. 
Article 2 
Definitions' 
1.  For  the  purposes  of  this directive  the  following  definitions  shall 
apply: 
a)  Biocidal  products 
active  substances  and  preparations  containing  one  or  more 
active  substances.  put  up  In  the  form  In  which  they  are 
suppl led  to  the  user.  Intended  to  destroy,  deter.  render 
harmless.  preVent  the  act ion  of.  or  otherwise  exert  a 
control! lng  effect on  any  harmful  organism. 
An  Indicative  list of  product  types  Is at  Annex  V. 
b)  Active Substances 
substances.  fungi  and  micro  organisms  Including  viruses  having 
general. or  specific action on  or  against  harmful  organisms. 
20  O.J.  No  L 374,  31.12.1990,  p.  1 - 10  -
c)  Harmful  organism 
any  organism  which  has  an  unwanted  presence  or  a  detrimental 
effect  for  man.  his  activities  or  the  products  he  uses  or 
produces.  or  for  animals or  for  the environment. 
d)  Placing on  the market 
any  supply.  whether  In  return  for  payment  or  free  of  charge. 
other  than  for  storage  followed  by  conslgnement  from  the 
territory  of  the  Community  or  disposal.  Importation  of  a 
biocidal  product  Into  the  territory  of  the  Community  shall  be 
deemed  to constitute  placing on  the  market  for  the  purposes  of 
this directive. 
e)  Authorisation 
administrative act  by  which  the competent  authority of  a  member 
state  ,au thor I  ses.  fo I I  owIng  an  app I I  cat ion  submItted  by  an 
appl !cant.  the  placing  on  the  market  of  a  biocidal  product  In 
Its  territory or  In  a  part  thereof. 
f)  Residues 
.  One  or  more  of  the  substances  present  In  a  b Joe Ida I  product 
which  remains  as  a  result  of  Its use  Including  the  metabol ltes 
of  such  substances  and  products  resu It I  ng  from  theIr 
degradation or  reaction. 
2.  For  the  purposes of  this Directive  the definitions  for 
(a)  substances. 
(b)  preparations. 
(c)  scientific research  and  development. - 11  -
(d)  process-orientated research and  development 
laid  down  In  Article  2  of  Directive  67/548/EEC  on  the 
c 1  ass  1  f 1  cat I  on,  paclcag I  ng  and  I  abe I I I  ng  of  dangerous  substances21 
shall  apply. 
Artlcle 3 
Authorization for  placing on  the market  of 
biocidal  products 
1.  Member  States shall  prescribe  that  a  biocidal  product  shal I  not  be 
placed on  the market  and  used  In  their  territory unless  It  has  been 
authorized  In  accordance with  this Directive. 
2.  Every  appl lcatlon  for  authorization  shall  be  decided  upon  within  a 
reasonable period. 
3.  A biocidal  product  that  has  already  been  authorized  In  one  Member 
State shall  be  authorized,  In  another  Member  State within  60  days 
of  ·an  application  being  received  by  the  other  Member  State, 
providing  that  -the  active  substance  of  the  biocidal  product 
conforms  to ·the entry  In  Annex  1. 
4.  If  In  complying  with Artlcle#4 a  Member  State establishes that 
(a)  unacceptable  resistance  .of  the  target  organism  to  the 
biocidal  product  Is  proven or 
(b)  the  relevant  cIrcumstances  of  use,  such  as  c II mate  or 
breeding  period  of  the  target  species.  differ 
significantly  from  those  In  the  Member  State  where 
biocidal  product  was  first  authorized,  and  an  unchanged 
21  O.J.  No  L 196,  16.08.1967,  p.  1  (as amended) - 12  -
authorization may  therefore present  unacceptable  risks  to 
man  or  the environment, 
the  Member  State  may  request  that  the  directions  for  use  and  the 
dose  rate  referred  to  In  Article  18  (3)  (e)  are  adjusted  to  the 
different  circumstances,  or,  If  the  risk  can  not  be  prevented  in 
any  other  way,  the  Member  State  may  request  changes  to  be  made  to 
the  biocidal  product  Itself  so  that  conditions  for  issue  of  an 
authorisation  provided  for  In  article 4  are satisfied. 
5.  Notwithstanding  paragraph  4  where  a  Member  State  believes  a 
biocidal  product  cannot  meet  the  conditions set  out  under  Article  4 
and  consequently  proposes  to  refuse  authorization,  it  shal I  notify 
the  Commission,  other  Member  States  and  the  applicant  and  shall 
provide  them  with  an  explanatory  document  giving  details  of  the 
product  and  setting out  the  grounds  on  which  it  proposes  to  refuse 
the authorization. 
The  Commission  shall  prepare  a  proposal  on  these  matters  In 
accordance  with  Art lcle  24  ·for  decision  In  accordance  with  the 
procedure  laid  down  In  Article  25(3). 
6.  Member  States  shall  prescribe  that  biocidal  products  shal 1  be 
classified,  packaged  and  label led  In  accordance  with  the provisions 
of  this Directive. 
7.  Authorizations  shal I  be  granted  for  a  fixed  period of  10  years  from 
the  date  of  first  entry  of  the  active  substance  onto  Annex  1;  they 
may  be  renewed  after  verification  that  the  conditions  imposed  in 
paragraphs  1  and  2  are  stl II  satisfied.  Renewal  may,  where 
necessary,  be  granted  only  for  the  period  necessary  to  allow  the 
competent  authorItIes  of  the  Member  States,  to  make  such 
verification,  where  an  appl lcatlon  for  renewal  has  been  made. 
8.  Member  States  shal 1  prescribe  tha~  biocidal  products  must  be 
proper I Y used.  Proper  use  sha I I  1  nc 1  ude  comp I i a nee  with  cond 1  t ions - 13  -
establ !shed  under  Article  4  and  specified  under  the  label I ing 
provisions  of  this  directive.  Proper  use  shall  also  involve  the 
rational  appl !cation  of  a  combination  of  physical.  biological, 
che~lcal  or  other  measures  as  appropriate  whereby  the  use  of 
biocidal  products  Is  limited  to  the  minimum  necessary.  Where 
~locldal  products  are  used  at  work  use  shall  also  be  in  accordance 
with  the  reQuirements  of  directives  for  the  protection of  workers. 
Article 4 
Conditions  for  Issue of  an authorization 
1.  Member  States shal I  authorise  a  biocidal  product  only  if 
(a)  the  active  substance(s)  included  therein  are  I isted  in  Annex 
and any  conditions  laid down  In  the  Annex  are· fulfilled; 
(b)  it  is  established,  in  the  light  of  current  scientific  and 
technical  knowledge  and  It  Is  shown  from  appraisal  of  the 
dossier  provided  for  In  Annex  IJJ·  and,  where  specified,  the 
relevant  parts of  Annex  IV  according  to  the  common  principles 
for  the  evaluation  of  dossiers,  that· when  used  as  authorised 
and  having  regard  to  : 
all  normal  conditions  under  which  the  biocidal  product 
may  be  used, 
how  the material  treated with  it  may  be  used, 
the  consequences  from  use  and  disposal. 
the  biocidal  product·,:·· - 14  -
(I)  Is  sufficiently effective, 
(I I)  has  no  unacceptable effect on  the  target organism, 
(Ill) has  no  harmful  effects  Itself  or  as  a  result  of  Its 
residues,  on  human  or  animal  health,  directly  or 
Indirectly  (eg  through  drinking  water,  food  or  feed)  or 
on  groundwater, 
(lv)  has  no  unacceptable  effect  on  the  environment  having 
particular  regard  to  the  following  considerations 
- Its  fate  and  distribution  In  the  environment; 
particularly  contamination  of  water  Including  drinking 
water  and  groundwater, 
- Its  Impact  on  non-target  organisms, 
{v)  does  not  cause  unnecessary  suffering  and  pain  to 
vertebrates  to be  controlled, 
(c)  the  nature  and  Quant I ty  of  1  ts  actIve  substances  and,  where 
appropriate,  ·any  toxicologically  or  ecotoxlcologlcally 
significant  Impurities  and  co-formulants,  and  Its  residues  of 
toxicological  or  environmental  significance,  which  result  from 
authorized  uses,  can  be  determined  according  to  the  relevant 
reQuirements  In  Annexes  tl.  Ill  and  IV; 
(d)  Its  physical  and  chemical  properties  have  been  determined  and 
deemed  acceptable  for  purposes  of  the  appropriate  use,  storage 
and  transport  of  the  product; 
2.  A biocidal  product  classified  according  to  Article  18  (1)  as  very 
toxic or  as  a  category  1  or  2  carcinogen,  or  mutagen  or  classified 
as  toxic  for  reproduction  category  1  or  2,  shall  not  be  authorized 
for  marketing  to,  or  use  by  the  general  public. - 15  -
3.  Authorization  may  be  conditional  on  requirements  relating  to 
marketing  and  use  necessary  to  ensure  compliance  with  the 
provisions of  paragraph  1. 
4.  Where  other  Community  provisions  Impose  requirements  relevant  to 
the  conditions  for  the  Issue  of  an  authorisation  and  particularly 
where  these  are  intended  to  protect  the  health  of  distributors, 
users.  workers  and  consumers  or  animal  health  or  the  environment, 
the  competent  authorIty .shall  take  these  into  account  when  issuing 
an  authorisation  and  where  necessary  shal 1  issue  the  authorisation 
subject  to  those  requirements: 
Article 5 
Review of an  authorization 
Authorization  may  be  reviewed  at  any  time  If  there  are  indications  that 
any  of  the  requirements  referred  to  In  Article 4  are  no  longer  satisfied. 
In  such  Instances  the  Member  States  may  require  the  applicant  for 
authorization  or  the  applicant  to  whom  a  modification  of  authorization 
has  been  granted  in  accordance  with  Article  6  to  submit  further 
information  necessary  for  the  review.  Renewal  may,  where  necessary,  be 
granted only  for  the  period  necessary  to  complete  a  review.  and  shal I  be 
granted  for  the  period necessary  to provide  such  further  information. 
Article 6 
Cancellation or modification of  an  authorization 
1.  An  authorization shall  be  cancelled  if 
(a)  the active substance  is no  longer  Included  in  Annex  I; ,..  16  -
(b)  the  conditions  under  Article  4  (1)  for  obtaining  the 
authorization are  no  longer  satisfied; 
(c)  it  Is  discovered  that  false  or  misleading  particulars  were 
suppl led  concerning  the  facts  on  the  basis  of  which  the 
authorization was  granted; 
2.  An  authorization  may  also  be  cancel led  If  the  authorization  holder 
requests  It  and  states  the  reasons  for  the  cancellation. 
3.  W!lere  a  Member  State  cancels  an  authorization,  it  shall  inform  the 
authorisation  holder  and  It  may  grant  a  period  of  grace  for  the 
disposal  or  for  storage,  marketing  and  use  of  existing stocks,  of  a 
length  In  accordance  with  the  reason  for  the  cancellation  without 
prejudice  to  any  period  provided  for  by  decision  taken  under 
Directive 76/769/EEC or  In  connection with  paragraph  1  (a). 
4.  An  authorization shal I  be  modified  If,  on  the  basis of  developments 
in  scientific  and  technical  knowledge,  the  conditions  of  use  and, 
In  particular,  manner  of  use  or  amounts  used  can  be  modified. 
5.  An  authorization  may  also  be  modified  If  the  authorization  holder 
requests  It  and  states the  reasons  for  the modification. 
6.  Where  a  proposed  modlflcatlo~ concerns  an  extent~on of  uses,  Membe~ 
State  shall  extend  the  authorization  subject  to  the  particular 
conditions placed  on  the  active substance  In  Annex  I. 
7.  Where  a  proposed  modification  of  an  authorization  involves  changes 
to  the  particular  conditions  placed  on  the  active  substance  in 
Annex  I,  these  can  be  made  only  after  evaluation  of  the  active 
substance,  with  regard  to  the  proposed  changes,  in  accordance  with 
the  procedures  laid  down  In  Article  10. - 17  -
a.  Modifications  shall  only  be  granted  If  It  is  establ ished.that  the 
conditions  under  Article  4  continue  to  be  satisfied. 
Article 7 
Requirements  for  authorization 
1.  Application  for  authorisation  shall  be  made  by  or  on  behalf  of  the 
person  who  wl I I  be  responsible  for  the  first  placing  on  the  market 
of  a  biocidal  product  In  a  particular  Member  State  and  shal I  be  to 
the  competent  authority of  that  Member  State.  Every  applicant  shal I 
be  required  to  have  a  permanent  office within  the  Community. 
2.  Member  States  shal I  require  that  applicants  for  authorization  of  a 
biocidal  product  shal I  submit  to  the  competent  authority  :. 
(a)  a  dossier  on  the  biocidal  product  satisfying,  in  the  I ight  of 
current  scientific  and  technical  knowledge,  the  requirements 
set  out  in  Annex  Ill  and, ·where  specified,  the  relevant  parts 
of  Annex  IV,  and 
(b)  for  each  active  substance  In  the  bloc:dal  product,  a  dossier 
satisfying,  In  the  light  of  current  scientific  and  technical 
know ledge,  the  requIrements  set  out  in  Annex  It  and,  where 
speclfled,  the  relevant  parts of  Annex  IV. 
3.  The·  dossiers  shall  Include  a  detailed  and  full  description  of  the 
studies  conducted  and  of  the  methods  used  or  a  bibliographical 
reference  to  those  methods.  The  Information  in  the  dossiers 
supplied  according  to  Article  7(2)  shall  be  sufficient  for  an 
evaluation  to  be  made  of  the  effects  and  properties  referred  to  In 
Artlcle.4  (1)(b),  (c)  and  (d).  It  shall  be  submitted  to  the 
competent  authority  in  the  form  of  technical  dossiers,  containing 
the  lnformat ion  and  results of  the  studies  referred  to  in  Annex  II 
and  Ill and,  where  specified,  the  relevant  parts of  Annex  IV. - 18'  -
4.  Information  which  Is  not  necessary  owing  to  the  nature  of  the 
biocidal  product  or  of  Its proposed  uses  need  not  be  suppl led.  The 
same  applies  where  It  Is  not  scientifically  necessary  or 
technically  possible  to  supply  the  Information.  In  such  cases,  a 
justification,  acceptable  to  the  competent  authority  must  be 
submitted. 
5.  If  the  evaluation  of  the  dossier  shows  that  further  information 
Including  Information  and  results  from  further  testing  is  necessary 
to  evaluate  the  risks  of  the  biocidal  product,  the  competent 
authority  shal 1  ask  the  applicant  to  submit  such  information. 
6.  The  name  of  an  active  substance  must  be  given  as  registered  in  the 
I 1st  contained  In  Annex  to  Directive  67/548/EEC  or,  if  not 
Included  therein,  as  given  In  the  European  Inventory  of  Existing 
Chemical  Substances. (EINECS)22,  or  if  not  included  therein,  it 
must  be  given  Its  ISO  common  name.  If  the  latter  is  not  avai table, 
the  substance  must  be  designated  by  Its  chemical  designation 
according  to  IUPAC  rules. 
7.  Tests  must  be  conducted  accordIng'  to  the  methods  described  in 
Annex  V  of  Directive  67/548/EEC.  In  the  event  of  a  method  being 
Inappropriate or  not  described,  other  methods  used  should,  whenever 
possible,  be  internationally  recognized  and  must  be  justified. 
Tests must  be  conducted  in  accordance  with  the  provisions  laid  down 




on  the 
other  scientific 
appl icatlon  of 
purposes  and 
the  principles 
Directive 
of  Good 
Laboratory  Practice  and  the  verification of  their  applications  for 
tests on  chemical  substances. 
8.  Competent  Authorities  as  referred  to  under  Article  23  shal I  ensure 
that  a  file  is  compiled ,on  each  application.  Each  file  shall 
22  0. J .  No .  c 146,  15 . 6. 1990,  p .  1 
2  3  0 . J .  No  L  15 ,  1  7 . 1 . 1  987 ,  p .  29 .- 19  -
contaIn  at  least  a  copy  of  the  application,  a  record  of  the 
administrative  decisions  taken  by  the  Member  State  concerning  the 
application  and  concerning  the  dossiers  submitted  in  accordance 
with  paragraph  2  together  with  a  summary  of  the  latter.  Member 
States  shal I  on  request  make  avai labie  to  the  other  Competent 
Authorities  and  to  the  Commission  the  flies  provided  for  in  this 
paragraph;  they  shall  supply  to  them  on  request  all  lnformat ion 
necessary  for  ful I  comprehension  of  applications,  and  shal I  where 
requested  ensure  that  applicants  provide  a  copy  of  the  technical 
documentation  laid  down  in  article 7. 
9.  Member  States  may  require  that  samples  of  the  preparation  and  of 
its  Ingredients  be  provided. 
Article 8 
Placing on  the market  of active substances 
1.  Member  States  shal I  prescribe  that  where  a  substance  is  an  active 
substance  for  use  In  biocidal  products  it  may  not  be  placed  on  the 
market  for  such  use unless 
(a)  where  the  active  substance  was  not  on  the  market  before 
the  date of  entry  into  force  of  this Directive,  a  dossier 
has  been  forwarded  to  a  Member  State,  which  satisfies  the 
requirements  of  Article  10  (1),  and  is  accompanied  by 
the  declaration  that  the  active  substance  is  intended  tor 
Inclusion  In  a  biocidal  product.  This  shal I  not  apply  to 
substances  for  use  under  Article  15. 
(b)  It  is  classified,  packaged  and  labelled  in  accordance 
with  the  provisions of  Directive  67/548/EEC. - 20  -
Article 9 
Inclusion of  an 
active substance  In  Annex 
1.  In  the  light  of  current  scientific  and  technical  knowledge,  an 
active substance  shal I  be  Included  In  Annex  1  for  an  Initial  period 
not  exceeding  10  years  If  It  may  be  expected  that  biocidal  products 
containing  the  active  substance  will  fulfil  the  conditions  laid 
down  In  Article  4  1  (b),  (c)  and  (d). 
2.  Inclusion  of  an  active  substance  In  Annex 
appropriate,  be  subject  to  the  following  : 
(I)  requirements  on 
sha I 1 ,  where 
(a)  the  minimum  degree  of  purity  of  the  active 
substance; 
(b)  the  nature  and  max I  mum  content  of  ·certain 
Impurities; 
(c)  product  type  In  which  It  may  be  used; 
(d)  manner  of  use; 
(e)  designation  of  categories  of  users  (e.g. 
Industrial,  professional  or  non-professional); 
(f)  other  particular  conditions  from  the evaluation of 
the  information  referred  to  in  Article  10  (2); 3. 
- 21  -
(II)  the  establ lshment  of  the  following 
(a)  a  suitable standard of  user  protection, 
(b)  where  relevant,  an  acceptable  dally  intake  for  man 
(AD I), 
(c)  fate  and  behaviour  In  the  environment  and  impact 
on  non-target  organisms. 
The  inclusion  In  Annex  of  an· active  substance  shal I  be 
restricted  to  those  product  types  In  Annex  v  for  which  acceptable 
·data  have  been  submitted  in  acco~dance with  Article  7. 
4.  The  inclusion  of  a  substance  In  Annex  I  may  be  renewed  on  one  or 
more  occasions  for  periods  not  exceeding  10  years.  The  initial 
Inclusion  as  well  as  any  renewed  Inclusion  may  be  rev,!·ewed  at  any 
time  If there  are  Indications  that  any  of  the  requirements  referred 
to  In  paragraph  are  no  longer  satisfied.  Renewal  may,  where 
necessary.  be  granted  on I y  for  the  period  necessary  to  camp lete  a 
rev lew,  where  an  appllcat ion  has  been  made  for  such  renewal  and 
shall  be  granted  for  the  period  necessary  to  provide  information 
requested  In  accordance  with Article  10  (2). 
5.  The  fnclusion  of  an  active  substance  In  Annex  1  may  be  refused  or 
reviewed,  if there  Is  another  active  substance  on  Annex  I  for  the 
same  product  type,  or  another  method  of  control  exists,  which  in 
the  I lght  of  scientific  or  technical  knowledge  present 
significantly  less  risk  to  health  or  to  the  environment.  When 
considering  such  a  refusal,  ~n evaluation of  the  alternative active 
substanc·es  or  methods  sha II  be  produced  in  accordance  with  common 
prlnclples  for  the evaluation of  dossiers,  to  demonstrate  they  can 
be  used  with  the  same  effect  on  the  target  organism  without 
significant  economic  and  practical  disadvantages  to  the  user.  The 
evaluation shal I  be  circulated  In  accordance  with  the  procedures  in 
Article  10(2)  for  decision  in  accordance  with  the  procedures  laid 
down  In Articles  24  and  25(3). - 22  -
Article 10 
Procedure  for  Inclusion 
of an active substance  In  Annex 
1.  An  active  substance  will  be  considered  for  Inclusion  In  Annex  I, 
and  any  changes  to Annex  I  will  be  considered when  : 
(a)  an  app II cant  has  forwarded  to  the  competent  authorIty  of  one 
of  the  Member  States 
(I)  a  dossier  for  the  active  substance  satisfying  the 
requirements  of  Annex  I 1  and,  where  ·specified,  the 
relevant  parts of  Annex  IV; 
(II)  a  dossier  for  at  least  one  biocidal  product  containing 
the active substance satisfying  the  requirements of  Annex 
I II  and,  where  specified,  the  relevant  parts of  Annex  IV; 
(b)  the  receiving  competent  authority  has  checked  the  dossiers  and 
bel !eves  them  to satisfy  the  reQuirements of  Annex  I I  and  Annex 
I I I  and  where  relevant  Annex  IV,  accepts  them  and  agrees  to  the 
applicant  forwarding  a  summary  of  the  dossiers  to  the 
Commission  and  the other  Member  States. 
2.  The  receiving  Competent  A~thority  shall,  within  6  months  of 
accepting  the  dossiers  carry  out  an  evaluation  thereof.  A copy  of 
the  evaluation  sha II  be  sent  by  the  Competent  AuthorIty  to  the 
Commission,  the ·other  Member  States  and  to  the  applicant,  together 
with  a  recommendation  for  the  Inclusion,  or  otherwise,  of  the 
active substance  In  Annex  1. 
If  during  the  evaluation  of  the  dossiers  It  appears  that  further 
Information  Is  necessary  for  ful I  evaluation  to  be  made,  the 
receiving  Competent  Authority  shall  ask  that  the  applicant  submit 
13 - 23  -
such  Information.  The  6  month  period  shall  be  suspended  from  the 
date  of  Issue  of  the  competent  authority's  request  until  the  date 
the  Information  Is  received.  The  competent  authority  shall  inform 
the  other  Member  States  and  the  CommIssion  of  Its  action  at  the 
same  time  as  It  Informs  the  applicant. 
- 3.  On  receipt  of  the  evaluation,  the  Commission  shall,  in  accordance 
with  In  Article  24,  prepare  a  proposal  without  undue  delay  for 
dec Is Jon  In  accordance  wIth  the  procedures  Ia I  d  down  In  Article 
25(3).  The  decision  shal I  be  taken  at  the  latest  15  months  after 
the  receipt  by  the  Commission  of  the  evaluation  referred  to  in 
paragraph  2. 
Article 11 
Use  of data  held  by  Competent  Authorities  for 
other  applicants 
1.  Member  States shall  not  make  use  of  the  information  referred  to  in 
Annex  II  and  the  relevant  parts  of  Annex  IV  for  the  benefit  of  a 
second or  subsequent  appl lcant  : 
a)  unless  the  second  or  subsequent  appl lcant  has  the  written 
agreement  of  the  first  applicant  that  use  may  be  made  of  such 
Information,  or 
b)  In  the  case  of  an  act lve  substance  not  on  the  market  on  the 
date of  coming  Into  force·of  this directive,  for  a  period of  15 
years  from  the date of  first  Inclusion  In  Annex  I  or; 
c)  In  the  case of  an active substance already on  the market  on  the 
date of  coming  Into  force  of  this directive; 
(I)  for  a  period  of  10  years  from  the  date  of  coming  into 
force  of  this directive  for  any  information  submitted  for 
the  purposes  of  this  directive  except  where  such - 24  -
Information  Is  already  protected  under  existing  national 
rules  relating  to  biocidal  products.  In  such  cases  the 
Information shall  continue  to  be  protected  in  that  Member 
State  unt 1 1  the  expIry  of  any  remaInIng  per lod  of  data 
protection  provided  for  under  national  rules,  up  to  a 
maximum  of  10  years  from  the  date or  coming  Into  force of 
this directive; 
I I)  for  a  per lod ·of  10  years  from  the  date  of  entry  of  an 
active  substance  onto  Annex  for  information  submitted 
for  the  first  time  In  support  of  the  first  inclusion  in 
Annex  I  of  either  the  active  substance  or  an  additional 
product  type  for  that  active  substance. 
d)  In  the  case  of  any  further  Information  submitted  for  the  first 
time  for  any  of  the  following  : 
(I)  variation of  the  conditions of  the  entry  on  Annex  I; 
(I i)  maintenance  of  the  entry on  Annex  1 
for  period  of  5  years  from  the  date  of  decision 
following  receipt  of  further  lnformat ion  unless  the  5 
year  period  expires  before  the  period  provided  for  in 
paragraph  1  (b)  &  (c),  In  which  case  the  period  of  5 
years  shal I  be  extended  so  as  to  expire  on  the  same  data 
as  those  periods. 
Where  an  active  substance  is  Included  In  Annex  I  of  this 
directive  and  also  In  Annex  I  of  directive  91/414/EEC, 
the  informat lon  referred  to  in  Annex  II  and  relevant 
parts  of  Annex  IV,  which  Is  required  under  both 
dIrectIves  and  has  been  provIded  under  both  directives, 
sha II  benefIt  on I y  from  the  periods  of  data  protect ion 
provided  for  under  directive 91/414/EEC. - 25  -
2.  Member  States shall  not  make  use  of  the  Information  referred  to  in 
Annex.  Ill  and  the  relevant  parts of .Annex  IV.  for  the  benet it  of  a 
second or  subsequent  applicant~ 
a)  unless  the  second  or  subsequent  applicant  has  the  written 
agreement  of  the  first  appl lcant  that  use  may  be  made  of  such 
Information,  or 
b)  In  the  case  of  a  biocidal  product  containing  an  active 
substance  not  on  the market  on  the  date of  coming  into  force  of 
this directive;  for  a  period of  jO  years  from  the  date  of  first 
authorization  In  any  Member  State;  or; 
c)  In  the  case  of  a  biocidal  ·product  containing  an  active 
.substance  already  on  the  market  on  the  date  o.f  coming  into 
force of  this directive; 
(I)  for  a  period  of  10  years.from  the  date  of  coming  Into 
force of  this directive for  any  Information  submitted  for 
the  purposes  of  this directive,  except  in  the  case  where 
data  are  already  protected according  to existing national 
rules  relating  to  biocidal  products,  in  which  case  such 
data  sha II  be  protected  In :that  Member  state  unt I 1  the 
expiry  of  any  remaining  period  of  data  protection 
provided  for  under  those  national  rules,  up  to  a  maximum 
o.f  10  years  from  the  da.~e  of  coming  into  force  of  this 
directive; 
(II)  for  a  per lod  of  10  years  from  the  date  of  entry  of  an 
active  substance  onto  Annex  I,  for  information.which  is 
·submitted  for  the  fl.rst  time  In  support  of  the  inclusion 
In  annex  eIther  of  ·the  actIve  substance·  or  of  an 
additional  product  type  for  that  active substance. 
d)  In  the case of  any  data  submitted  for  the  first  time  for  either 
of  the  following  : - 26  -
(I)  variation  of  the  conditions  of  authorisation  of  a 
biocidal  product; 
(II)  submission  of  data  necessary  to  maintain  entry  of  an 
active substance onto Annex  I 
for  a  period of  5  years  from  the  date of  first  receipt  of 
further  Information  unless  the  5  years  period  expires 
before  the  per tod  In  Paragraph  2  (b)  and  (c)  above  In 
which  case  the  period of  5  years  shall  be  extended  so  as 
to expire on  the  same  date as  those  periods. 
Where  a  biocidal  product  contains  an  active  substance  which  is  included 
In  Annex  I  of this directive and  also  In  Annex  I  of  O.lrectlve  91/414/EEC, 
the  Information  referred  to  In  Annex  II  I  and  relevant  parts of  Annex  IV, 
which  Is  reQuired  under  both  directives  and  has  been  provided  under  both 
directives,  shall  benefit  only  from  the  periods  of  data  protection 
provided  for  under  directive 91/414/EEc: 
Article 12 
Second  and  subsequent  applications for  authorization 
1.  In  the  case of  a  biocidal  product  which  has  already  been  authorized 
In  accordance  with  Artlcles.3  and  4,  and  without  prejudice  to  the 
obligations  Imposed  under  Article  11,  the  Competent  Authority  may 
agree  that  a  second  or  subseQuent  applicant  for  authorization  may 
refer  to data  provided  by  the  first  applicant  insofar  as  the  second 
or  subsequent  applIcant  can  provide  evidence  that  the  biocidal 
product  and  Its active substances  is  the  same  as  the  one  previously 
authorized,  Including degree of  purity  and  nature of  impurities. - 27  -
2.  Notwithstanding  Article  7,  paragraph  2,  where .the  active  substance 
Is  I isted  In  Annex 
(a)  applicants  for  authorization of  biocidal  products shall,  before 
carrying out  experiments  Involving  vertebrate  animals,  enquire 
of  the  competent  authority  of  the  Member  State  to  which  they 
Intend making  appl !cation 
whether  the  biocidal  product  for  which  an  application  is 
to  be  made  Is  the  same  as  a  biocidal  product  for  which 
authorization  has  been  gr~nted; and 
as  to  the  name  and  address  of  the  holder  or  holders  of 
the  authorization or  authorizations. 
The  enquiry shall  be  supported  by  evidence  that  the  prospective 
applicant  Intends  to  apply  for  authorization  on  his  own  behalf 
and  that  the  other  Information  specified  in  Article  7(2)  Is 
aval'labte . 
.  ·(b)  the  competent  authority  of  the  Member  State,  If  satisfied  that 
the  app l.i cant  Intends  to  app I  y,  sha I I  provIde  the  name  and 
address  of  the  holder  or  holders  of  previous  relevant 
authorizations  and  shal I  at  the  time  Inform  the  holders  of  the 
authorizations of  the  name  and  address of  the  appl !cant. 
The  holder  or  holders  of  previous  authorizations  and  the 
applicant  shall  take all. reasonable steps  to  reach  agreement  on 
the  sharing  of  Information  so  as  to  avoid  the  duplication  of 
testing on  ver~ebrate animals. 
Where  data  Is  requested with  a  view  to  Inclusion  In  Annex  I  of 
an.actlve substance  already  on  the  market  on  the  date  of  entry 
Into  force  of  this Directive,  the  competent  authorities of  the 
t.eem.b~r  States  ,~ha II  encourage  data  holders  to  cooperate  In  the 
provision  of  the  requested  data,  with  a  view  to  limiting  the - 28  -
dupl !cation of  testing on  vertebrate animals. 
If  the  applicant· and  holders  ~f previous  authorizations  of  the 
same  product  can still  not  reach  an  agreement  on  the  sharing of 
data,  Member  States  may  Introduce  national  measures  obliging 
the  applicant  and  holders  of  previous  authorizations  located 
within  their  territory  to  share  the  data  with  a  view  to 
avoiding  duplicative  testing  on  vertebrate  animals  and 
determine  both  the procedure  for  utilizing  Information.  and  the 
reasonable  balance of  the  Interests of  the  parties concerned. 
Article 13 
New  lnformat lon 
1.  Member  States  shal1  prescribe  that  the  holder  of· an  authorisation 
for  a  biocidal  product  shal 1  Immediately  notify  the  competent 
authority  of  Information  which  they  may  reasonably  be  expected  to 
be  aware  concerning  an  active  substance  or  a  biocidal  product 
containing  It  and  which  may  affect  continuing  authorization.  In 
particular  the  foi1Qwlng  shall  be  notified: 
new  knowledge  or  Information  on  the  effects  of  the  active 
substance or  biocidal  product  for  man  or  the  environment; 
changes  In  the ·source or  composition of  active substance; 
changes  in  composition of  a  biocidal  product 
2.  Member  States  shall.  Immediately  notify other  Member  States  and  the 
Commission  any  such  Information  they  receive concerning potentially 
harmful  effects  for  man:  or  the  environment  of  a  biocidal  product, 
Its active substances,  Impurities,  co-formulants or  residues. 
, ... - 29  -
Article 14 
Transitional  measures  and 
derogations  from  the  requirements 
1.  ·,By  way  .of  derogat lon  from  Art lcle  3  and  4,  a  Member:  State  may 
authorize  tempor.arlly  for  a  period  not  exceeding  120  days  the 
placing  on  the  market  of  biocidal  products  not  complying  with  the 
provisions  of  this  Directive  for  a  limited  and  controlled  use  if 
such  a  measure  appears  necessary  because  of  an  unforseen  danger 
which  cannot  be  contained  by  other  means ..  In this  case,  the  Member 
State  .concerned  .sha II  lmmed I ate I y  Inform  the  other  Member  States 
and  the  Commission  of  Its  action  and  the  justification  for  it.  The 
Commission  shall  make  a  proposal  and  It  shall  be  decided  without 
delay,  In  accordance  with  the  procedure  laid  down  In  Article  25, 
whether  and  under  which  condltlons.the  action  taken.~y  the  Member 
State  may  b•  extended  for  a  period  to  be  determined,  be  repeated, 
or  be  revoked. 
2.  By  way  of  derogation  from  .Article  4.  (1)·  (a)  and  until  an  active 
substance  is  I lsted  In  annex  1  a  Member.  State  maj  authorize 
provls!ona' ly,  for  a  per.lod  not  ~xce~dlng three  years,  the  placing 
on  the  market  of  a  biocidal  product  containin~ an  active  substance 
not  listed  In  Annex  r  and .not  yet  avai table  on  the  m?trket  on  the 
date  of  coming  Into  force  of  this Directive.  Such  an  authorisation 
may  only  be  Issued  if,  after  evaluation  of  dossiers  in  accordance 
with  the Article  10  the  Member  State bel leves  that  : 
the  active  substance  satisfies  the  reQu.irements  of  Article  9 
and; 
the  biocidal  product  may  be  expected  to  satisfy  t.he  conditions 
of  Article 4(1)  (b),  (c)  and  (d), 
and  no  other  Member  State,  on  the  basis of  the  summary  it  receives, 
makes  legitimate objection  In  accordance  with  Article  16  (2)  to  the - 30  -
completeness of  the  dossiers.  Where  an  objection  is made  a  decision 
on  the  completeness  of  dossiers  shall  be  taken  In  accordance  with 
the  procedures  laid  down  In  Article 25(3)  without  undue  delay. 
If  following  the  procedures  laid  down  In  Article  24  and  25(3),  It 
Is  decided,  that  the  active  substance  does  not  satisfy  the 
requirements  specified  In  Article 9,  the  Member  State shall  ensure 
that  the  provisional  authorization  Is cancelled. 
In  cases where  evaluation of  dossiers  for  the  purposes of  Inclusion 
of  an  active  substance  In  Annex  1  Is  not  completed  when  the  period 
of  3  years  eicp I res,  the  competent  authorIty  .may  further 
provisionally  authorize  the  product  for  a  period  not  exceeding  1 
year,  providing  there  are  good  reasons  to  believe  the  active 
substance  wi  I I  satisfy the  requirements of  Article 9.  Member  States 
shal I  Inform  other  member  states and  the Commission  of  such  action. 
3.  By  way  of  further  derogation  from  Article  4(1),  Article  7<2>  and 
Article  7(3)  and  without  preJudice  to  paragraph  4  and  paragraph  6, 
a  Member  State may,  for  a  period of  10 years  from  the date of  entry 
Into  force  of  this  Directive,  authorize  the  placing  on  the  market 
In  Its territory of  a  biocidal  product  containing active substances 
not  listed  In  Annex  I  that  are  on  the  market  on  the  date  of  entry 
into  force  of  this Directive. 
4.  Following  the  adoption  of  this  Directive,  the  Commission  shall 
commence  a  10  year  programme  of  work  for  the systematic examination 
of  active  substances  not  on  Annex  I.  A  Regulation,  adopted 
according  to  the  procedure  laid  down  In  Article  25(2),  wl  I I  provide 
for  all  provisions  necessary  for  the  establishment  and 
implementation  of  the  programme.  No  later  than  two  years  before 
completion  of  the  work  programme,  the  Commission  shall  forward  to 
the  Council  and  the  European  Parliament  a  report  on  the  progress 
achieved with  the  programme. - 31  -
During  this ·10  year  period,  It  may  be  decided  under  the  procedure 
laid  .down  In  Article  25(3)  that  an  active  substance  shal I  be 
Included  In  Annex  1  and  under  which  conditions.  or,  In  cases  where 
the  requirements  of  Article  9  are  not  satisfied  or  the  requisite 
Information  and  data  have  not  been  submitted  within  the  prescribed 
period,  that  such  active  substance  shall  not  be  Included  In 
Annex  I. 
Following  a  decision,  the  Member  States  sha II 
authorizations  for  biocidal  products  containing 
substances are  modified or  cancelled as  appropriate. 
ensure  that 
the  active 
5.  Where  following  a  rev lew  of  an  actIve  substance  it  Is  cone luded 
that  the  substance  does  not  meet  the  requirements  of  Article  9  and 
consequently  cannot  be  Included  In  Annex  I,  the  Commission  shall 
bring  forward  proposals  for  restricting  the  marketing  and  use  of 
that  substance  In  accordance with  directive 76/769/EEC. 
6.  When  authortzlng  biocidal  products  containing  an  active  substance 
to  be  reviewed  In  accordance  with  paragraph  4  and  before  such 
review  has  taken place.  Member  States shall  apply  the  conditions  In 
Art lcle  4  (1)  (b).  (c)  and  (d)  on  the  basis  of  dossiers  which 
address  the  requ I r'ements  In  Annex  II  and  11 I. 
Article  15 
Research  and  development 
1.  Member  States  shall  prescribe  that  any  experiment  or  test  for  the 
purposes of  research or  development  Involving  placing on  the market 
of  an  unauthorized  biocidal  product  or  an  active substance  Intended 
exclus.lvely  for  use  In  a  biocidal  product  shall  not  take  place 
unless 
(a)  In  the  case  of  scientific  research  and  development  the  persons 
concerned  draw  up  and  maintain  written  records  detai I ing  the - 32  -
Identity  of  .the  product  or  substance,  1  abe I 1  i ng  data, 
quantities  suppl led  and  the  names  and  addresses  of  those 
persons  receiving_  the  product  or  substance  and  compiles  a 
dossier  containing  all  available  data  on  possib-le  effects  on 
human  or  an lma I  hea I th  or  Impact  on  the- envIronment.  ThIs 
Information  shal I,  as  requested,  be  made  aval lable  to  the 
Competent  Authority. 
(b)  In  the  case  of  process orientated  research  and  development  the 
Information  required  In  (a)  Is  notified  to  the  Competent 
AuthorIty  where  and  before  _PI acIng  on  the  market,  occurs  and  to 
the  Competent  Authority  of  the  Member  State  where  the 
experiment  or  test  is  to  be  conducted. 
2.  Member  States shall  prescribe  that  an  unauthorized  biocidal  product 
or  an  active  substance  for  exclusive  use  In  a  bioc-idal  product' may 
not  be  placed  on  the  market  for  the  purpose  of  trials  which  may 
Involve  or  result  In  release  Into  the  environment  unless  the 
Competent  Authority  has  assessed  the  available  data  and  Issued  an 
authorization  for  trials purposes  which  limits  the  quantities  to be 
used  and  the  areas  to be  treated _and  may  Impose  further  conditions. 
3.  Where  trials  take  place  In  a  Member  State  other  than  the  Member 
State  where  placing  on  the  _market  occurs,  the  applicant  shal 1 
obtain  trials  authorization  from  the  Competent  authority  of  the 
Member  State  In  whose  terrltery  the  trials are  to  be  conducted. 
If  the  proposed  experiments  or  tests referred  to  In  paragraph  1  and 
2  are  liable  to  have  harmful  effects  on  human  or  animal  health  or 
to  have  an  unacceptable  adverse  influence  on  the. environment;  the 
Member  State concerned  may  either  prohibit  them  or  only  permit  them 
subject  to  such  cond i tlons  as  It  cons lders  necessar.Y  to  prevent 
those  consequences. 
4.  Paragraph  2  shall  not  apply  If  the  Member  State  has  granted  the 
person  concerned  the  r lght  to  undertake  certain  experiments  and - 33  -
tests and  has  determined  the conditions  under  which  the experiments 
and  tests have  to be  undertaken; 
5.  Common  conditions  for  the  application  of  this  Article,  in 
particular  the  maximum  quantities of  active  substances  or  biocidal 
products  that  may  be  released  during  experiments,  and  the  minimum 
data  to  be  submitted  In  accordance  with  paragraph  2,  shall  be 




1.  Within  a  period  of  one  month  from  the  end  of  each  Quarter  Member 
States  shall  Inform  each  other  and  the  Commission  of  any  biocidal 
products  which  have  been  authorized  within  their  territory  or  for 
which  an  authorization  has  been  refused,  modified,  renewed  or 
cancelled,  Indicating at  least  : 
(a)  the  name  or  bu~lness name  of  the  holder  of  the authorization; 
(b)  the  trade  name  of  the  biocidal  product; 
(c)  the  name  and  amount  of  each  active  substance  which  it  contains; 
(d)  the  product  type  and  the  use  or  uses  for  which  it  Is 
authorized; 
(e)  the  type of  formulation; 
(f)  any proposed  I imits on  residues which  have  been  established; 
,  .  t'·•  ,,_.I ~ \ 
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(g)  I Imitations,  conditions  and  requirements  of  the  authorisation 
and  where  relevant,  the  reasons  for  the  modification  or 
cancel latlon  of  an  authorization. 
2.  Where  a  Member  State  receives  a  summary  of  the  dossiers  in 
accordance  with  Article  10  (1)  (b)  and  has  legitimate  reason  to 
believe  the  dossiers  are  Incomplete  It  shall  Immediately 
communicate  its concerns  to  the  competent  authority  responsible  for 
the  evaluation  of  the  dossiers  and  shall  immediately  inform  the 
Commission  and other  Member  States of  its concerns. 
3.  Each  Member  State  shall  draw  up  an  annual  1 ist  of  the  biocidal 
products  authorized  In  its  territory  and  shall  communicate  that 
list  to  the other  Member  States and  the Commission. 
4.  In  accordance  with  the  procedure  laid  down  In  Art lcle  25(2)  a 
standardised  Information  system  shall  be  set  up  to  facilitate  the 
application of  paragraphs  1  and  2. 
Art lela 17 
ConfIdent Ia II ty 
1.  Without  prejudice  to  Council  Directive 90/313/EEC  on  the  freedom  of 
access  to  Information  on  #the  envlronment24  an  applicant  may 
Indicate  to  the  Competent  Authority  the  Information  which  he 
considers  to  be  commercially  sensitive  and  disclosure  of  which 
might  harm  him  Industrially or  commercially  and  which  he  therefore 
wishes  to  be  lcept  confidential  from  all  persons  other  than  the 
competent  authorities  and  the  Commission.  Full  justification  wi  II 
be  reQuired  In  each  case. 
24  O.J.  No  L158,  23.06.1990,  p.  56 - 35  -
2.  The  competent  authority  rece.tving  the  application  shall  decide 
which  information  shall  be  confidential  within  the  terms  of 
paragraph.· l  . 
.Information  accepted  as  being  confidential  by  the  receiving 
competent  authority  shall  be.treated  as.·belng  confidential  by  the 
other  Competent  Authorities,  Member  States and  the  Commission. 
3.  Confidentiality shall  not  In  any  case  apply' to: 
(a)  the  name.of·the  ~ppllcant 
(b)  the  name  of  the  biocidal  product  ma~ufacturer 
(c) -the  name  of  the  active substance manufacturer 
(d)  the  names  and  content  of  the  act1ve  substance  or  substances  in 
the  biocidal  product  and  the-name  of  the  biocidal  product; 
(e)  the  name  of  other  substances  whIch  are  regarded  as  dangerous 
under  Directives  67/548/EEC  and  contribute  to  the 
classification' of  the  product; 
(f)  physico-chemical  data  concerning  the  active  substance  and. 
biocidal  product; 
(g)  any  ways  of  rendering  the  active  substance  or  biocidal  product 
harmless;· 
(h)  a  summary  of  the  results of  the  tests  required  under  Article  7 
to  establIsh  the  substance's or  product's  efficacy  and  effects 
on  humans~  animals  and  the  environment; 
(i)  recommended  methods  and  precautions  to  reduce  dangers  from 
handling,  storage,  transport  and  use  as  well  as. from  fire  or 
other  hazards; - 36  -
(J)  methods of analysis  referred  to  In  Article  4(1)  (c) 
(k)  methods  of disposal  of  the  product  and  of  its packaging; 
( l) decontaminat ton  procedures  to  be  followed  In  the  case  of 
accidental  spit lage  or  leakage; 
(m)  first  aid  and  medical  treatment  to  be  given  In  the  case  of 
Injury  to persons. 
If  the  applicant  or  manufacturer  or  Importer  of  the  biocidal 
product  or  active  substance  should  later ·disclose  previously 
confIdent I a I  I nformat ton.  the  Competent  Authority  sha I I  be 
Informed  accordingly. 
4.  The  detailed  provisions  and  format  for  making  information 
publ leal ly  aval table  shal I  be  decided  in  accordance  wirh  the 
procedures  set out .in Art·tcle  25(2). 
Article  18 
Classification.  packaging  and  labelling of biocidal  products 
1.  Biocidal  products  shall  be  classified  according  to  the  provisions 
relating  to  classification  In  Directive  88/379/EEC  on  the 
classification, 
preparat ions25. 
packaginQ  and  I abe I ling  of  dangerous 
2.  Biocidal  products .shal I  be  packaged  according  to  Article  6  of 
Directive 88/379/EEC.  In  addition  : 
25  0. J.  No  L  187,  16.07. 1988,  p.  14 - 37  -
'a)  products ·which·  may  be  mistaken  for  fOOd  or  drink  Shall  be 
packaged · to·  mIn I mIse.  the  I lice' /'1 hood  of  such  a  m is  fake  be i ng 
made; 
b)  products ·avar·rable ·to  the  general  public  which  may  be  mistaken 
for  food  or  drink  shall  contain  components  to  discourage  their 
consumption. 
3.  Biocidal  products  shall  be  labelled  according  to.the  provisions  of· 
Directive  88/379/EEC  concerning  labelling.  In  addition  the  label 
must,·show  c I early and  I nde I Jb 1  Y-· ·the  fo I I owl ng:  ( 
·'' 
(a)  the  Identity  of  the  active  substance  and  its  concentration  in 
metrIc unIts 
(b)  the  authorIzation  number  a I located  to  the  b ioc Ida I  product  by 
the  competent  Authority; 
('c'). the  type  of  prepar:at ion :{e.g.· I I Quid  ·concentrates,  granules, 
powders,  sol Ids,  etc,); 
(d)  the  uses  for  which  the  biocidal  product  is  author i zed  (e.g  . 
. wood  preservation, .·dlsl·nfect-lon,.surface  b·iocidEf,  ant i-·foul ing, 
etc); 
(e)  directions  for  use  and- the  dose  rate,  expressed  in  metric 
unIts, ·  for  each · use  · provIded ·for  .under.  the  terms  of  the 
author lzat ion;. 
(f) partlculars,of  lllcely  direct  or  Indirect  adverse  side  effects 
and  any  directions for  first aid; 
(g)  if  ·accompanied  ·.by  a  lea;flet. ·the·  sentence  :"Read  attached 
,Jnstruct Ions: before· use"; - 38  - . 
(h)  dlr,ect Ions  for  saf~  disposal  of  the  biocidal  product  and  its 
packaging:  Including  where  relevant  any  prohibition  on  re-use 
of.packaglng; 
(I)  the  formulation  batch  number  or  designation and  the expiry date 
relevant  to normal  conditions of  storage; 
and  where  applicable 
<J>  the  Interval  to  be  observed. between  applications  of  the 
biocidal  product  or  between  application and  the  next  use of  the 
product  treated,  or  the  next  access  by  man  or  animals  to  the 
area  where  the  biocidal  product  has  been  used; 
(k)  the  categories  of  users  to  which  the  biocidal  product  is 
restricted; 
{I)  Information  on  any  specific  dangers  to  the  environment 
particularly  concerning  protection  of  non-target  species  and 
avoidance of  contamination of water. 
Member  States  sha II  requl re  that . I terns  3  (a).  (b).  (d)  and  where 
applicable  (g)  and  (k)  always  be  carried  on  the  label  of  the 
product. 
Member  States shall  permit  Items  3  (c).  (e).  (f),  (h),  (i),  (j)  and 
(I)  to  be  carried elsewhere  on  the  packaging  or  on  an  accompanying 
leaflet  integral  to  the  packaging.  These  items of  information  shal I 
be  regarded  as  label  information  for  the  purposes  of  this 
dl rectI ve. 
4.  By  way  of  derogation  from  paragraphs  1  and  2  and  the  first  sentence 
of  paragraph  3;  Biocidal  products  authorised  as  Insecticides, 
acaricldes,  rodentlcides,  avlcldes  or  mollusclcides  shal I  be 
class if led  packaged  and  t"abe lied  In  accordance  with  directive 
,, - 39  -
78/631/EEC  on. the  approx lmat ion  of  the  laws  of  the  Member  States 
relating  to  the  classification.  packaging  and·  Iabeii ing  of 
dangerous  preparations  (pestlcfdes)26  Insofar  as  there  is  no 
other  Community  provisions  specifically  covering  these  matters  for 
such  products. 
5.  Where  a  biocidal  product  Identified  In  paragraph  4  Is  authorised 
under  this  directive  ahd. Is  also  subject  to  classification. 
packaging  and  labelling according  to Directive 78/631/EEC  by  virtue 
of  other  Community  provisions;  Member  States  shal I  permit  changes 
-to  the  packagln~  and. Iabeii lng  of  that  product  which  ~ay  be 
required  as  a  consequence  of  those  provisions.  insofar  as  t~ey  do 
not  confl let  with  the  requirements of  an  authorrsatlon  issued  under 
this directive. 
~ 
6.  Member  States  may  require  the  provision  of  samples,  models  or 
drafts of  the  packaging,  labelling and  leaf lets,. 
· Art lcle 19 
Safety Data Sheets 
Member  States  shall  ensure  that  a  system  of  specific  information  (in 
safety-data-sheet  form)  Is  established  to  enable  professional  and 
Industrial  users  of  biocidal  produdts  to  take  the  necessary  measure  for 
the  protection of  the  environment  and  health safety at  the  workplace. 
For  active  substances  used  exclusively  In  biocidal  products  safety  data 
sheets  shal I  be  prepared  In  accordance  with  the  requirements  of  Article 
27  of  Directive 67/548/EEC . 
. 26  O.J.  No  L  206,  29.7.78,  p.  13 - 40  -
For  biocidal .products safety data  sheets  shal I  be  prepared  in  accordance 
with  Article 10  of  Directive 88/379/EEC. 
Article 20 
Advertising 
1.  Member  States shall  require  that  every  advertisement  for  a  biocidal 
product  Is.  accompanIed  by. the  sentences·  "Use  bloc I  des  safe I y. 
Always  read  the  label  and  product  Information  before use•. 
The  sentences  shal 1  be  clearly  distinguishable  In  relation  to  the 
whole  advertisement. 
Member  States shall ,prescribe  that. advertisers may  replace  the  word 
"Biocldes"  in  the  prescribed sentences with  an  accurate  description 
of  the  product  type  being  advertised  e.g.  wood  preservatives, 
disinfectants,  surface bloc ides,  anti-fouling  products,  etc. 
2.  Member  States  shall.  require  that  advertisements  for  biocidal 
products  sha II  not  refer  to  the  product  In  a  manner  which  is 
misleading  In  respect  of  the effects of  the  substance  on  man  or  the 
environment. 
Article  21 
Po I son COnt ro.l 
Member  States  shal I  appoint  the  body  or  bodies  responsible  for  receiving 
information  on  biocidal  products  which  have  been  placed  on  the  market, 
including  Information  on  the  chemical  composition,  of  such  products, .~md - 41  -
for  making  such  Information  available  In  cases  where  suspected  poisoning 
arises  from  the  use  of  biocidal  products.  Such  Information  may  only  be 
used . to  meet  any  med lea 1  demand  by  formu I at lng  preventIve  and  cur at 1  ve 
measures,  In  particular  In  emergencies.  Member  States  shall  ensure  that 
the  Information  Is  not  used  for  other  purposes. 
Member  States shal I  take  the  necessary  steps  to ensure. that  the  appointed 
bodies  provide  all  the  requisite  guarantees  for  maintaining  the 
confidential lty  of  the  Information  received.  Member  States  shall  ensure 
that  the  appointed  bodies  shall  have  at  their  .disposal  all  the 
Information  required  to  carry  out  the  tasks  for  which  they  are 
responsible  from  the  manufacturers or  persons  responsible  for  marketing. 
For  biocidal  products  already  on  the  market,  Member  States  shall  take 
measures  to  comply  with  this  Directive  within  three  years  from  the 
adoption  thereof. 
Article 22 
COmpliance  with  requirements 
Member  States  sha II  make  suItable  arrangements  for  b ioc ida 1  products 
which  have  been  placed  on  the  market  to  be  officially  monitored  to 
establIsh whether  they  comply  with  the  requirements of  this Directive. 
Every  three  years  after  the  entry  Into  force  of  this  dfrective,  Member 
States  shall  forward  to  the  Commission  by  the  30  November  of  the  third 
year  a  report  on  their  action  In  these  ma~ters  together  with  information 
on  any  poI son I  ngs 
within  1  year  of 
composite  report. 
lnvo I  v lng  b ioc Ida I  products.  The  Comm Iss ton  sha II 
receipt  of  this .Information  prepare  and  publish  a - 42  -
Article  23 
Competent  Authorities 
1.  Member  States shal I  designate  a  competent  authority  responsible  for 
carrying  out  the  duties  Imposed  on  Member  States  under  this 
0 i rectI ve. 
2.  Member  States shall  Inform  the  Commission  of  the  identity  of  their 
competent  authorIty  6  months  before  the  entry  into  force  of  this 
0 i rectI ve. 
Article  24 
Commission  Procedures 
1.  When  the Commission  receives  from  a  Member  State either 
(a)  an  evaluatIon  and  recommendatIons  concernIng  an  actIve 
substance as  foreseen  In  Article  10  (2)  and  Article 9  (5)  or 
(b)  a  proposal  to  refuse  an  authorization  and  an  explanatory 
document  as  foreseen  In  Article  3  (5); 
it  shal I  allow  a  period of  45  days  during  which  other  Member  States 
and  the  applicant  may  submit  comments  to  it  in  writing. 
2.  At  the  end  of  the  period  for  comment,  the  Commission  shal 1.  on  the 
bas·is  of  : 
the  documents  received  from  the  membe'r  state  evaluating  the 
dossiers  and  ; -43  -
any  advice  obtained  from  advl.sory  committees  In  particular  the 
Scientific  Advisory  Committee  on  the  toxicology  and 
ecotox I  co logy  of  chemical  substances  as  ~stab_llshed  by 
Commission  decision  78/618/EEc27  and  In  the  case  of  act tve 
substances  Included  In  Insecticides,  acarlcldes, .rodentlcldes, 
avlcldes  and  mol lusclcldes which  are also  authorised under  the 
reQuirements  of  Directive  91/414/EEC,  the  Scientific  Committee 
for  Pesticides,  as  establ lshed  ~Y  Commission  decision 
78/436/EEc28 
comments  receIved  from  other  member· States  and.  the  app II cants 
and; 
any  other  relevant  Information 
prepare  a  proposal  for  decision  In  accordance  with  the  procedures 
laid  down  In  Article 25(3). 
3.  The  applicant  or  his  authorized  representative  may  be  as~ed. by  the 
Commission  to  submit  remarks  to  It,  In  particular  whenever  an 
unfavourable  decision  Is  envisaged. 
Article 25 
Committees  and  procedures 
1.  The  Commission  shall  establish. a  Standing  Committee  on .. Biocldal 
products  (the  Standing  Committee)  to  assist  Jt.  The  Standing 
Commlttee.shal I  be  composed  of  representatives of  the  Member  States 
and  chaired  by  a  representative  of  the  COmmission .. The  standing 
committee shal I  adopt  Its own  rules of  procedure. 
27  O.J.  N.  L 198,  22.07.1978,  p.  17 
28  0. J .  N L  124 ,  12. 05. 1978,  p.  16 - 44  -
2.  For  matters  referred  to  the  Standing  Committee  by  virtue  of 
Articles  14(4)  first  paragraph,  16(4)  and  17(4)  the  representative 
of  the  Commission  shall  submit  to  the  committee  a  draft  of  the 
measures  to  be  taken.  The  cornm It tee  sha I I  de I I  ver  Its  opInIon  on 
the  draft,  within  a  time  limit  which  the  chairman  may  lay  down 
according  to  the  urgency  of  the  matter,  If  necessary. by  talc ing  a 
vote. 
The  opinion  shall  be  recorded  In  the  minutes;  In  addition,  each 
Member  State  sha II  have  the  r lght  to  ask  to  have  its  posit ion 
recorded  in·the minutes. 
The  Commission  shall  take  the  utmost  account  of  the  opinion 
delivered  by  the  committee.  It  shall  Inform  the  committee  of  the 
manner  In  which  Its opinion  has  been  taken  Into  account. 
3.  For  all  other  matters  referred  to  the  committee  In  accordance  with 
the  requirements  of  this  directive  the  representative  of  the 
Commission  shall  submit  to  the  committee  a  draft  of  the  measures  to 
be  taken.  The  committee  shall  deliver  Its  opinion  on  the  draft 
within  a  time  limit  which  the  chairman  may  lay  down  according  to 
the  urgency  of  the  matter.  The  opinion  shall  be  delivered  by  the 
majority  laid  down·  In  Article  148  {2)  of  the  Treaty  In  the  case  of 
decisions  which  the  Council  is  required  to adopt  on  a  proposal  from 
the  Commission.  The  votes  of  the  representatives  of  the  Member 
States within  the  committee  shal I  be  weighted  in  the manner  set  out 
In  that  Article.  The  chalrma~ shall  not  vote. 
The  Commission  shall  adopt  the  measures  envisaged  if  they  are  in 
accordance  with  the opinion of  the  committee. 
If  the  measures  envisaged .are not  In  accordance with  the  opinion of 
the ·Committee,  or  If  no  opinion  Is delivered,  the  Commission  shal I, 
without  delay,  submit  to  the  Council  a  proposal  relating  to  the 
measures  to  be  taken.  The  Council  shall  act  by  a  qualified 
.majority. - 45  -
If; on  the  expiry of  a  period of  30  days  the  Council  has  not  acted, 
the  proposed  measures  shal I  be  adopted  by  the  Commission. 
Article 26 
Common  principles ·for  the evaluation of dossiers 
The  common  pr"lnclples  for  :eva·luatlon  of  dossiers  referred  to  in 
Article  4  ·(1)  (b)  above,  shall  be  adopted  in  accordance  with· the 
procedure  laid  down  In  Article  25(3).·  These  principles  shall  be 
regularly  reviewed  and  where  appropriate  revised,  in  accordance 
with  the  same  procedure. 
Article 27 
Adaptation  to technical  progress 
The  amendments  necessary  for  adapt lng ·Annexes  ·11, ·  Ill,  IV  and  v  to 
technical  progress  shal r be  adopted  In accordance  with  the  procedure  laid 
down  In Article 25(3). 
. ...  · 
Article 28 
Civil  and  Criminal  Liability 
·  .. ·: 
The  granting  of ·authorization  and  all  other ·measures  in  conformity  with 
this  Directive  shal I  be  without  prejudice  to  general  clvi 1  and  criminal 
liability  In  the  Member  States of  the manufacturer  and,  where  applicable, - 46  -
of  the  person  responsible  for  placing  the  biocidal  product  on  the  market 
or  using  it. 
Article 29 
Safeguard clause 
Where  a  Member  State  has  valid  reasons  to  consider  that  a  biocidal 
product  which  It  has  authorized  or  Is  bound  to  authorize  under  Article  3 
constitutes  an  unacceptable  risk  to  human  or  animal  health  or  the 
environment.  It  may  provisionally restrict or  prohibit  the  use or  sale of 
that  product  on  Its territory.  It  shall  Immediately  Inform  the  Commission 
and  the  other  Member  States  of  such  action  and  give  reasons  for  its 
decision.  A  decision  shall  be  taken  on  the  matter  within  90  days  in 
accordance  with  the  procedure  laid down  in  Article  25(3). 
Article 30 
Implementation of  the Directive 
1.  Not  later  than  18  months  after  the  date  of  the  adopt ion  of  the 
Directive  Member  States  shall  adopt  and  publish  the  laws. 
regulations  and  administrative  provisions  necessary  to  comply  with 
this  Directive.  They  shall  forthwith  inform  the  Commission 
thereof. 
2.  When  Member  States  adopt  these  measures,  they  sha 1 1  contain  ·a 
reference  to  this  Directive  or  shall  be  accompanied  by  such 
reference  on  the  occasion  of  their  official  publication.  The 
methods  of  making  such  a  reference  shall  be  laid  down  by  the  Member 
States. - 47  -
Article  31 
This  Directive  Is  addressed  to  the  Uember  States. 
Done  at  Brussels, 
For  the  Counci 1. 
The  President - 48  -
ANNEX 
LIST  OF  ACTIVE  SUBSTANCES  WITH  REQUIREMENTS  AGREED  AT  COMMUNITY  LEVEL 
FOR  INCLUSION  IN  BIOCIDAL  PRODUCTS - 49  -
ANNEX  II 
Requirements  for  The  Dossier  To  Be  Introduced  for  the 
Inclusion of  An  Actlye  Substance  ln.Annex  I - 50  -
PART  A 
CHEMICAL  SUBSTANCES 
1.  Dossiers on  active substances are  required  to address at  least  all 
the  points  listed  under  •eossler  requirements•.  Responses  are 
required to be supported by  data. 
2.  lnformatlon  which  Is  not  necessary  owing  to  the  nature  of  the 
biocidal  product or of  Its proposed uses  ne~d not  be supplied.  The 
same  applies  where  It  Is  not  scientifically  necessary  or 
technicallY  possible  to _supply  the  Information.  In  such  cases.  a 









Dossier  requirements 
Applicant 
Identity of  the  active substance 
Physical  and  chemical  properties of  the active substance 
Methods  of  detection and  Identification 
Effectiveness against  target  organisms  and  Intended uses 
Toxicological  profile for  man  and  animals  Including metabolism 
Ecotoxlcologlcal  profile  Including  environmental  fate  and 
behaviour 
(viii)  Measures  necessary  to protect man.  animals  and  the environment 
(IX)  Classlflcat Ion  and  labell_lng 
(x)  Summary  and  evaluation of  (I I)- (IX) 
The  following  data  wl  II  be  required  to support  submission  on  the  above 
points. - 51  -
I.  APPLICANT 
1.1  Name+  address 
1.2  Active  substance  manufacture~  (name,  address,  location  of 
plant) 
II.  IDENTITY  OF  THE  ACTIVE  SUBSTANCE 
2.1  Common  name  proposed or  accepted  by  ISO  and  synonyms 
2.2  Chemical  name  (IUPAC  nomenclature) 
2.3  Manufacturer's  development  code  number(s) 
2.4  CAS  and  EEC  numbers  (If  aval !able) 
2.5  Empirical  and  structural  formula  (Including  ful I  details of  any 
Isomeric  composition),  molecular  mass 
2.6  Method  of  manufacture  (synthesIs  pathway  In  brIef  terms)  of 
active substance 
2.7  Specification of  purity of  the  active substance  In  g/kg or  g/1, 
as  appropriate 
2.8  Identity of  Impurities and  additives  (eg stabilisers),  together 
with  the structural  formula  and  the  possible  range  expressed as 
g/kg or g/1,  as appropriate  j 
2.9  The  origin of  the  natural  active  substance  or  the  precursor(s) 
of  the act lve  substance,  eg  an  extract of ·a  flower· 
Ill.  PHYSICAL  AND  CHEMICAL  PROPERTIES  OF  THE  ACTIVE  SUBSTANCE 
3.1  Melting  point,  boiling  p~lnt,  relative denslty<1> 
3.2  Vapour  pressure  (In Pa)  (1) 
3.3  Appearance  {physical  state,  colour)C2) 
3.4  Absorption  spectra  (UV/VIS,  IR,  NMR),  and  a  mass  spectrum, 
molar  extinction at  relevant  wavelengths,  where  relevant(1) 
3.5  Solubility  In  water  Including  effect  of  pH  (5  to  9)  and 
temperature on  solubility,  where  relevant(1) 
(1)  These  data  must  be  submitted  for  the  purified  active  substance  of 
stated specification. 
(2)  These  data  must  be  submitted  for  the  act lve  substance  of  stated 
specification. - 52  -
3.6  Solubility  In  organic solvents,  Including effect of  temperature 
on  solubility  (1) 
3.7  Partition coefficient n-octanol/water  Including effect of  pH  (5 
to 9)  and  temperature  (1) 
3.8  Stability  In  organic solvents used  In  preparations and  Identity 
of  relevant  breakdown  products  (2) 
3.9  Thermal  stability,  Identity of  relevant  breakdown  products 
3.10  Flammability  Including  auto-flammabl llty and  Identity of 
combustion  products 
3.i1  Flashpolnt 
3.12  Surface  tension 
3.13  Explosive properties 
3.14  Oxidising properties 
3.15  Reactivity  towards  container material 
IV.  ANALYTICAL  METHODS  FOR  DETECTION  AND  IDENTIFICATION 




methods  for  the  determination  of  pure  active 
and,  where  appropriate,  for  relevant  degradation 
Isomers  and  Impurities  of  the  active  substance  and 
(eg stabilisers) 
4.2  Analytical  methods.  Including  recovery  rates  and  the  I lmlts  of 
determination  for  the  active  substance,  and  for  residues 
thereof.  and  where  relevant  In/on  the  following: 
a)  Soli 
b)  AIr 
c)  Water  :  the  appllcapt  should  confirm  that  the  substance 
Itself  and  any  of  Its  degradation  products  which  fal I 
within  the  definition of  pesticides  given  for  parameter  55 
In  Annex  I  of  Directive  80/778/EEC  on  the  qual lty  of  water 
Intended  for  human  consumption  (O.J.  No.  L229,  30.8.1980, 
p.  11)  can  be  estimated  wlth  adequate  reliability  at  the 
MAC  specified  In  that  Directive  for  Individual  pesticides. 
d)  Animal  and  human  body  fluids  and  tissues 
e)  Food  or  feedlngstuffs  and  other  products where  relevant - 53  -
V.  EFFECTIVENESS  AGAINST  TARGET  ORGANISMS  AND  INTENDED  USES 
5.1  Function,  eg  fungicide,  rodenticide,  Insecticide,  bacterloclde 
5.2  Organlsm(s)  controlled  and  products,  organisms or objects to  be 
protected 
5.3  Effects  on  target  organisms,  eg  contact,  Inhalation or  stomach 
polson,  fungitoxic,  or  fungistatic 
5.4  Mode  of  action 
5.5  Field of  use  envisaged 
5.6  User.  profess lona I or  non-profess lona I,  genera I  pub II c 
5,7  Information  on  the  occurrence  or  possible  occurrence  of  the 
development  of  resistance  and  appropriate management  strategies 
5.8  Likely,  tonnage  to be  placed on  the market  per  year 
5.9  Observations  on  undesirable  or  unintended  side-effects,  eg  on 
beneficial  and  other  non-target  organisms 
VI.  TOXICOLOGICAL  AND  UETABOLIC  STUDIES 
6.1  Acute  ToxIcIty 
6.1 .1  Ora I 
6.1.2  ·Dermal 
6.1.3  Inhalation 
6.1.4  Skin  and  eye  Irritation 
6.1.5  Skin sensltlsatlon 
6.2  Metabolism studies  In  mammals 
Basic  toxlcoklnetlcs,  Including a  dermal  absorption study 
For  the  following  studies  6.~ (where  necessary),  6.4,  6.5,  6.7 
and  6.8,  the  required  route of administration  Is  the oral  route 
unless  It  can  be  justified  that  an  alternative  route  Is  more 
ap~rQprlate. 
6.3  Short  term  repeated  dose  toxicity  (2~ days) 
This study  Is  not  required when  a  sub-chronic  toxicity study  Is 
available  In  a  rodent 
6.4  Subchronlc  toxicity 
90-day study, . 2  specIes, .one  rodent  and  one  non-rodent - 54  -
6.5  Chronic  toxicity 
One  rodent  and  one other  mammalian  species 
6.6  Mutagenicity studies 
6.6.1  In  yltro gene  mutation study  In  bacteria 
6.6.2  In  yltro cytogenlclty study  In  mammalian  cells 
6.6.3  In  yltro gene  mutation assay  In  mammalian  cells 
6.6.4  If  positive  In  6.6.1,  6.6.2  or  6.6.3,  then  an  In  ylyo 
mutagenicity  study  will  be  required  (bone  marrow  assay  for 
chromosomal  damage  or  a  micronucleus  test) 
6.6.5  If  negative  In  6.6.4 but  positive  In  vitro tests then undertake 
a  second  In  ylyo  study  to  examine  whether  mutagenicity  or 
evidence of  DNA  damage  can  be  demonstrated  In  tissue other  than 
bone  marrow 
6.6.6  If  positive  In  6.6.4  then  a  test  to  assess  possible  germ  cell 
effects may  be  required 
6.7  Carcinogenicity study 
One  rodent  and  one  other  mammalian  species.  These  studies may 
be  combined  with  those  In  6.5 
6.8  Reproductive  toxicity 
6.8.1  Teratogenicity test- rabbit  and  one  rodent  species. 
6.8.2  Fertl I tty  study- at  least  two  generations,  one  species,  male 
and  female 
6.9  Neurotoxicity study 
If  the  active  substance  Is  an  organophosphorus  compound  or  If 
. there  are  any· other  lndlcat Ions  that  the·  test  substance  may 
have  neurotoxic  properties  then  neurotoxicity  studies  will  be 
requIred.  The  test  specIes  Is  the  adu It  hen  un I  ess  a not her· 
species  Is  Justified  to  be  more  appropriate.  If  appropriate, 
delayed  neurotoxicity  tests  will  be  required.  If  antlchollne 
esterase  activity  Is  detected,  a  test  for  response  to 
reactivating agents  shou~d be  considered. 
6.10  toxic effects on  livestock and  pets 
6.11  Studies  related to  the exposure of  the active substance  to man 
6.11.1  Food  and  feedlngstuffs- If  the  active  substance  Is  to  be  used 
In  prepar  at Ions  for  use  where  food  for  human  consumptIon  Is 
prepared,  consumed  or  stored,  or  where  feedlngstuff  for 
livestock  Is  prepared,  consumed  or  stored  the  tests referred  to 
In  Annex  IV,  Part  A,  point  1  shall  be  required. 
6.11.2  If  any  other  tests  related  to  the  exposure  of  the  active 
substance  to man,  In  Its  proposed  preparations,  are  considered 
necessary,  then  the  test(s)  In  Annex  IV,  Part  A ,  Point  2  shall 
be  requIred  · - 55  -
6.12  Supplementary studies 
6.12.1  If  the  active  substance  Is  to  be  used  In  products  for  action 
agaInst  pI ants  then  tests  to  assess  toxIc  effects  of 
met abo II tes  from  treated  pI ants,  If  any,  where  dIfferent  from 
those  Identified  In  animals  shal I  be  required 
6.12.2  Mechanistic  study  - any  studies  necessary  to  clarify  effects 
reported  In  toxicity studies 
6.13  Uedlcal  data  In  anonymous  form 
6.13.1  Uedlcal  surveillance  data  on  manufacturing  plant  personnel  If 
available 
6.13.2  Direct  observation  eg  clinical  cases,  poisoning  Incidents  If 
available 
6.13.3  Health  records,  both  from  Industry  and  any  other  available 
sources 
6.13.4  Epidemiological  studies on  the general  population,  If  aval !able 
6.13.5  ~lagnosis  of  poisoning  (determination  of  active  substance, 
metabolites  In  body  fluids  or  exhaled  air)  specific  signs  of 
poisoning,  cl lnlcal  tests. 
6.13.6  Sensltlsatlon/al lergenlclty observations,  If  aval !able 
6.13.7  Proposed  treatment:  first  aid  measures,  antidotes,  medical 
treatment 
6.13.8  Prognosis  following  poisoning 
6.14  Summary  of  mammalian  toxicology  and  conclusions,  Including  no 
observable  adverse  effect  level  (NOAEL),  no  observable  effect 
level  (NOEL),  overall  evaluation  with  regard  to  all 
toxicological  data  and  any  other  Information  concerning  active 
substance.  Where  possible  any  suggested  worker  protection 
measures  should  be  Included  In  summary  form. 
·• 
VII.  ECOTOXICOLOGICAL  STUDIES  ON  THE  ACTIVE  SUBSTANCE 
7.1  Acute  toxicity  to  fish 
7.2  Acute  toxicity  to  Daphnia  magna 
7.3  Growth  Inhibition  test on  algae 
7.4  Acute  toxicity  test  on  one  other,  non-aquatic,  non-target 
organism 
7.5  If  the  results of  the  ecotoxlcologlcal  studies and  the  Intended 
use(s)  of  the  active  substance  Indicate  a  danger  for  the 
environment  then  the  tests  described  In  Annex  IV,  Parts  B  and 
c,  shal I  be  required. - 56  -
Fate and  Behaviour  In  The  Enylronmont 
7.6  Degradation 
7 .6.1  Blot lc 
7.6.1.1  Ready  biodegradability 
7.6.1.2  Inherent  blodegradabll tty,  where  appropriate 
7.6.1.3 If  the  result  of  the  test  In  7.6.1.2  Is  negative  and  If  the 
likely  route  of  disposal  of  the  active  substance  and  Its 
preparations  Is  by  sewage  treatment,  then  the test described  In 
Annex  IV,  Part  C,  Point  4.1  shall  be  required 
7 .6.1 .4 Any  other  b lodegradab Ill ty  tests  that  are  relevant  from  the 
results  In  7.6.1.1  and  7.6.1.2 
7.6.2  Abiotic 
7.6.2.1  Hydrolysis  as  a  function  of  pH  and  Identification of  breakdown 
product(s) 
7.6.2.2 Phototransformatlon  In  water  Including  Identity of  the  products 
of  transformatlon<1> 
7.6.2.3 Phototransformation  In  air  (estimation  method),  Including 







If  the  results  of  7.6.1.2  or  7.6.1.4  Indicate  the  need  to  do 
so,  or  the  active  substance  has  an  overal I  tow  or  absent 
ab lot ic  degradatIon,  then  the  tests  descrIbed  In  Annex  IV, 
Part  8,  Points  1.1  and  2.1,  and  where  appropriate  the  tests 
described  In  Annex  IV,  Part 8,  Point  3  shal I  be  required. 
Adsorption/desorption screening test 
Where  the  results of  this test  Indicate  the  need  to  do  so,  the 
test  described  In  Annex  IV,  Part  8,  Point  1.2  shal I  be 
required,  and/or  the  test  described  In  Annex  IV,  Part  8,  Point 
2.2. 
Summary  of  ecotoxlcologl~al effects and  fate  +behaviour  In  the 
environment 
MEASURES  NECESSARY  TO  PROTECT  MAN.  ANIMALS  AND  THE  ENVIRO~ENT 
Recommended  methods  and  precaut tons  concern tng  hand 1 lng,  use. 
storage. transport  or  fire 
In  case  of  fire,  nature of  reaction  products,  combustion  gases 
etc ... 
(1)  These  data  must  be  submitted  for  the  purified  active  substance  of 
stated specification - 57  -
8.3  Emergency  measures  In  case of  an  accident 
8.4  Possibility  of·  destruction  or  de-contamination  following 
release  In  or  on  the  following: 
al  Air 
b)  Water~  Including drinking water 
C)  Soli 
8.5  Substances falling within  the  scope of List  I  or  List  II  of  the 
annex  to  Directive  80/68/EEC  on  the  protection  of  groundwater 
against  pollution  caused bi certain  dangerous  substances  (O.J. 
No.  L20,  26.1.1980,  p.43) 
8.6  .Procedures  for  waste  management  of  the  active  substance  for 
Industry or  professional  users 
8.6.1  Posslbl llty of  re-use or  recycling 
8;6.2  Posslbll lty of  neutralisation 
8.6.3  Conditions  for  controlled  discharge 
qualities on  disposal. 
8.6.4  Conditions  for  control led  Incineration 
8.6.5  Others,  If  appropriate 
IX.  CLASSIFICATION  AND  LABELLING 
Including  leachate 
.Proposals  Including  justification  for  the  proposals  for  the 
classlf~catlon and  labelling of  the  active  substance  according 
to Directive 67/548/EEC 
Hazard  symbo I ( s) 
Indications of  danger 
Risk  phrases 
Safety phrases 
X.  SUWMARY  AND  EVALUATION  OF  (II  - I  x) - 58  -
PART  B 
FUNGI.  MICRQ-ORGANISUS  AND  VIRUSES 
1.  Dossiers  on  active organisms  are  required  to  address  at  least  all 
the points  listed under  •eossler requirements•  below.  Responses  are 
required to be  supported by  data. 
2.  Information  wh lch  Is  not  necessary  owing  to  the  nature  of  the 
biocidal  product or of  Its proposed uses need  not  be  supplied.  The 
same  applies  where  It  Is  not  scientifically  necessary  or 
technically  possible  to  supply  the  Information.  In  such  cases.  a 
Justification.  acceptable  to  the  ,competent  authority  must  be 
submitted. 
( I} 
( I I} 





Dossier  Requirements 
Applicants details 
Identity of  active organism 
Source of  active organism 
Methods  of  detection and  Identification 
Biological  properties  of 
pathogenicity  and  Infectivity 
organisms  Including man 
Effectiveness  and  Intended uses 
active  organism 
for  target  and 
Including 
non  target 
Toxicological  profile  for  man  and  animals  Including  metabolIsm 
of  toxIns 
(vi II)  Ecotoxlcologlcal  proflla  Including  environmental  fate  and 
behaviour  of  the organisms  and  of  toxins  It  produces 
(IX}  Measures  necessary  to  protect  man.  non-target  organism  and  the 
envIronment 
(x)  Classification and  labelling 
(XI}  Summary  and  evaluation of  (I I}- (x} 
The  following  data wll I  be  required  to support  submissions  on  the  above 
points. - 59  -
I.  APPLICANT 
1.1  Applicant  (name,  address,  etc.) 
1.2  Manufacturer  (name,  address,  plant  location) 
II.  IDENTITY  OF  THE  ORGANISM 
2.1  common  name  of  organism  (Including  alternative  and  superseded 
names) 
2.2  Taxonomic  name  and  strain  lndlcat lng  whether  It  Is  a  stock· 
variant  or  a  mutant  strain;  for  viruses,  taxonomic  designation 
of  the  agent,  serotype,  strain or  mutant 
2.3  Collection  and  culture  reference  number  where  the  culture  Is 
deposited 
2.4  Methods,  procedures  and  criteria used  to establish  the  presence 
and  Identity  of  the  organism  (e.g.  morphology,  biochemistry, 
serology,  etc.) 
I I I .  SOURCE  OF  THE  ORGANISM 
3.  1  Occurance  In  nature or  otherwise 
3.2  Isolation methods  for  organism or  active strain 
3.3  Culture methods 
3.4  Production  methods  Including  details  of  containment  and 
procedure  to  rna I nta In  qua II ty  and  ensure  a  unIform  source  of 
active organism.  For  mutant  strains detailed  Information should 
be  provided  on  production  and  lsolatl.on,  together  with  all 
known  differences  between  the  mutant  strains  and  parent  and 
naturally occurring strains. 
3.5  Compos'ltlon  of  the  final  active  organism  material  I.e.  nature, 
purity,  Identity,  properties,  content  of  any  Impurities  and 
extraneous organisms 
3.6  Methods  to  prevent  contamination  of  seed  stock  and  loss  of 
virulence of  seed  stock 
3.7  Procedures  for  waste  management 
. ,,  .... ·. 
.  -.~~;.._:  .. • - 60  -
IV.  METHODS  OF  DETECTION  +  IDENTIFICATION 
4.1  Methods  for  establishing  the  presence  and· Identity  of  the 
organism 
4.2  Methods  for  establishing  the  Identity  and  purity of  seed  stock 
from  which  batches are produced  and  results obtained,  Including 
Information on  variability 
4.3  Methods  to show  microbiological  purity of  the  final  product  and 
showing  that  contaminants  have  been  controlled to an  acceptable 
level,  results obtained and  Information on  variability 
4.4  Methods  used  to show  that  there are  no  human  or other  mammalian 
pathogens as  contam lnan·ts  In  the ·act lve  agent,  Inc lud lng  In  the 
case  of  protozoa  and  fungi,  the  effects  of  temperature  (35"C 
and  other  relevant  temperatures> 
4.5  Methods  to  determine  viable  and  non-viable  (e.g.  toxins) 
residues  In  or  on  treated  products,  foodstuffs,  feedlngstuffs, 
animal  and  human  body  fluids  and  tissues.  soil,  water  and  air, 
where  relevant 
V.  BIOLOGICAL  PROPERTIES  OF  THE  ORGANISM 
5.1  History  of  the  organism  and  Its  uses  Including  as  far  as  Is 
known  Its  general  ,_n~tural  history  and  If  relevant  Its 
geographical  distribution 
5.2  RelatloQShlp  to  existing  pathogens  of  vertebrates, 
Invertebrates~ plants or other organisms 
5.3  Effects on target  organism.  Pathogenicity or  kind of  antagonism 
to  the  host.  Detal·ls  of  host  specificity  range  should  be 
Included. 
5.4  Transm Iss I bIll ty.  InfectIve  dose  and  mode  of  act I  on  Inc lud lng 
lnfQrmatlon  on  presence,  absence  or.  production of  toxlcs with, 
If  appropriate,  lnformatLon  on  their  nature,  Identity,  chemical 
structure and  stability and  potency 
5.5  Possible effects on  non-target  organisms closely related  to  the 
target  organism  Including  Infectivity,  pathogenicity, 
transmtsslbl llty 
5.6  Transmissibility  to other  non-target  organisms 




Infectivity ahd  physical  stability when  properly-used 
, ..... , --.- -. -· 
GenetIc  stab II I ty  under  env I ronmenta I  condItIons  of  proposed 
use - 61  -
5.10  Any  pathogenicity  and  Infectivity  to  man  +  animals  under 
conditions of  Immunosuppression. 
5.11  Pathogenicity  and  Infectivity  for  known  parasites/predators  of 
the  target  species. 
VI.  EFFECTIVENESS  AND  INTENDED  USES 
6.1  Harmful  organisms  controlled  and  mater lals.  substances.' 
organisms or  products  to be  treated or  protected 
6.2  Uses  envisaged  e.g.  Insecticide  disinfectant.  anti-foul lng 
biocide.  etc 
6.3  lnformat lon  or  observatIons  on  undesirable  or  unintended  side 
effects 
6.4  Information  on  the  occurrence  or  possible  occurrence  of  the 
development  of  resistance  and  possible management  strategies to 
deal  with  this 
6.5  Effects on  target  organisms 
6.6  Category of  user 
VII.  TOXICOLOGICAL  AND  METABOLIC  STUDIES 
7.1  Acute  toxicity 
In  cases where  a  single dose  Is not  appropriate,  a  set of  range 
finding  tests must  be  carried out  to reveal  highly  toxic agents 
and  Infectivity. 
(1)  oral 
(2)  dermal 
(3)  Inhalation 
(4)  skin and  where  necessary eye  Irritation 
(5)  skin.  sensitization.  and  where  necessary 
sentlzatlon and 
respiratory 
(6)  for  viruses  and  vlrolds.  cell  culture  studies  using 
purified  Infective  virus  and  primary  eel I  cultures  of 
mammal  ian.  avian and  fish cells 
7.2  Sub  chronic  toxicity 
40  day  study.  2  species.  one  rodent.  one  non-rodent 
(1)  oral  administration 
(2)  other  routes  (Inhalation.  dermal)  as appropriate and 
(3)  fo~  viruses and  vlrolds  test  for  Infectivity carried out  by 
blo  assay  or  on  a  suitable  cell  culture  at  least  7  days 
after  administration  to test  animals. - 62  -
7.3  Chronic  toxicity 
2  species,  rodent  and  one  other  mammal,  oral  admlnlstrat ton 
unless other  route more  appropriate 
7.4  carcinogenicity study 
May.  be  combined  with  studies  In  6.3.  One  rodent  and  on  other 
mammal 
7.5  Mutagenicity studies 
As  specified ·In  PART  A I  6.6 
7.6  Reproductive  toxicity 
Teratogenicity test - rabbit  +one  rodent  species. 
Fertility study- 1  species,  min  2  generations,  male+  female 
7.7  Metabolism studies 
Basic  toxlcoklnetlcs,  absorption  (Including  dermal  absorption) 
distribution  and  excretion  In  mammals  Including  elucidation of 
metabolic pathways. 
7.8  Neurotoxicity  studies  :  required  where  there  Is  any  Indication 
of  antlchollnerterase  activity  or  other  neurotoxic  effects. 
Delayed  neurotoxicity  tests  using  adult  hens  should  be 
performed where  appropriate. 
7.9  lmmunotoxlclty studies e.g.  allergenlclty 
7.10  Incidental  exposure  studies  required  where  the  active 
substance  w  I I I  be  In  products  for  use  where  human  food  or 
animal  feedlngstuffs  are  prepared,  consumed  or  stored and  where 
humans  livestock  or  pets  are  likely  to  be  exposed  to  treated 
areas or  materials 
7.11  Human  ~xposure data  Including 
(1)  Medical  data  In  anonymous  form  (If aval table) 
(2)  Health  records,  medical  surveillance  data  on  manufacturing 
plants  personnel  (If ·available) 
(3)  Epidemiological  data  (If available) 
(4)  Poisoning  Incidents data 
(5)  Poisoning  diagnosis  (signs,  symptoms)  Including  detal Is  of 
any  analytical  tests 
(6)  Proposed  treatment  of  poisoning  +  prognoses. 
7.12  Summary  of  mammalian  toxicology- conclusions  (Including  NOAEL 
NOEL  and  If  appropriate  ADI)  overal I  evaluation  with  regard  to 
all  toxicological,  pathogenicity  and  Infectivity  data  and  any 
other  Information  concerning  the  active  organism.  Where 
possible  suggested  user  protection  measures  should  be  Included 
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ECOTOXICOLOGICAL  STUDIES 
Acute  toxicity  to  fish 
Acute  toxicity  to Daphnia  magna 
Effects on  algal  growth  (Inhibition test) 
Acute  toxicity on  one  other,  non-aquatic,  non-target  organism. 
Pathogenicity and  Infectivity  for  honeybees  and  earthworms 
Acute  toxicity  and/or  pathogenicity  and  Infectivity  for  other 
non-target  organisms  believed  to  be  at  risk 
Effects  (If any)  on  other  flora  & fauna 
8.8  Potential  for  Indirect  contamination  of  areas  adjacent:  to 
treatment  areas. 
8.9  In  cases  where  toxins  are  produced,  data  as  outlined  In  Annex 
I I,  Part  A.  VI  I  7.1-7.5 should  be  produced. 
Fate  +  behaviour  In  the  environment 
8.10  Spread,  mobility,  multiplication  and  persistence  In  air,  soil 
and  water. 
8.11  In  cases  where  toxIns  are  produced,  data  as  out II ned  In  Annex 
I I,  Part  A,  VII  7.6-7.8 
IX.  MEASURES  NECESSARY  TO  PROTECT  MAN.  NON-TARGET  ORGANISMS  AND  THE 
ENV I  ROt-1.4ENT. 
9.1  Methods  and  precautions,  to  be  taken  -ror  storage,  handling, 
transport  and  use;  or  In  event  of  fire  on  other  likely  Incident 
9.2  Any  circumstances  or  environmental  conditions  under  which  the 
active organism should  not  be  used 
9.3  The  possibility  of  rendering  the  active  organism  unlnfectlve 
and  any  method  for  doing  this. 
9.4  Consequences  of  the  contamination  of  air,  sol I  and  water, 
particularly drinking water 
9.5  Emergency  measures  In  case of  accident 
9.6  Procedures  for  waste  management  of  the  active  organism 
Including  leachate qualities on  disposal 
9.7  Posslbll lty of  destruction or  decontamination  following  release 
In  or  Into  the  following  air,  water,  soli,  others  If 
appropriate. - 64  -
X.  CLASSIFICATION  AND  LABELLING 
Proposals  for  allocation  to one  of  the  risk  groups  outlined  In  Article 
2  (d)  of  Directive  90/679/EEc(29)  with  justifications  for  the 
proposal.  Together  with  Indications  on  the  need  for  products  to  carry 
the  biohazard sign specified  In  annex  II  of  90/679/EEC. 
XI.  SUMMARY  AND  EVALUATION  OF  (II)- (X) 
{29)  OJ  No  L  374,  31.12.90,  p.1 - 65  -
ANNEX  I II 
Reaulrements  For  The  Qossler  To  Be  lntrodyced For  The 
Authorisation of A Biocidal  product - 66  -
PART  A 
CHEMICAL  PRODUCTS 
1.  Dossiers  on  biocidal  products  are  required  to  address  at  least  alI 
the  points  I lsted  under  "Dossiers  requirements".  Responses  are 
required  to be  supported  by  data. 
2.  Information  which  Is  not  necessary  owing  to  the  nature  of  the 
biocidal  product  or  of  Its proposed uses  need  not  be  supplied.  The 
same  applies  where  It  Is  not  scientifically  necessary  or 
technically  possible  to  supply  the  Information.  In  such  cases,  a 
justification,  acceptable  to  the  competent  authority  must  be 
subml tted. 
Qossler  reaulrements 
(I)  Appl !cant 
(II)  Identity  and  composition of  the biocidal  product 
(Ill)  Physical,  chemical  and  technical  properties  of  the  biocidal 
product 
(IV)  Methods  for  Identification and  analysis of  the  biocidal  product 
(v)  Intended uses of  the  product  and  efficacy for  these uses 
(vi)  Toxicology  data  for  the  biocidal  products 
(additional  to  that  for  the active substance) 
(v11)·  Ecotoxlcologlcal  data  for  the  biocidal  products 
(additional  to that  for  the active substance) 
(viii)  Measures  to  be  adopted  to  protect  man,  animals  and  the 
environment 
(lx)  Classification,  packaging  and  labelling of  the  biocidal  product 
(x)  Summary  and  evaluation ot (II)-> (IX) 
The  following  data will  be  required  to support  submissions on  the  above 
points. - 67  -
I.  APPLICANT 
1.1  Appl  lcant  (name  and  address etc.) 
1. 2  Manufacturer  of  the  preparat ton  and  the  actIve  substance(s) 
(names  and  addresses,  Including  location of plant{s)). 
II.  IDENTITY  OF  THE  BIOCIDAL  PRODUCT 
2.1  Trade  name  or  proposed  trade  name,  and  manufacturer's 
development  code  number  of  the preparation,  If  appropriate 
2.2  Detailed  quantitative  and  qualitative 
composItIon  of  the  preparatIon  eg 
Impurities,  adjuvants,  Inert  components 
Information  on  the 
actIve  substance(s), 
2.3  Physical  state  and  nature  of  the  preparation  eg  emulsifiable 
concentrate,  wettable  powder,  solution 
Ill.  PHYSICAL,  CHEMICAL  AND  TECHNICAL  PROPERTIES  OF  THE  BIOCIDAL 
PRODUCT 
3.1  Appearance  (physical  state,  colour) 
3.2  Explosive  properties 
3.3  Oxidising  properties 
3.4  F I  ash  poInt  and  other 
spontaneous  Ignition 
Indications  of  flammabl I lty  or 
3.5  Acidity/alkalinity and  If  necessary  pH  value  (1%  In  water) 
3.6  Relative  density 
3.7  Storage  stabll lty  st.ablllty  and  shelf-1 lfe.  Effects  of 
I lght,  temperature  and  humidity  on  technical  characteristics of 
the  biocidal  product 
3.8  Technical  characteristics of  the  preparation 
3.8.1  Wettab Ill ty 
3.8.2  Persistent  foaming 
3.8.3  F lowab Ill ty,  pourab Ill ty  and  dustablllty 
3.8.4  suspenslblllty and  suspension stability 
3.8.5  Wet  sieve  test  and  dry  sieve  test - 68  -
3.8.6  Particle  size  distribution,  content  of  dust/.fJnes, ·attrition 
and  friability 
3.8.7  In  the  case  of ·granules,  steve  test  and  Indication  of  weight 
distribution  of  the  granules,  at  least  of  the  fraction  with 
particle sizes bigger  than  1mm 
3.8.8  Emulslflabi ilty,  re-emulsiflablllty,  emulsion stability 
3.8.9  Wetting,  adherence  and  distribution  to target ~rganlsms 
3.9  Physical  and  chemical  compatibility  with  other  products 
Including  other  Biocidal  Products  with  which  Its  use  Is  to  be 
authorised 
3.10  If  the  Biocidal  Product  Is  to be  used  In  the  form  of  a  bait or 
granules,  then  specify  any  repellants  or  polson  control 
measures  Included  wl th  the  preparatIon  that  are  present  to 
prevent  action against  non  target  organisms 
IV.  METHODS  OF  I DENT IF  I CATION  AND  ANALYSIS 
4.1  Ana lyt I  ca I  ·  method  for  determlnl ng  the  composItIon  of  the 
biocidal  product 
4.2  In  so  far  as  not  covered  by  Annex  II,  point  4.2  analytical 
methods  Including  recovery  rates  and  the  limits  of 
determination  for  toxicologically  and  ecotoxlcologlcally 
relevant  components  of  the  Biocidal  Product  and/or  residues 
thereof,  where  relevant  In  or  on  the  following: 
· a)  Soli 
. b)  AIr 
c)  Water  (Including drinking water) 
d)  Animal  and  human  body  fluids  and  tissues 
e)  Treated  food  or  feed~ngstuffs 
V.  INTENDED  USES  AND  EFFICACY 
5.1  Field of  use envisaged 
5.2  Method  of  app•tcatlon 
5.3  Application rate and  If appropriate,  the  final  concentration of 
biocidal  product  and  active  substance  In  system  In  which  the 
preparation  Is  to  be  used,  eg  cooling  water,  surface  water, 
water  used  for  heating  purposes. - 69  -
5.4  Number  and  timing  of  applications,  and  where  relevant,  any 
particular  Information  relating  to  geographical  variations, 
climatic  variations,  or  necessary  waiting  periods  to  protect 
man  and  livestock 
5.5  Any  other  necessary  Information 
5.6  Function,  eg  fungicide,  rodenticide,  Insecticide,  bacterloclde 
5.7  Pest  organlsm(s)  controlled  and  products,  organisms  or  objects 
to be  protected 
5.8  Effects  on  target  organisms,  eg  contact,  Ingestion  or  stomach 
polson,  fungitoxic,  fungistatic 
5.9  Mode  of  action  In  so  far  as  not  covered  by  Annex  II,  Point  5.4 
5.10  User,  professional  or  non-professional 
5.11  ObservatIons  on  undesIrable  or  unIntended  sIde-effects,  eg  on 
beneficial  and  other  non-target  organisms 
Efficacy oata 
5.12  Data  to  support  the  efficacy  claims  of  the  preparation  label, 
Including  any  available  standard  protocols  used,  laboratory 
tests,  or  where  appropriate  field  trials.  For  each  application 
a  reasoned case wl  I I  be  required. 
5.13  The  effect  of  factors  such  as  climate,  temperature,  humidity, 
preclpltatlon.etc.  Insofar  as  not  covered by  Point  5.4 
5.14  Compatibility  with  different  cultural  practices  and  other 
measures  that  may  be  used  against  the  target  organism  under  the 
conditions of  use  envisaged 
5.15  Any  other  known  limitations on  efficacy 
5.16  Relative  advantages  of  the  preparation  or  Its  Intended  use 
compared  to any  existing preparations or  treatment  methods 
5.17  Summary  and  evaluation of  data  presented under  5.12  to 5.17 
VI.  TOXICOLOGICAL  STUDIES 
6.1  Acute  toxIcIty 
6.1 .1  Oral 
6.1. 2  Dermal 
6.1.3  Inhalation 
6.1 .4  Skin  and  eye  I rr I tat I  on 6.1.5 
6.2 
- 70  -
For  biocidal  products  that  are  Intended  to  be  author I  sed  for 
use  with  other  biocidal  products,  the  mixture  of  preparations, 
where  possible,  shal I  be  tested  for  acute  dermal  toxicity  and 
skin  and  eye  Irritation~ as  appropriate 
Dermal  absorption test,  where  necessary 
6.3  Available  toxicological  data  relating  to  toxicologically 
relevant  non-active  substances 
6.4  Studies related  to  the exposure of  the  preparation  to man 
6.5 
6.6 
Where  necessary,  the  test(s)  described  In  Annex  IV,  Part  A 
shall  be  required  for  the  toxicologically  relevant  non-active 
substances of  the preparation 
If  the  biocidal  product  Is  In  the  form  of  a  bait  or  granules, 
pet or  livestock  acceptance studies may  be  required 
Summary  and  evaluation  of  data  presented  In  6.1  to  6.6, 
Including  where  possible  any  suggested  work:er  protection 
measures  In  summary  form 
VII.  ECOTOXICOLOGICAL  STUDIES  ON  THE  BIOCIDAL  PRODUCT 
7.1  The  Information  provided  must,  where  relevant,  Include  that 
referred  to  In  Annex  I I,  point  7.1  to 7.4. 
7.2  If  the  results of  the ecotoxlcologlcal  studies and  the  Intended 
use(s)  of  the  active  substance  Indicate  a  danger  for  the 
environment  then  the  tests described  In  Annex  IV,  Parts  D and  E 
shal I  be  required 
Fate And  Behaviour  In The  Environment 
7.3  The  Information  provided  must,  where  relevant,  Include  that 
referred  to  In  Annex  I I,  point 7.6. 
VIII.  MEASURES  TO  BE  ADOPTED  TO  PROTECT  MAN,  ANIMALS  AND  THE 
ENV I  ROt>&tENT 
8.1  Recommended  methods  and  precautions  concerning  handling,  use, 
storage,  transport  or  fire 
8.2  Emergency  measures  In  case of  an  accident 
8.3  Procedures,  If  any,  for  cleaning application equipment 
8.4  Possible  routes of entry  Into  the environment 
8.5  Identity of  relevant  combustion  products  In  cases of  fire - 71  -
8.6  Procedures  for  waste management  of  the biocidal  product  and  Its 
packaging  for  Industry,  professional  users  and  the  general 
public 
8.6.1  Posslbll lty of  re-use or  recycling 
8.6.2  Posslbll lty of  neutralisation 
8.6.3  Conditions  for  controlled discharge 
8.6.4  Conditions  for  control led  Incineration 
8.6.5  Others,  If  appropriate 
8.7  Possibility  of  destruction  or  de-contamination  following 
release  In  or  on  the  following: 
a)  AIr 
b)  Water,  Including  drinking water 
c)  Soli 
8.8  Leachate.Qualltles  on  disposal,  In  so  far  as  not  covered  by 
point  8.6.3 of  Annex  I I 
8.9  Any  Information on  authorisation  In  other  countries 
IX.  CLASSIFICATION.  PACKAGING  AND  LABELLING 
Proposa Is  Inc I  ud I  ng  JustIfIcatIon  for  the 
Iabeii lng  according  to  Directive  88/379/EEC 
rodentlcldes,  lnsectlcldes/acarlcldes, 
mollusclcldes  Directive 78/631/EEC 
Hazard  symbol(s) 
Indications of  danger 
Risk  phrases 
Safety phrases 
Instructions  for  use. 
classIfIcatIon  and 
or,  In  the  case of 
avlcldes  and 
Packaging  (type,  materials,  size  etc.),  compatibility  of 
the  preparation  with  proposed  packaging  materials  to 
Include. 
Spec I  mens  of  the  proposed  packagIng  and  of  the  proposed. 
label(s)  If  so  required 
X.  SUMMARY  AND  EVALUATION  OF  ALL  ANNEX  Ill  INFORMATION  AND 
REQUIREMENTS - 72  -
PART  B 
FUNGI •  Ml CRQ-ORGAN ISMS  AND  VI RUSES 
1.  Dossiers on  biocidal  products  are  required  to address at  least  all 
the  points  listed  under  •Dossier  requirements".  Responses  are 
required  to be  supported by  data. 
2.  lnformat Jon  wh lch  Is  not  necessary  owing  to  the  nature  of  the 
biocidal  product  or of  Its proposed uses need  not  be  supplied.  The 
same  applies  where  It  Is  not  scientifically  necessary  or 
technically  possible  to  supply  the  Information.  In  such  cases.  a 




( II I ) 
(IV) 
(V) 
Dossier  requirements 
Applicant 
Identity and  composition of  the biocidal  product 
Technical  properties of  the  biocidal  product  and  any  biocidal 
propertIes add It I  ona I  to those of the actIve organIsm.· 
Methods  for  Identification+ analysis of  the biocidal  product 
Intended  uses  and  efficacy for  those uses 
(vi)  Toxicological  Information  (additional  to  that  for  the  active 
organism) 
(vii)  Ecotoxlcologlcal  Information 
(additional  to that  for  the active organism) 
(viii)  Measures  to  be  adopted  to  protect  man,  non-target  organisms+ 
the environment 
Clx)  Classification,  packaging  and  labelling of  the biocidal  product 
(X)  Summary  of  (II)-> (IX) 
The  following  data  will  be  required  to support  submission  on  the  above 
points. - 73  -
I.  APPLICANT 
1.1  Name  and  address etc. 
1.2.  Manufacturers  of  biocidal  products  and  active  organisms 
Including  location of plants 
II.  IDENTITY  OF  BIOCIDAL  PRODUCT 
2.1  Trade  name 
development 
appropr l·ate. 
or  proposed 
code  number 
trade  name  and 
for  the  biocidal 
manufacturer's 
product.  If 
2.2  Detailed  quantitative  and  qualitative  Information  on  the 
composItIon  of  the  bloc Ida I  product  (actIve  organisms,  Inert 
components,  extraneous organisms, ·etc.) 
2.3  Physical  state and  nature of  the  biocidal  prod~ct  (emulsifiable 
concentrate.  wettable  powder.  etc  .. ) 
2.4  Concentration 'of  active organism  In  material  used 
Ill.  TECHNICAL+  BIOLOGICAL  PROPERTIES 
3.1  Appearance  (colour .and  odour) 
3 .. 2  Storage  - stability  and  shelf-life.  Effects  of  temperature, 
method  of  packaging  and  storage,  etc.  on  retention  of 
biological  activity 
3.3  Methods .for  establishing storage and  shelf-life stability 
3.4  Technical  characteristics of  the preparation 
3.4.1  Wettabl llty 
3.4.2  Persistent  foaming 
3.4.3  suspenslblllty and  suspension stability 
3.4.4  Wet  sieve  test  and  dry  sieve test 
3.4.5  Particle  size  distribution,  content  of  dust/fines,  attrition 
and  f r I  ab I I I t y 
3.4.6  In  the  case  of  granules~  steve  test  and  Indications  of  weight 
dlstr I  but I  on  of  the  granules,  at  least  of  the  fractIon  wl th 
particle sizes bigger  than  1  mm 
3.4.7  Content  of  active  substance  In  or  on  bait  particles,  granules 
or  treated material - 74  -
3.4.8  Emulslnabl llty,  re-emulslflablllty,  emulsion stabll lty 
3.4.9 
3.5 




and  chemica I  compat lb Ill ty  wl th 




Is  to  be 
3.6  Wetting,  adherence and  distribution following  application 
3.7  Any  changes  to  biological  propert les  of  the  organism  Is  a 
result  of  formulation.  In  particular  changes  In  pathogenicity 
on  Infectivity 
IV.  METHOD  FOR  IDENTIFICATION  +ANALYSIS  OF  THE  BIOCIDAL  PRODUCT 
4.1  Analytical  methods  for  determining  the  composition  of  the 
biocidal  product 
4.2  Methods  for  determining  residues  (e.g.  blotest) 
4.3  Methods  used  to  show  mlcroblolog I  ca I  purIty  of  the  bloc Ida 1 
product 
4.4  Methods  used  to  show  the  biocidal  product  to  be  free  from  any 
human  and  other  mammal lan  pathogens  or,  If  need  be,  from 
pathogens  harmful  to non-target organisms and  the  environment 
4.5  Techniques  used  to  ensure  a  uniform  product  and  assay  methods. 
for  Its standardization 
V.  INTENDED  USES  AND  EFFICACY  FOR  THESE  USES 
5.1  Use 
Product  type  (e.g.  wood  preservative,  public  hygiene  biocide 
etc.) 
5.2  Details  of  Intended  use,  e.g.  types  of  harmful  organism 
controll~d. materials  to be  treated etc. 
5.3  Application  rate· 
5.4  Where  necessary,  In  the  light of  the  test  results,  any  specific 
circumstances  or  environmental  conditions  under  which  the 
product  may  or  may  not  be  used. 
5.5  Method  of  application 
5.6  Number  and  timing of  applications 
5.7  Proposed  Instructions  for  use - 75  -
Eff!cacv data 
5.8  Pre! lmlnary  range-finding tests 
5.9  Field experimentation 
5.10  Information  on  the  possible  occurence  of  the  development  of 
resistance 
5.11  Effects on  the quality of materials or  products  treated 
VI.  TOXICITY  INFORMATION  ADDITIONAL  TO  THAT  REQUIRED  FOR  THE  ACTIVE 
ORGANISM 
6.1  Oral  single dose 
6.2  Percutaneous single dose 
6.3  Inhalation 
6.4  Skin  and  where  relevant  eye  Irritation 
6.5  Skin  sensitization 
6.6  Ava! !able toxicological  data  relating to non-active  substances 
6.7  Operator exposure 
6.7.1  Percutaneous absorption/Inhalation depending  on  formulation  and 
method  of  application 
6.7.2  Likely  operator  exposure  under  field  conditions,  ·Including 
where  relevant  quantitative analysis of operator  exposure 
VII.  ECOTOXICITY  INFORMATION  ADDITIONAL  TO  THAT  REQUIRED  FOR  THE 
ACTIVE  ORGAN I  SN 
7.1  Observations concerning undesirable or  unintended side-effects, 
e.g.  on  beneficial  and  other  non-target  organisms  or 
persistence  In  the environment 
VIII.  MEASURES  TO  BE  ADOPTED  TO  PROTECT  MAN.  NON-TARGET  .ORGANISMS  AND 
THE  ENVIRONMENT 
8.1  Recommended  methods  and  precautions  concerning  handling, 
storage,  transport  and  use 
8.2  Re-entry  periods,  necessary  waiting  periods  or  other 
precautions  to protect  humans  and  animals - 76  -
8.3  Emergency  measures  In  case of  an  accident 
8.4  Procedures  for  destruction  or  decontamination  of  the  biocidal 
product  and  Its packaging 
8.5  Procedures  for  cleaning application equipment 
8.6  Procedures  for  safe  disposal  of  the  concentrated  biocidal 
product or diluted product 
IX.  CLASSIFICATION.  PACKAGING  AND  LABELLING 
9.1  P·roposals  Including  Justification  for  the  classification, 
packaging and  labelling 
(I)  with  regard  to  non-biological  components  of  the  product 
In  accordance with  Directive 88/379/EEC 
Hazard  symbol(s) 
Indications of  danger 
Risk  phrases 
Safety phrases 
(II)  with  regard  to  the  active  organisms  labelling  with  the 
appropriate  risk  group  as  outlined  In  Article  2  (d)  of 
Directive  90/679/EEC  together  with  the.  biohazard  sign 
specified  In  that directive  If appropriate 
9.2  Packaging  (type,  materials,  size,  etc.),  compatibility  of  the 
preparation with  proposed packaging materials 
9.3  Speclments of proposed  packaging 
X.  SUMMARY  OF  (II) -(II) 
.  -·.  -~  ;  '. - 17 -
ANNEX  IV 
Further  Reaulrements  For  the Dossiers  To  Be  Introduced 
For  the Authorisation Of  Biocidal  prodycts 
.····· - 78  -
ANNEX  IY 
PART  A 
Further  HUman  Health Related Studies On  Tho  Actlyo substance 
And/Or  The  Preoaratlon 
1..  Food  and  Feedlnggtuffs Studies 
1.1  Identification  of  degradation  and  reaction  products  and  of 
metabolites  of  the  active  substance  In  treated or  contaminated 
foods  or  feedstuffs 
1.2  Behaviour 
degradation 
treated  or 
kinetics of 
of  the  residue  of  the  active  substance,  (ts 
products  and  where  relevant  its metabolites on  the 
contaminated  food  or  feedstuffs  Including  the 
disappearance 
1.3  overall  material  balance  for  the  active  substance.  Sufficient 
residue  data  from  supervised  trials  to  demonstrate  that 
res I  dues  I Ike I  y  to  arIse  from  proposed  use  wou I  d  not  be  of 
concern  for  human  or  animal  health 
1. 4  Est I  mat !on  of  potent  I· a I  or  actua I  exposure  of  the  actIve 
substance to humans  through  diet and  other means 
1.5  lf.the residue of  the Biocidal  Product  remains  on  feedlngstuffs 
for  a  significant  period  of  time  then  feeding  and  metabolism 
studies  In  livestock  shall  be  required  to  permit  evaluation of 
residues  In  food  of  animal  origin 
1.6  Effects of  Industrial  processing and/or  domestic preparation on 
the  nature  and  magnitude  of  residue of  the  biocidal  product  or 
active substance 
1.7  Proposed  acceptable  residues  and  the  Justification  of  thelr-
acceptab I 1 1  ty 
1.8  Any  other available  Information  that  Is  relevant 
1.9  Summary  and  evaluation of data submitted under  1.1  to 1.8 
2.  Other  Testes>  Related To  The  Exposure To  Man 
Suitable  test(s)  and  a  reasoned  case  will  be  required  for  the 
active substance or  the preparation,  as appropriate - 79  -
ANNEX  IV 
PART  B 
Further Studies On  The  Fate And  Behaviour  Of  The  Actlye 
Substance  In  The  Environment 
1.  Fate And  Behay!gyr  In  sol! 
1.1  Rate  and  route  of  degradation  Including  Identification  of  the 
processes  Involved  and  Identification  of  any  metabolites.  and 
degradat lon  products  In  at  least  3  soli  types  under  appropr late 
conditions. 
1.2Adsorptlon  and  desorption  l.n  at  least  3·soll  types  and  where 
relevant  adsorption  and  desorption  of  metabolites  and  degradation 
products. 
1.3 Mobility  In  at  least  3  soli  types  and  where  relevan't  mobility  of 
metabol ltes and  degradation  products. 
1.4 Extent  and  nature of  bound  residues. 
2.  Fate And  Behay!gyr  In Water 
2.1  Rate  and  route of  degradation  In  aquatic  systems  (as  far  as  Is  not 
covered  by  Annex  II,  point  7.6)  Including  Identification  of 
metabolites and  degradation products. 
2.2 Adsorpt lon  and  desorpt lon  In  water  (soli  sediment  systems)  and 
where  relevant  adsorption·  and  desorption  of  metabolites  and 
degradation  products. 
3. ·  Fate And  Behaylgu[  In  Air 
If  the  active  substance  Is  to  .be  used  In  preparations  for 
fumigants,  If  It  Is  to  be  applied  by  a  spray  method,  If  It  Is 
volatl le,  or  If  any  othe~  Information  Indicates  that  . this  Is 
relevant,  then  the  rate  and  route  of  degradation  In  air  sh~ll  be 
determined as  far  as  Is  not  covered by  Annex  II,  point  7.6.2.3 
4.  Summary  And  Eyaluatlon Of  Pacts 1.2 and  3 
.  '· 
\ ~  - 80  -
ANNEX  IV 
PART  C 
Further  EcotoxiCQioglcal  Stydlos Qo  The  Active SUbstance 
1.  Effects Qo  Birds 
1.1  Acute oral  toxicity- this need  not  be  done  If  an  avian species was 
selected for  study  In  Annex  11.  point 7.4. 
1.2 Short  term  toxicity- 8  day  dietary  study  In  at  least  one  species 
(other  than chicken). 
1.3 Effects on  reproduction. 
2.  Effects On  Aquatic Organisms 
2.1  Prolonged  toxicity to an  approprl~te species of fish 
2.2 Effec·ts  on  reproduction  and  growth  rate  on  an  appropriate  species 
of  fish 
2.3 Bloaccumulatlon  In  an  appropriate species of  fish 
2.4 Daphnia  magna  reproduction and  growth  rate 
3.  Effects Qo  Other  Non  Target OrganIsms 
3.1  Acute  toxicity  to  honeybees  and  other  beneficial  arthropods  eg 
predators.  A different  test organism shall  be  chosen  from  that  used 
In  Annex  11.  point 7.4. 
3.2 Toxicity  to  earthworms  and  to  other  soli  non-target  macro 
organisms. 
3.3 Effects on  soli  non-target  microorganisms 
3.4 Effects  on  a~y  other  specific.  non-target  organisms·  (flora  and 
fauna)  bel_leved  to be at  risk. 
4.  Other  Effects 
4.1  Activated sludge respiration  Inhibition test 
5.  SUirnary  And  Evatuat lon of 1.  2  and  3. - 81  -
ANNEX  IY 
PART  D 
Further Studios On  Tho  Fate And  Behayloyr  Of  Tho  Enylronmentally 
Boloyant  Cgmpononts  Of  Tho  Biocidal  product 
In  Tho  Enylronmont 
1.  Where  relevant all  the  Information required  In  Annex  IV,  Part B 
2.  Testing for  distribution and  dissipation  In  the  following: 
a)  So II 
b)  Water 
C)  Air 
Test  requirements  1  and  2  are  applicable  only  to  ecotox lcologlcally 
relevant  components  of  the preparation. - 82  -
Further  E00toxlcoloqlcal  Stydles On  The  Biocidal  products 
1.  Effects On  Birds 
ANNEX  IV 
PARI  E 
1.1  Acute  oral  toxicity,  If  not  already  done  In  accordance  with 
Annex  Ill,  point  7. 
2.  Effects On  Aauatlc Organisms 
2.1  In  case of  application on.  In  or  near  to surface waters: 
2. 1 . 1  Particular studfes with  fish  and  other  aquatic organisms 
2.1.2  Residue  data  In  fish  concerning  the  active  substance  and 
Including  toxicologically relevant metabolites 
2.1.3  The  studies  referred  to  In  Annex  IV,  Part  c  points  2.1,  2.2. 
2.3  and  2.4  may  be  required  for  relevant  components  of  the 
preparation 
2.2  If  the biocidal  product  Is  to be  sprayed near  to surface waters 
then  an  overspray  study  may  be  required  to  assess  risks  to 
aquatic organisms under  field conditions 
3.  Effects On  Other  Non-Target  organisms 
3.1  Toxicity  to terrestrial  vertebrates other  than  birds 
3.2  Acute  toxicity  to honeybees 
3.3  Effects on  beneficial  arthropods other  than  bees 
3.4  Effects on  earthworms  and  other soli  non-target  macroorganisms. 
believed  to be  at  risk 
3.5  Effects on  soli  non-target  microorganisms 
3.6  Effects  on  any  other  specific.  non-target  organisms  (flora  and 
fauna)  believed to be  at  risk 
3.7  If  the biocidal  product  Is  In  the  form  of bait or granules.  the 
following  will  be  requl red 
3.7.1  Supervised trials to assess  risks to non-target  organisms under 
field conditions 
3.7.2  Studies  on  acceptance  by  Ingestion  of  the  biocidal  product  by 
any  non-target  organisms  thought  to  be  a·t  risk;  In  so  far  as 
not  covered  by  Annex  Ill, Point 6.6 
4.  SummarY  ·And  Eyalyatlon Of  1.  2  and  3. - 83  -
ANNEX  V 
Biocidal  products shall  Include  those product  types set out below which 
can be  used  for  the purposes described  : 
product  hoe 
Disinfectant 
Swimming  pool  disinfectant 
Food  Industry disinfectant 
General  biocide 
Sanitary. biocide 
Air  conditioning  biocide 
Wood  preservative 
TextIle preservatives 
Masonry  preservatives 
Descrlotlon of use 
Disinfection  of  skin  (human  or 
animal)  and  articles  Intended  to come 
Into contact  with  s~ln. 
Disinfection of  water  used  for  public 
bathing. 
DIsInfect I  on  of  contaIners  sur faces 
and  plpework  ·associated  with  the· 
production  of  food  and  drink·  for 
humans  and  animals. 
Control  of  harmful  micro-organisms  In 
premIses  veh I  c I  es  and  areas  used  by 
humans  and  animals. 
Contro I  of  harmfu I  mIcro- organIsms 
In  sanitary  convenancles  and 
eQuipment 
Control  of  harmful  organisms  In  air 
conditioning  systems. 
Protection  of  sawn  timber  and  timber 
products  from  harmful  organisms. 
Protection  of  textiles  from  harmful 
organisms. 
Protect I  on  of  masonry  and  other 
construction  materials  (except  wood) 
from  harmful  organisms. COnsumer  product  preservatives 
Industrial  blocldes 





Anti  fouling  biocide 
- 84-
Protect I  on  of  products  marketed  to 
the  consumer.  other  than  food  and 
feed.  from  harmful  organisms. 
COntrol  of  harmful  organisms 
affecting  Industrial  processes 
COntrol  of  harmful  organisms  In 
connection  with  specific.  products. 
substances.  materials.  articles  on 
areas  not  covered  by  other  product 
types. 
Control  of  rats.  mi-ce·  or  other 
rodents  for  purposes of public health 
and  we I I  be I  ng . 
Control  of  birds  for  purposes  of 
public health and  wellbeing. 
Control  of snails and  other molluscs. 
both  terrestrial  and  aquatic  for 
purposes  of  public  health  and 
wellbeing. 
Control  of  Insects.  mites  and  other· 
arthropods  for  purposes  of  pub II c 
health and  wellbeing. 
Control  of  fouling  organisms  on 
ships.  boats.  aquatic  structures  and 
. art lcles. FINANCIAL  STATEMENT 
SECTION  1 
1. Title of operation:  Proposal  for  a  Council  Directive concerning  the 
placing of  biocidal  products on  the market. 







Environment  legislation 
Technical  and  administrative assistance  ln.  support 
of dtfferent  activities 
National  experts on  secondment 
Expenditure on  meetings of  committees whose 
consultation  Is  compulsory  In  the procedure  for 
drafting Community  legislation 
Studies  and  consultations 
Departmental  data processing. 
3. Legal  basts: Article 100a  of  the  EEC  Treaty. 
4.· Description of operation 
4.1  Specific objective of  operation:  To  harmonize  the  rul.es  relating to. 
the placing of  biocidal  products on  the market.  This objective fits 
Into  the more  general  framework  of  the  legislation on pollution by 
toxic  and  dangerous  chemicals.  on  evaluation of  the risks posed  to 
man  and  the environment  by  chemicals.  on  Industrial  Installations 
and  on biotechnology. -8€'-
4.2  Duration:  Unl  imlted. 
4.3  Target  population:  Cheml~al  Industry  (producers,  Importers, 
distributors and  formulators),  general  public  (consumers)  and 
professional  users  (potentially all  branches of  ~ndustry). 
5.  Classification of expenditure or  revenue 
5.1  Non-compulsory  expenditure. 
5.2  84-3040:  Differentiated appropriations. 
5.3  No  revenue  Is  expected. 
6.  Type  of expenditure 
Part  A of  the Budget 
The  Directive provides  for  the establishment of  a  network  for  exchanges of 
Information on  biocidal  products and.the active substances which  they 
contain.  This will  require  funds  for  services,  consultations and  purchases 
of  computer  hardware  In  order  to set  up  a  central  unit  for  the network· 
within  the Commission. 
Part  B of  the Budget 
Technical  advice will  be  needed on  scientific and/or  specific  technical 
questions.  This  will  be  financed  by  means  of  study  contracts  and  In  the 
form  of  financial  contributions. Expenditure on  thl's specific operation  (biocidal  products)  comes  under  the 
general  heading of expenditure  In  connection with  environment  legislation 
(Article 84-304 of  the  preliminary draft  budget  for  1993).  More 
specifically,  It  comes  under  the  heading  "Products,  Industrial  Installations 
and  biotechnology",  which  has  been  allocated a  total  of  ECU  1.620 million  In 
the preliminary draft  budget  for  1993  (Article 84-304,  point 7.2). 
7.  Financial  Impact  on appropriations for operations {part  B of  the Budget) 
The  studies,  consultations with experts and  various  financial  contributions 
will  cost  an estimated  ECU  300  000  per  year  from  1993  on. 
This expenditure will  take  the  form  of  contracts of  limited duration with 
third parties.  These  services will  be  provided extra muros.  These 
·contracts could serve such  obJectives as development  of  cr~terla for 
evaluating  the risks posed  by  biocidal  products,  feasibility studies on  a 
step-by-step approach  to  the data  to be  suppl·led  by  applicants or,  finallY. 
evaluation of  the  Impact  of selected active substances on  man  and  the 
environment.  Financial  contributions  to conferences  and  International. 
workshops  organized  by,  for  example,  the OECD  or  NGOs  are also envisaged. 
The  total  expenditure· Is expected  to break  down  as  follows:  financial 
contributions:  80%  or  approximately  ECU  240  000;  studies and  consultations: 
10%,  I.e.  approximately  ECU  30  000,  each. 1.  Human  resources. 
(a)  In-house staff 
-~-
SECTION  2:  ADMINISTRATIVE  EXPENDITURE 
(Part  A of  the  Budget) 
The  operation wl  I I  require extra  In-house staff  to administer  the Directive. 
Category A,  Band C staff will  be  needed  for  the decision-making  procedures 
to  Implement  the  Directive  {review of  existing active substances, 
examination of  applications for  Inclusion of  new  active substances  In 
Annex  I, establishment of  the  common  principles for  the evaluation of 
dossiers,  administration,  etc.).  It will  be  possible  to cover  these 
requirements  by  Interdepartmental  redeployment  or  by  allocating vacant 
posts. 
In  1993  and.  1994  a  team  of one A grade  and  one  C grade  co~ld perform  the 
necessary  tasks. 
From  1995  on,  the  total  number  of  In-house staff  required wll I  be:  one  A 
grade,  two  B grades  and  one  C grade. 
The  estimated  annual  costs  Incurred will  be: 
1993  and  1994: 
1995  on: 
ECU  180  000/year · 
ECU  360 .000/year 
Method  of  calculation:  ECU  90  000  per  official  per  year. (b)  outside staff 
(I)  preparation and  scientific monitoring of  Implementation of  the 
Directive  <Item  A1520  and/or  Article A260l 
For  lack  of  vacant  posts,  the  support  of outside scientific experts wll I  be 
required  for  the  preparatory  work  for  Implementation of  the  Directive and 
for  Implementation  Itself. 
In  1993  and  1994  an  estimated one  man-year  wl  I I  be  needed. 
From  1995  on  an  estimated  two  man-years  will  be  needed. 
The  appropriations  needed  for  these outside staff have  been  reQuested  In  the 
pre! lmlnary  draft  budget  for  1993.  However,  these  functions  could  be 
performed  by  officials appointed  to posts authorized under  the  procedure  for 
converting appropriations  Into posts.  In  this case,  the  funds  needed  to  pay 
the salaries  woul~ be  taken  from  these  budget  headings. 
The  estimated  annual  costs.lncurred wl  II' be: 
1993  and  1994: 
1995  on: 
ECU  40  000/year 
·ECU  80  000/year 
Method  of  calculation:  ECU  40  000  per  expert  per  year. (II)  Establishment  of  an  Information exchange  network  Cltem  A1178l 
To  ensure correct  Implementation of  the Directive,  the assistance of 
service-providers and  consultants wll I  be  needed  to set  up  the  Information 
exchange  network  and  the central  unit  within the Commission.  Based on 
experience with  the establishment of  a  similar  network  on  dangerous 
chemicals,  to  Implement  Directive 67/548/EEC,  the  total  expenditure  Is 
estimated at  ECU  350  000 or  four  mao-years. 
From  1996 on,  provision must  also be  made  for  the costs of  adapting  the 
system  to any  changes  and  for  maintenance. 




1996 et  sea. 
ECU 
150  000 
100  000 
100  000 
30  000  <maintenance) 
The  ECU  150  000  earmarked  for  1993  have  been  entered  In  the preliminary 
draft  budget  for  1993  under  the  heading  "Flanking pol lcies". -_,,_ 
2.  Equipment  (Item A5010) 
Establishment  of  the  Information exchange  network  and,  In  particular, of  the 
central  unit  within  the Commission  will  entail  purchases of  equipment  and 
computer  hardware.  Based  on  experience with establishment of  a  similar 
network  for  chemicals,  the  total  cost  Is estimated at  ECU  500  000. 
From  1996 on,  provision must  also be  made  for  the cost of  maintenance of  the 
equipment  acquired  (10%  of  the  Initial  cost). 




1996  et sea. 
3.  Meetings  (Item A2510) 
ECU 
50  000 
250  000 
200  000 
50  000  (maintenance> 
The  Directive provides  for  the establishment of  a  committee  to manage  the 
Directive and,  In  particular,  to adapt  It  to  technical  and  scientific 
progress.  The  meetings of  this committee  and  of  Its working  parties will 
cost  an  estimated  ECU  77  000  pe(  year  from  1994  on. 
/ Method  of  calculation: 
2  plenary meetings  (24 experts): 
482  X  24  X  2  c  ECU  23  000/year 
6  meetings of  wor~ing parties  (12 experts): 
482.  X  12  X  6  ..  ECU  35  000/year 
- 4  restricted meetings  (5  Member  States): 
482  X  10  X  4  =  ECU  19  000/year 

































MEETINGS  TOTAL 
(Part  A) 
A2510 
420 
77  647 
77  817 
77  597 - 93-
SECTION  3:  ELEMENTS  OF  COST-EFFECTIVENESS  ANALYSIS 
1.  ObJectives and  coherence with  financial  programming 
This Directive  forms  part of  the  programme  to complete  the  Internal  market 
and  Is  designed  to supplement  the Convnunlty's  poll.cy  to control  chemicals  In. 
general  and  pesticides  (biocidal  products)  In  particular.  It  Is  Included  In 
the  Fifth Action  Programme  on  the  Environment,  as-adopted  by  the.Commlsslon 
In  Mar.ch  1992  (Doc ..  COM(92)23  final). 
The  operation  Is  provided  for  In  DG  Xl's  financial ·programming  and  comes 
under  the  heading  "Products,  Industrial  Installations and  biotechnology" 
(ECU  1.620 ml  II ion  In  the  preliminary draft  budget  for  1993). 
2.  Grounds  for  the operation 
The  diverging national  authorization systems  for  biocidal .products  cause  an 
enormous  waste of  human  and  financial  resources;  at  the  expense of  the 
Member  States and  manufacturers,  due  to.repetltlon of. the  tests,  procedures 
and  evaluations of  the  active substances used  In  the blocldes. ·  The 
Community  procedure  for'ev~luatlon of ·the active substances will  enable  the 
Industry  to obtain approval  (In practice,  Inclusion  In  Annex  1. to  the 
·Directive)  for  each  active substance  In  a  single Community-wide  evaluation 
procedure. At  the  same  time,  the national  authorizations  for  products on  the market 
will  be  based on criteria defined at  Community  level  and  the  requirements 
concerning  the dossier  to  be  submitted will  also be  harmonized.  In 
addition,  virtually automatic mutual  recognition of  the  authorlzatlo~s  Is 
proposed.  The  Directive will.  therefore,  allow  free movement  of  biocidal 
products and  of  the active substances which  they contain,  with  the obJective 
of  completing  the  Internal  •r.~arket.  These  measures will  also cut  the 
financial  and  staff costs for  the  Industry and  the national  authorities. 
At  the  same  time  the operation will  ensure a  high  level  of  protection  for 
man  and  the environment  by  applying strict, harmonized .evaluation criteria. 
The  proposal  wl  II  provide  a  means  of  keeping  dangerous products off  the 
market  and  will  encourage  the placing of  cleaner.  healthl~r products on  the 
market.  In  this context,  although  It  Is  hard  to quantffy  the  benefits of 
this operation,  they  are sure to be  considerable  (lower  health care costs, 
less pollution,  etc.). 
Burden-sharing 
The  Member  States wil I  be  responsible  for  most  of  the  work  generated by  this 
Directive.  The  Commission's  role will  be  limited to  the coordination 
necessary,  to settling disputes and  to  laying down  common  guldellnes·for 
granting authorizations  for  products,  which  wl.ll  continue  to be  done  at 
nat I  on a I  I  eve I . 
All  In  a II,  the  resources  to be .. mob Ill zed  at  CommunIty  I  eve I  by  the 
Member  States and  the parties concerned  should  reflect  this share of 
responsibll ltles. 3. Monitoring and  evaluation of  the operation 
The  Directive  requires  each  Member  State  to report  every  three years on  the 
measures  taken  to  Implement  the Directive.  The  Commission  will  compile  a 
summary  of  these national  reports. 
.·~ .. IMPACT  ASSESSMENT  FORM 
THE  IMPACT  OF  THE  PROPOSAL  ON  BUSINESS 
with special  reference  to  small  and  med.lum  sized 
enterprises  (SUEs) 
Title of proposal 
Proposal  for  a  Council  Directive  concerning  the  placing  of  biocidal 
products on  the market. 
Reference  Number  (Repertoire)  392.1T I  (1991) 
The  DCOQOSal 
1.  Why  Is COmmunity  legislation necessary  In  this area  ? 
During  discussions  In  Council  of  Directive  91/414/EEC  concerning  the 
placing  of  plant  protection  products  on  the  market  and  following  the 
adopt I on  of  the  8th  Amendm~nt  to  DirectIve  76/769/EEC  concernIng  the 
restriction  on  the  marketing  and  use  of  certain  dangerous  substances 
and  preparations,  the  Council  reQuested  that  a  Community  strategy  on 
the marketing  and use of biocidal  products  be  developed. 
Accordingly.  the  Conlnlsslon  services  have  assessed  the  possibilities 
for  Introducing  regulatory  measures  at  community  level  for  biocidal 
products. This  assessment  has  shown  that  biocidal  products  currently  haye  a 
widely  different  regulatory  status  in  the  Member  States.  This  ranges 
from  very  comprehensive  in  a  few  Member  States  to  little  or  no 
legislation  in  others.  such  disparities  In  regulation  can  lead  to 
barriers  to  trade  between  Member  States  and  may  create  unequal 
conditions of  competition,  thereby directly affecting the establishment 
and  functioning  of  the  EEC  Internal  market  for  chemicals. 
The·  assessment  a I  so  showed  that  b Joe Ida I  products  themse I  ves  are  an 
extremely  var·ied  group  of  chemicals  in  terms  of  their  nature  and  their 
current  uses.  Such  products  have  widely  varying  exposure  scenarios  and 
can  present  potential  hazards  for  the  environment,  risks  at  the 
workplace  and  possible  hazards  for  the  consumer.  Given  that  existing 
Community  legislation  and  Initiatives  Involving  biocidal  products  have 
up  to  now  been  aimed  at  quite  specific  problems  Involving  Individual 
active  substances,  there  is  now  an  urgent  need  to effectively  regulate 
this wide  range  of  chemicals  to  provide  a  high  level  of  protection  for 
man  and  the  environment  throughout  the communities. 
There  are  several  thousand  biocidal  product  formulations  and  several 
hundred  actIve  substances  whIch  are  used  . In  them  cur rent 1  y  on  the 
Community  market.  This  group  of  chemicals  therefore  represents  a 
significant  sector  of  the  EEC  chemicals  market  (some  400  MECU)  and  as 
such  should  urgently be  given attention with  regard  to regulation. 
The  main  aims  of  the current  proposal  are  therefore 
harmonisation  of  the  internal  market  for  biocidal  products  and 
their  active substances; 
to  provIde  a  hIgh  I  eve I  of  protect ion  for  hea It  h,  safety,  the 
environment  and  consumers. The  lmoact  on Business 
2.  Who  will  be  affected by  the proposal  1 
The  0 I rect 1  ve  w  I 1  I  be  app I I  cab I  e  to  any  named  person  on  bus I  ness 
Including  manufacturers  and  Importers  with  a  permanent  office  within 
the  Community  and  who  wishes  to  place  on  the  EEC  market  a  biocidal 
product.  It will  also affect  those  who  provide  active substances  to  be 
used  In  a  biocidal  product.  It  Is  expected  that  manufacturers  and 
importers  of  such  chemica Is  w  iII  be  both  from  I  arge  mu It inat iona I 
businesses and  also from  SUEs. 
Given  the enormous  diversity of  the chemicals  involved  and  their  uneven 
regulatory  status  throughout  the  EEC,  It  has  been  difficult  to 
accurately  assess  to  which  sectors of  business  this  Directive  will  be 
most  app II cable  to  and  the  geograph lc  areas  In  wh lch  they  wIll  be 
concentrated.  It  Is  clear  however,  that  generally  larger  businesses  of 
the  EEC  chemical  Industry  are  primarily  concerned  with  the  research, 
development  and  manufacture  of  actIve  substances  for  use  In  fInished 
products.  Conversely,  the  SUE  sector  of  the  chemical  industry  is 
particularly  concerned  with  the  formulation  of  preparations  using 
existing  active  substances  together  with  appropriate  co-formulants, 
stabilisers,  antl...oxidants  and  wetting agents etc. 
3.  What  will  business  have  to do  to comply  with  the  proposal  ? 
Under  the  terms  of  this  proposal  any  manufacturer  or  Importer  of  a  new 
biocidal  product  or  active substance  who  wishes  to place  this onto  the 
market  will  first  require  authorisation  to  do  this.  For  an  active 
substance,  authorisation  will  be  at  Community  level  whereas· for 
biocidal  products,  authorisation will  be  by  the  COmpetent  Authority of 
the  Member  State where  the preparation  Is  to be  marketed. In  anticipation of  any  risks  for  man  and  the  environment  that  marketing 
may  entail,  the  application  for  an  authorisation of  a  biocidal  product 
will  reQuire  an  applicant  to  submit  tecl:mlcal  dossiers.  However,  the 
Information  to  be  provided  In  the  dossiers  will  be  dependant  upon  the 
uses of  the  product  and  the  risks  It  Is  likely  to pose  for  man  and  the 
environment.  It  may  include  data  on  physico-chemical  properties, 
efficacy  data  for  preparations,  Information  reI at i ng  to  safety 
precautions  during use  and  information  on  the  necessary  action  in  case 
of  an  accident.  Where  appropriate  It  will  also  include  relevant 
toxicological  and  ecotoxlcological  data on  the active substance. 
Given  the  diversity  of  chemicals  being  considered  under  the  proposal. 
the  Commission  has  sought  to  develop  a  flexible  approach  as  to  which 
data  are  reQuired  for  each  product  type.  Therefore,  certain  pieces  of 
Information  which  are not necessary owing  to  the nature of  the chemical 
or  Its proposed or existing uses  need  not  be  supplied.  Such  flexibi 1 ity 
Is  particularly  necessary  for  existing  substances  and  products  which 
have  a  long  history of  safe use  as. biocldes. 
In  the  event  of  any  new  information  becoming  available  concerning 
either  an  authorised  active  substance  or  biocidal  product,  the  current 
proposal  also  lays  down  an  obligation  on  the  authorisation  holder  to 
make  such  Information  available  Immediately  to  the  Member  State  where 
the authorisation was  granted. 
Furthermore,  before  authorisation  can  be  granted  for  a  biocidal 
product,  the  Member  State  concerned  will  also  check  that  .the  applicant 
has  a  permanent  office  In  the  Community  and  that  any  advertisement  for 
the  product  Is  accompanied  by  a  warning  notice. 
4.  What  economic  effects  Is  the proposal  likely to have? 
The  harmonisation  of  the  EEC  market  in  this  area"will  lead  to  clear 
advantages  for  the  chemical  Industry.  A  Community-wide  authorisation 
scheme  will  mean  that  an  authorisation  holder  will  essentially  be  free -180-
to  market  his  product  In  any  of  the  12  Member  States  and  depending  on 
the  products,  reach  a  potential  consumer  base  of  340  ml  Ilion. 
Additionally,  the authorised product  will  have  been  assessed  for  a  risk 
to  hea I th  and  the  envIronment.  In  the  EEC  thIs  wl  I I  mean  that  the 
authorization  holder  could  potentially  enjoy  a  competitive  advantage 
when  exportIng  hIs  product  outside  of  the  Community  to  countries  in 
which  simi Jar  levels  of  protection  are  afforded  for  man  and  the 
envIronment  and  to  those  NON-EC  count r I  es  which  demand  evIdence  of 
registration  in  the  supplying state (e.g.  Middle  Eastern countries). 
CUrrently,  the  basic  data  set  reQuired  for  a  new  substance  under 
Directive  67/548/EEC  costs  approximately  150,000  ECU.  The 
implementation of  this Directive may,  for  some  industries,  also  lead  to 
additional  costs  compared  to  the  current  situation  in  the  EEC.  These 
additional  costs will  be  most  apparent  to  the  industry  in  those  Member 
States  which  presently  have  less  stringent  regulatory  provisions  than 
are  proposed  here  and  to  those  whose  regulatory  regimes  do  not  embrace 
all  the  proposed  biocidal  products.  Levels  of  cost  recovery  for 
registration work  undertaken  by  competent  Authorities will  be  a  matter 
for  Member  States.  In  some  Member  States  it  is  expected  that  a  more 
thorough  assessment  will  need  to  be  undertaken  of  chemicals  currently 
marketed  than  is presently  reQuired.  It  may  be  speculated  that  for  such 
Industries  the  incentive  to market  new  products may  be  slightly reduced 
as  a  result  of  the  additional  cost  Involved  in  supplying  Information 
for  the authorisation of  their  products.  However  the existence of  clear 
rules  for  authorisation  in  all  member  states  together  with  provision 
for  mutual  authorisation  of  products  offers  clear  benefits  to  these 
marketing biocidal  products  in  the Community. 
In  order  to allow  the chemical  industry  to adjust  to  the  new  regulatory 
provisions,  a  ten  year  transitional  period  is  provided  for  in  the 
proposed  Directive.  In  this  period  biocidal  products  and  active 
substances  already  being  marketed  before  the  Directive  is  implemented 
will  be  permitted  to  continue  to  be  marketed  with  the  provision  that 
the  Commission  will  lnlt late  a  programme  for  the  gradual  review  of 
these chemicals. ..:._let-
5.  Does  fhe  proposa I  contaIn  measures  to  take  account  of  the  spec! f I  c 
situation of  SMEs?  · 
In  order  to  avoid  suffocating  the  development  of  new.products  by  an 
overly  bureaucrat lc  procedure.  the  proposa 1.  foresees  that  new  products 
may  be  afforded. provls·lonal  national  authorizations  for  a  .limited 
period.  Such  national  procedures can be  more :flexible and  allow product 
and  market  development  at a  national  level  before going Community  wide. 
This option should  be  a  distinct advantage ·to SUE's. 
6.  CQNSUL TA Tl ONS 
Industry Consultations 
International  Group  of  National 
Associations of Manufacturers of 
Agrochemlcal  Products  (GIFAP) 
European  Confederation of Woodwork-
Ing  Industries  (CEI-Bols) 
Confederation of  European  Pest 
Control  Associations  (CEPA) 
European  Chemical  Industry  Council 
(CEFIC)  ·· 
Other organisations 
European  Environmental  Bureau  (EEB) 
Worldwide  Fund  for  Nature  (WWF) 
EEC  Union  of Water  Suppliers  (EUREAU) 
I, .. 
Consultations  with  the  above  listed  groups  Indicated  a  generally 
favourable  response  to  the  proposed  Directive.  particularly  with 
respect  to  the  harmonization  of  the  EEC  market  for  biocidal  products. 
This was  seen as advantageous both  for  Industry  and  to groups which  are 
primarily concerned with  the protection of man  and  the environment. -l'bL-
Nevertheless,  In  a  series of  discussions with  Industry  which  have  taken 
place over  the  last  18  months,  concern  has  been  expressed  about  certain 
aspects  of  the  proposal.  These  have  principally  been  concerned  with 
exactly which  products will  fall  within  the scope of  the directive.  the 
need·to ensure a  common  approach  by  Competent  Authorities  to. evaluation 
of  data,  the  Issue  of  confidentiality,  and  the  extent  to  which  data 
provided  by  applicants will  be  subject  to data protection. 
The  revised  text of  the COmmission  proposal  addresses all  these points. 
In  order  to  Indicate  which  products  are  within  the  scope  of  the 
proposal,  a  series  of  Indicative  "product  types"  has  been  drawn  up, 
broadly  along  the  lines  already  followed  by  Industry._  So  far  as  a 
commOn  approach  to  evaluation  of  data  is  concerned,  the  proposal 
Included  a  commitment  for  the  Commission  to  develop  "Common  Principles 
for  the  Evaluation  of  Dossiers".  It  Is  anticipated  that  studies 
currently  being undertaken  In  this field will  be  useful  in  helping  the 
Commission  develop  these  "COmmon  Principles".  With  regard  to  the  Issue 
of  confidentiality,  the  proposal  draws  heavily  on  the  approaches 
already  agreed  under  Directive 91/414/EEC  on  plant  protection products 
and  on  the  7th  Amendment  to  directive  67/548/EEC  concerning  the 
classification.  packaging  and  labelling  of  dangerous  substances. 
Finally,  on  the matter of data  protection.  the COmmission  has  responded 
to  Industry's  concern  that  a  realistic period  of  data  protection must 
be  provided,  not  only  in  respect  of  data  on  new  active  substances  but 
also  for  new  data  generated  for  existing  active  substances.  In 
developing  the  proposal  the  Commission  has  been  conscious  of  the  need 
to  balance  the  Interests  of  those  who  generate  such  data  with  the 
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